Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42610,-0.122413634836979,0.00304838859426764,-0.128388476481744,-0.116438793192215,0
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42678,-0.101562359814641,0.00309666380212996,-0.107631820866816,-0.0954928987624666,4.71520977106701e-227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40482,-0.0825712880943133,0.00351469754298493,-0.0894600952785638,-0.0756824809100629,3.37971922520266e-119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42643,-0.106230487507328,0.0048940954666095,-0.115822914621883,-0.0966380603927736,1.03650541032192e-102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42617,-0.0592248914170193,0.00297131676857922,-0.0650486722834346,-0.0534011105506041,3.8786018053694e-87
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42769,-0.202722367494164,0.0115626858122798,-0.225385231686233,-0.180059503302096,4.54720746194821e-68
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42753,-0.0415547710453035,0.00246207490221441,-0.0463804378536437,-0.0367291042369632,2.88918825487303e-63
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40450,0.0850758240322165,0.00529964511143519,0.0746885196138035,0.0954631284506295,2.35065642533578e-57
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42678,-0.0577472636199116,0.00389706961432991,-0.0653855200639982,-0.0501090071758249,2.73052949688926e-49
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,42415,-0.0758428295234897,0.00515258945561632,-0.0859419048564977,-0.0657437541904817,1.17458574326062e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9,Complement component C9,40531,-0.073081903225113,0.00513485720983825,-0.083146223356396,-0.06301758309383,1.42048787386555e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,40531,-0.0325509681412307,0.00230770161691974,-0.0370740633103934,-0.028027872972068,8.41416704896777e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FST,Follistatin,42653,-0.0662850093017196,0.00475060756453857,-0.0755962001282152,-0.056973818475224,6.10557851237656e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42653,-0.0266757065473967,0.00192487215570913,-0.0304484559725866,-0.0229029571222068,2.24577911556388e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42793,-0.0330833200145012,0.00240436832856567,-0.0377958819384899,-0.0283707580905124,8.61870200653214e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42567,0.0554882053719758,0.00405415267253165,0.0475420661338138,0.0634343446101378,2.34974297826733e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42720,-0.0467669211553448,0.00348742395727012,-0.0536022721115942,-0.0399315701990954,9.59791562716122e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42658,-0.0680175101891415,0.0052088453892157,-0.0782268471520043,-0.0578081732262787,9.82331372108404e-39
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42720,-0.0735944436358802,0.00567358710683522,-0.0847146743652772,-0.0624742129064831,3.00471155027298e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,40510,0.0994507206673525,0.00801895610192658,0.0837335667075764,0.115167874627129,4.30981687919899e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,40283,-0.0363776296149827,0.00300456197344351,-0.042266571082932,-0.0304886881470334,1.56895309053195e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42675,-0.0490012767646906,0.00406004134119382,-0.0569589577934305,-0.0410435957359508,2.2838509348508e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFP,Properdin,40538,-0.0260765560383316,0.00216158258867762,-0.0303132579121398,-0.0218398541645235,2.62741444386772e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42793,-0.033972687043768,0.00283386443208553,-0.0395270613306556,-0.0284183127568803,6.01114003803281e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42619,-0.0371232953663762,0.00312112166878255,-0.04324069383719,-0.0310058968955624,1.84610568844939e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42653,-0.0511586450574802,0.00434330253232931,-0.0596715180208456,-0.0426457720941147,7.20206710624725e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40538,-0.0291695832068318,0.00248408380610598,-0.0340383874667995,-0.0243007789468641,1.17519370001587e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42586,-0.0463029297239839,0.0039881004596206,-0.0541196066248402,-0.0384862528231275,5.14437555984458e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42710,-0.0524517125263723,0.00452073136005086,-0.061312345992072,-0.0435910790606726,5.61217722538693e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42720,-0.0530006071268571,0.00457989237929111,-0.0619771961902677,-0.0440240180634466,7.93858900713358e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42653,-0.0359992747866998,0.00313554055802874,-0.0421449342804361,-0.0298536152929635,2.27493214999545e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42635,-0.029223256969906,0.00254695551156186,-0.0342152897725672,-0.0242312241672447,2.47273323703432e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,40282,-0.0492157242379012,0.00430832553488883,-0.0576600422862834,-0.0407714061895191,4.70362625896959e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42610,-0.0317822483089256,0.00278660689144841,-0.0372439978161645,-0.0263204988016867,5.40403376053575e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELL,L-selectin,40538,-0.0261087886934802,0.00231942727181388,-0.0306548661462355,-0.021562711240725,3.07124796636158e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42494,0.0642562962663766,0.00571253899528769,0.0530597198356127,0.0754528726971404,3.19926472384225e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42688,-0.0492055825106915,0.00437726571040737,-0.05778502330309,-0.0406261417182931,3.45055213190857e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,40381,-0.0458496928515287,0.00411488238603228,-0.053914862328152,-0.0377845233749054,1.10379509663242e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42637,-0.0388091325085618,0.00349131108192005,-0.0456521022291251,-0.0319661627879985,1.3982400289615e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,40282,-0.0584937008413975,0.00531143249270135,-0.0689041085270922,-0.0480832931557029,4.63356145731992e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,42415,-0.0447174616300913,0.00406311285310932,-0.0526811628221855,-0.036753760437997,4.74689506950585e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,40418,-0.0364152647258283,0.0033136521520839,-0.0429100229439128,-0.0299205065077439,5.96105366592698e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42635,-0.0365655767536415,0.00340493285714769,-0.043239245153651,-0.029891908353632,8.57449524440942e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42635,-0.0488079483453514,0.00456803138161192,-0.0577612898533108,-0.0398546068373921,1.53435982725467e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYY,Peptide YY,40115,0.106099817003511,0.00994999615236632,0.0865978245448734,0.125601809462149,2.03823156913219e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42710,-0.064712145105848,0.00607526269242352,-0.0766196599829981,-0.0528046302286979,2.17752232430487e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,42345,0.129751356025157,0.0122293890483227,0.105781753490444,0.153720958559869,3.42395919461688e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42610,-0.036478590314351,0.00345411775621056,-0.0432486611165237,-0.0297085195121783,5.71926227142623e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42635,-0.0415301801240583,0.00394725029653182,-0.0492667907052607,-0.033793569542856,8.68095286326319e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42586,0.0930077846446438,0.00884838814475813,0.0756649438809178,0.11035062540837,9.6548875519848e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42606,-0.0227342743503608,0.00216596610006979,-0.0269795679064976,-0.018488980794224,1.1315570200598e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42610,-0.03541638496209,0.00337542569165285,-0.0420322193177296,-0.0288005506064504,1.17650252378831e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40508,-0.0761442471013294,0.00725615875034769,-0.0903663182520109,-0.0619221759506479,1.21036184098639e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,42487,-0.0283255485238009,0.00270083269154078,-0.0336191805992208,-0.0230319164483809,1.23874574584166e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40531,-0.0274982338541279,0.00262213586243661,-0.0326376201445037,-0.0223588475637521,1.29880981006826e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42675,-0.0686107698584773,0.00655337379656692,-0.0814553824997485,-0.0557661572172061,1.49407732128682e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42635,0.0613846928467356,0.00586337964343832,0.0498924687455965,0.0728769169478747,1.50085682712486e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40501,-0.0154499590345809,0.00147759962719525,-0.0183460543038836,-0.0125538637652782,1.79474903650413e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42442,-0.0310303255420253,0.00297562599950455,-0.0368625525010542,-0.0251980985829964,2.31177387041973e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,40508,-0.0365926816989017,0.00351609765248471,-0.0434842330977717,-0.0297011303000317,2.98878200699673e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40282,-0.0437778412897021,0.00421710030615147,-0.052043357889759,-0.0355123246896452,3.94274641988688e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,40526,-0.0604487232232699,0.00584235148786726,-0.0718997321394897,-0.0489977143070501,5.59831301638535e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42615,0.099089383689703,0.00959349385963968,0.0802861357248092,0.117892631654597,6.47146897387763e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,40222,0.0586427006570115,0.00569253397090979,0.0474853340740283,0.0698000672399947,8.96565612551449e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42688,-0.0372001116664566,0.00363969516105439,-0.0443339141821232,-0.03006630915079,1.96686467697129e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39837,0.112419837384287,0.0109959099461143,0.0908678538899035,0.133971820878671,2.01197073095575e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42753,-0.0279347530402828,0.0027359153110246,-0.033297147049891,-0.0225723590306746,2.18291111804726e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42751,0.035414899190716,0.00346970244594302,0.0286142823966677,0.0422155159847643,2.26225832661169e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42569,-0.0305296945864757,0.00300380447842558,-0.0364171513641898,-0.0246422378087616,3.52573044634897e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42617,0.0556844978549051,0.00548848760587979,0.0449270621473807,0.0664419335624295,4.23055052635279e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42793,-0.0157017481831145,0.00154971744895936,-0.0187391943830748,-0.0126643019831541,4.84896267671599e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42651,-0.0350243212046678,0.00347044499133784,-0.04182639338769,-0.0282222490216457,7.27512862589196e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASN,Vasorin,42448,-0.0269103733780081,0.00267642419875263,-0.0321561648075632,-0.0216645819484529,1.06617201572776e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42678,0.0342307263849158,0.00340759932001315,0.02755183171769,0.0409096210521416,1.1657102564224e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42672,-0.031660824084735,0.00315591722503267,-0.037846421845799,-0.0254752263236709,1.33136921281918e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42678,-0.0305843167636656,0.00306018280294572,-0.0365822750574392,-0.024586358469892,1.94805742620795e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42710,-0.0287330227093117,0.00287813169266905,-0.0343741608269431,-0.0230918845916804,2.1751735856631e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,42508,-0.0512093388131212,0.00514079426089295,-0.0612852955644714,-0.041133382061771,2.71384851459463e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40526,0.0400412913595021,0.00401850314035471,0.0321650252044069,0.0479175575145974,2.72493235595566e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42688,-0.0429431038541368,0.00431352582986605,-0.0513976144806743,-0.0344885932275994,2.87174413482849e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42720,-0.0587832521704572,0.0059237039730291,-0.0703937119575942,-0.0471727923833201,3.95095033998315e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42586,-0.0227197987646314,0.00230929388721679,-0.0272460147835763,-0.0181935827456865,9.18623639313714e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,40282,-0.0298187704255709,0.00303635322937971,-0.0357700227551551,-0.0238675180959867,1.13580785025383e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42710,-0.0360754273277391,0.00369443353160468,-0.0433165170496843,-0.0288343376057939,1.89123631492857e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42610,-0.0278450643519944,0.00286497603086392,-0.0334604173724877,-0.0222297113315011,2.95927632449116e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42676,-0.0406963276179649,0.00420465362602345,-0.0489374487249708,-0.0324552065109589,4.37465523895897e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42635,-0.0381359010503514,0.00395650796283996,-0.0458906566575177,-0.0303811454431851,6.45603570329474e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),40323,-0.169841892541301,0.0176908591921034,-0.204515976557824,-0.135167808524779,9.65380911544215e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42586,-0.0275576476161914,0.00287168973981227,-0.0331861595062234,-0.0219291357261593,9.7324221466954e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,40478,-0.0445791862191979,0.00464595374766547,-0.0536852555646222,-0.0354731168737736,1.01294418232355e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42634,-0.0349846193734155,0.00366173981024294,-0.0421616294014917,-0.0278076093453393,1.45954208880372e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42601,-0.0527757907616424,0.00554356709810889,-0.0636411822739358,-0.0419103992493489,2.02021724482592e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42753,-0.0402737926732393,0.00423488653209063,-0.048574170276137,-0.0319734150703417,2.22273195862325e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42586,-0.0360227194295503,0.00381671103789432,-0.0435034730638232,-0.0285419657952775,4.41132277150185e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,40538,-0.0190330477115325,0.00202235046322823,-0.0229968546194599,-0.0150692408036052,5.83986065571662e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42770,-0.0565471326467988,0.0060127461884655,-0.0683321151761912,-0.0447621501174064,6.05110008304881e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,40282,-0.1048449163318,0.0111927896237318,-0.126782783994315,-0.0829070486692859,8.88823472393514e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40198,0.114350298658568,0.0122076604761479,0.090423284125318,0.138277313191818,8.90769654977241e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42710,0.125280981990008,0.0134249451387146,0.0989680895181269,0.151593874461888,1.1989845131647e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42678,0.0359202031346158,0.00385014154528024,0.0283739257058665,0.043466480563365,1.22639384666856e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40531,-0.0265568053197347,0.00284655390292805,-0.0321360509694736,-0.0209775596699957,1.26134027199346e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40282,-0.0252554789928638,0.00272052670443605,-0.0305877113335585,-0.0199232466521692,1.94833519605234e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42593,-0.0317174882943936,0.00343021882443235,-0.038440717190281,-0.0249942593985061,2.66570194444378e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42610,-0.048491387368547,0.0052511684959372,-0.0587836776205839,-0.0381990971165101,2.9819885966089e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42610,-0.0346116808494998,0.00375350730393148,-0.0419685551652055,-0.0272548065337941,3.37167719745808e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42678,-0.0337885654045297,0.00366451601185257,-0.0409710167877608,-0.0266061140212987,3.39083459266823e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40481,-0.0820935072515452,0.00890206057024399,-0.0995415459692234,-0.064645468533867,3.43743322812613e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42610,-0.0275139527290479,0.00299509678700598,-0.0333843424315797,-0.0216435630265162,4.65340486568896e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42639,-0.035736822356543,0.0038906822673554,-0.0433625596005595,-0.0281110851125264,4.69950272178411e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40448,-0.0782062905026596,0.00851271504389005,-0.0948912119886841,-0.0615213690166351,4.74607472922742e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42793,-0.0205898972485054,0.00224365874993184,-0.0249874683983718,-0.016192326098639,5.06614952290256e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42516,-0.0372344832869485,0.00405730234161663,-0.0451867958765171,-0.0292821706973799,5.06964129143511e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42494,-0.0308399748133697,0.00336954434907195,-0.0374442817375507,-0.0242356678891887,6.35997859379761e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42675,-0.0381892140889158,0.00419961070380672,-0.0464204510683769,-0.0299579771094546,1.09128958633018e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42662,-0.0266077318722508,0.00292918426526905,-0.0323489330321781,-0.0208665307123235,1.19420922996417e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42571,-0.0391535046927151,0.00432042258037293,-0.047621532950246,-0.0306854764351841,1.45088762520711e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42610,0.0382593879574245,0.0042303621436392,0.0299678781558917,0.0465508977589573,1.71529571889884e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42678,-0.0246442336637024,0.00273139703902175,-0.0299977718601851,-0.0192906954672198,2.08258713785809e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42586,-0.0260805195221037,0.00290368196498614,-0.0317717361734765,-0.0203893028707309,3.01321144282796e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40222,-0.0398326621764656,0.00443759187056826,-0.0485303422427794,-0.0311349821101518,3.25695768822778e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42710,-0.0260190054721628,0.00290101261312618,-0.0317049901938901,-0.0203330207504355,3.38286768895536e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRN,Agrin,42675,-0.0316191217673337,0.00352939716201326,-0.0385367402048797,-0.0247015033297878,3.70836380075856e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42710,-0.0399637253458926,0.00448014830555802,-0.0487448160247863,-0.0311826346669989,5.24662387253598e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42688,-0.0364508661930225,0.00410001849438456,-0.0444869024420162,-0.0284148299440287,6.85193694895311e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,42338,-0.0331151586642222,0.00373900951711926,-0.040443617317776,-0.0257867000106685,9.29099643618684e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42582,-0.0283474023626147,0.00320535643357837,-0.0346299009724283,-0.0220649037528011,1.0400453210349e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42688,-0.0371880198663645,0.00420854471966717,-0.0454367675169122,-0.0289392722158169,1.11028455089542e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42793,-0.0282829432222033,0.00320140284074119,-0.034557692790056,-0.0220081936543506,1.12686774949777e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42678,-0.0243149199609068,0.00275353456647731,-0.0297118477112023,-0.0189179922106113,1.16992008620714e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42710,-0.0308369144279695,0.00349655542694065,-0.0376901630647732,-0.0239836657911658,1.29211526526983e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,40531,-0.0433283106789386,0.00491279620342237,-0.0529573912376464,-0.0336992301202307,1.31771736637257e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42652,-0.0421082011035661,0.0047877692612041,-0.0514922288555261,-0.032724173351606,1.60320938124843e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40518,-0.0169633239366614,0.0019287308709663,-0.0207436364437553,-0.0131830114295674,1.63601920532263e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42593,-0.050365425091422,0.00573655400677477,-0.0616090709447006,-0.0391217792381435,1.83516586006226e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40222,-0.0779511615225411,0.0088872300088242,-0.0953701323398366,-0.0605321907052457,2.02832422807276e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42793,-0.0215492259157585,0.00245863291533338,-0.0263681464298119,-0.0167303054017051,2.09200307759156e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40282,-0.0321884985872726,0.00367646219242433,-0.0393943644844243,-0.0249826326901209,2.33071260632571e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,40510,-0.0297088333391934,0.00340169077243983,-0.0363761472531754,-0.0230415194252113,2.81431350339879e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42589,-0.0257171046160523,0.00294826923081699,-0.0314957123084536,-0.019938496923651,3.03154937080599e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42793,-0.0228267322860477,0.00261701210229668,-0.0279560760065492,-0.0176973885655462,3.03559661885739e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42591,-0.0474444123099304,0.00545206166261105,-0.0581304531686481,-0.0367583714512128,3.63451835736007e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42594,-0.0246437960183574,0.00283750917921355,-0.030205314009616,-0.0190822780270989,4.22128266480786e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42712,-0.0243320196077684,0.00281731461939781,-0.0298539562617881,-0.0188100829537487,6.43383325349963e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42345,-0.031795075147083,0.00368884358110427,-0.0390252085660474,-0.0245649417281186,7.50278528994142e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42494,-0.0306252597977255,0.00355576888496154,-0.0375945668122501,-0.0236559527832009,7.92295849170673e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42494,-0.0379717981565692,0.00441061996797028,-0.046616613293791,-0.0293269830193475,8.17877448440064e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42494,-0.0435601163267786,0.00506398696103747,-0.0534855307704121,-0.0336347018831452,8.70819174713898e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42593,0.0446434728858434,0.00522036924405622,0.0344115491674932,0.0548753966041935,1.3423286029131e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,42369,-0.0334670951133873,0.00391451201081266,-0.0411395386545801,-0.0257946515721944,1.37146139970589e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42688,-0.026896081156419,0.00314637926329098,-0.0330629845124693,-0.0207291778003686,1.38268206986641e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42593,-0.0292870613043153,0.00342988741684336,-0.0360096406413283,-0.0225644819673023,1.50138376398053e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.0339774816845698,0.00397890827555639,-0.0417761419046603,-0.0261788214644793,1.52547165277377e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42494,0.0432212542928389,0.00506540625166777,0.0332930580395701,0.0531494505461077,1.58413125008505e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42593,-0.0274269029349307,0.00321477086867185,-0.0337278538375275,-0.0211259520323339,1.59808086209182e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42637,-0.0197556039502182,0.00232990053154112,-0.0243222089920388,-0.0151889989083976,2.50285589632568e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42635,0.0309087961111658,0.00365234251125532,0.0237502047891053,0.0380673874332262,2.87992216165173e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40510,-0.02251065477472,0.00265969547937974,-0.0277236579143043,-0.0172976516351357,2.91088135976224e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42593,-0.0322925704794763,0.00382873638976549,-0.0397968938034166,-0.0247882471555359,3.67141270776125e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42675,-0.0345649200695661,0.00410754084231019,-0.042615700120494,-0.0265141400186381,4.32198460040693e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,42129,-0.0204327955098479,0.00243166558996439,-0.0251988600661781,-0.0156667309535177,4.81192219987532e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42635,0.0568262459564522,0.00677179924728932,0.0435535194317652,0.0700989724811393,5.27094246785728e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42675,-0.0227012302661724,0.00270666414179538,-0.0280062919840914,-0.0173961685482535,5.4712166774935e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42591,-0.0397869599370808,0.00477027681163512,-0.0491367024878857,-0.030437217386276,8.10849180955072e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42720,-0.0275600097617551,0.0033054174806492,-0.0340386280238275,-0.0210813914996826,8.2921896813312e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42653,-0.0251315790313247,0.00301609953812115,-0.0310431341260422,-0.0192200239366073,8.67793485342321e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42635,-0.0280492899989322,0.00337451756897506,-0.0346633444341233,-0.0214352355637411,1.02993441697191e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42710,-0.0644566319674153,0.00775534617185055,-0.0796571104642424,-0.0492561534705883,1.03667089918583e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42675,-0.0167449978917409,0.00201573665755416,-0.0206958417405471,-0.0127941540429348,1.07331549281194e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40448,-0.0822124999252557,0.00990097514890925,-0.101618411217118,-0.0628065886333935,1.12664253088567e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40448,-0.0244938043731671,0.00295478080854932,-0.0302851747579238,-0.0187024339884104,1.26577979212513e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42494,-0.028214303812527,0.00340552474770012,-0.0348891323180192,-0.0215394753070348,1.29486535262804e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42581,-0.027453041420748,0.00331517374009714,-0.0339507819513383,-0.0209553008901576,1.33626359781374e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42599,0.0833443912230163,0.0100671098315912,0.0636128559530975,0.103075926492935,1.36028229893366e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42565,-0.024337033708939,0.00294009878997181,-0.0300996273372838,-0.0185744400805943,1.37493263022834e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42720,-0.0262121907008254,0.00318294935302294,-0.0324507714327504,-0.0199736099689005,1.95610305934801e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42753,-0.0330228555358104,0.0040102560138137,-0.0408829573228853,-0.0251627537487356,1.96528727576175e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42658,-0.0241081367345459,0.00293791134598546,-0.0298664429726774,-0.0183498304964144,2.49570380991426e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42369,-0.0345158546628533,0.00421121574176703,-0.0427698375167167,-0.0262618718089899,2.7095209364355e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_E,,42593,-0.0244729165379452,0.00299543308384114,-0.0303439653822739,-0.0186018676936166,3.35646169948441e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42736,-0.0275742684143116,0.00337538260049787,-0.0341900183112874,-0.0209585185173358,3.37700480781128e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40222,-0.0203977807567305,0.00249789236962679,-0.025293649801199,-0.015501911712262,3.5351755981544e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42793,-0.0155743888445203,0.00191209782080624,-0.0193221005733005,-0.01182667711574,4.11508270689344e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42720,-0.0273122096954572,0.00335689090106352,-0.0338917158615417,-0.0207327035293727,4.43382231093624e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,40256,-0.0395216573925261,0.00486226989415209,-0.0490517063850642,-0.029991608399988,4.8199448403737e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40538,-0.0211448263835724,0.00260203745847074,-0.0262448198021751,-0.0160448329649698,4.88634497027723e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42586,-0.0349287366197778,0.00430843943254992,-0.0433732779075756,-0.0264841953319799,5.63407487447993e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42688,-0.0218620594115472,0.00269708605496435,-0.0271483480792774,-0.0165757707438171,5.68817083458052e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42476,-0.0546693601601502,0.00677328008251242,-0.0679449891218745,-0.0413937311984258,7.5484468418176e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42586,-0.019678429807498,0.00243872348078508,-0.0244583278298367,-0.0148985317851592,7.67833404209138e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,40448,0.0567907645028109,0.00703662269697664,0.0429989840167367,0.0705825449888851,7.69707338826218e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42688,-0.0390224529699523,0.00485237083937959,-0.0485330998151363,-0.0295118061247683,9.57588958717735e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42581,-0.0211609922376417,0.00263206809813556,-0.0263198457099874,-0.016002138765296,9.75890879649207e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42568,-0.0573995620330042,0.00714290321033361,-0.0713996523252581,-0.0433994717407503,1.00651380186168e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,40482,-0.0239394446169385,0.00298067977479534,-0.0297815769755374,-0.0180973122583396,1.05812068399461e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNC,Tenascin,42688,-0.0377654427629534,0.00470342546082601,-0.0469841566661723,-0.0285467288597344,1.06060392472874e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42612,-0.0303388449943726,0.00378740503661948,-0.0377621588661468,-0.0229155311225984,1.23657828297038e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42635,-0.045581123680307,0.00572738098699482,-0.0568067904148168,-0.0343554569457971,1.88085273881731e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,40510,0.0693950301107881,0.0087237157883125,0.0522965471656956,0.0864935130558806,1.96564978657631e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40526,-0.0216388053412301,0.00272249208767238,-0.0269748898330679,-0.0163027208493922,2.07226921942651e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42610,-0.0284062009683886,0.00357542108524338,-0.0354140262954657,-0.0213983756413116,2.09842153232121e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42494,-0.0262222278052495,0.00330359608488463,-0.0326972761316234,-0.0197471794788757,2.22784214787292e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42720,-0.0561601548904214,0.00710709226901151,-0.0700900557376839,-0.0422302540431588,2.95611678210494e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42610,-0.0205020857502047,0.00259714173076982,-0.0255924835425135,-0.0154116879578958,3.15026986048025e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42705,-0.0276622245668123,0.00350683742675307,-0.0345356259232483,-0.0207888232103762,3.30333504373141e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42610,-0.0293541234968791,0.00372823814016803,-0.0366614702516085,-0.0220467767421498,3.71350344365443e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,40526,-0.0195747282870845,0.00248662615798691,-0.0244485155567389,-0.0147009410174302,3.8077649646458e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,40378,-0.0832487235385032,0.0106065443802952,-0.104037550523882,-0.0624598965531246,4.58303616664224e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42720,-0.0227024629953228,0.00289517967708566,-0.0283770151624107,-0.017027910828235,4.78511107459155e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42562,-0.0291187623215213,0.00371409667476813,-0.0363983918040668,-0.0218391328389757,4.84276016642884e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42753,-0.0365609588966115,0.00466601361202798,-0.0457063455761863,-0.0274155722170366,5.01260281352313e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42682,-0.0280958983945001,0.00358579124134398,-0.0351240492275343,-0.0210677475614659,5.02428238469191e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40482,-0.0238807769235816,0.00305032988801559,-0.0298594235040922,-0.0179021303430711,5.36066563746419e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42637,-0.0224476664678495,0.00287624553824549,-0.0280851077228107,-0.0168102252128884,6.41341281359326e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41947,-0.0332808546788285,0.00426856819019455,-0.0416472483316098,-0.0249144610260472,6.84531236682617e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFD,Complement factor D,40538,-0.0159244155806108,0.00204414529480591,-0.0199309403584304,-0.0119178908027912,7.26991179637879e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40482,-0.0568326865310681,0.00730098979841427,-0.0711426265359601,-0.0425227465261761,7.62528201675589e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42793,-0.02074609338144,0.00266834756143219,-0.0259760546018471,-0.0155161321610329,8.0925459581723e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,42325,-0.0368527807126271,0.0047574288955798,-0.0461773413479635,-0.0275282200772907,1.01478624923171e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40448,-0.0422198679591413,0.00546687389336252,-0.0529349407901318,-0.0315047951281507,1.23396312059164e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,40538,0.0207001737513495,0.00268972229274221,0.0154283180575748,0.0259720294451243,1.51996549398513e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,42140,-0.024190613841508,0.00314424267411446,-0.0303533294827723,-0.0180278982002436,1.53354833955384e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42710,-0.0213340395912105,0.00277315623083565,-0.0267694258036484,-0.0158986533787727,1.53583705984817e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40510,-0.0259791445104077,0.00339340768834811,-0.03263022357957,-0.0193280654412454,2.07788372642789e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,42369,-0.0220496855958786,0.00289268821248709,-0.0277193544923533,-0.0163800166994039,2.6567879484652e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42617,-0.0254455492075249,0.00333937546275401,-0.0319907251145228,-0.018900373300527,2.7095344206551e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42648,-0.0158853967543014,0.00208666762277287,-0.0199752652949362,-0.0117955282136666,2.86038449175336e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40428,-0.0638310597651852,0.00839410779907067,-0.0802835110513637,-0.0473786084790067,3.09358957881513e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42753,-0.0202371147995158,0.00266390714826835,-0.0254583728101217,-0.0150158567889098,3.2344390607665e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40115,0.0411845161828085,0.00543943108212638,0.0305232312618408,0.0518458011037762,3.98772586390096e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42680,-0.0200801139026045,0.00265336687664393,-0.0252807129808266,-0.0148795148243824,4.04216879980429e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42356,0.0394240486668978,0.00521902519491792,0.0291947592848586,0.0496533380489369,4.50212916660459e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,42356,-0.0363050960153486,0.00481418583993708,-0.0457409002616253,-0.0268692917690719,4.95860376877993e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREH,Trehalase,40526,0.0543677641174307,0.0072091033354944,0.0402379215798617,0.0684976066549998,4.9991913355082e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42456,-0.0323653212684707,0.00430183008694979,-0.0407969082388923,-0.0239337342980491,5.67087240926633e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40482,-0.0275773828713737,0.0036724406411264,-0.0347753665279815,-0.020379399214766,6.39345424852603e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42523,-0.0316370619581332,0.00421650920224827,-0.0399014199945398,-0.0233727039217266,6.62500548398667e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42720,-0.0446982419920753,0.00595814674589306,-0.0563762096140257,-0.0330202743701249,6.67481942245942e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40448,-0.0757781369999284,0.0101443254425432,-0.095661014867313,-0.0558952591325438,8.61280421436247e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40448,-0.0686317531762631,0.00920881957725485,-0.0866810395476826,-0.0505824668048436,9.80582000066622e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42586,-0.0242736762071075,0.00325994602015634,-0.0306631704066139,-0.0178841820076011,1.020603224335e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40115,-0.0410093658184266,0.00550766569869542,-0.0518043905878696,-0.0302143410489835,1.03562987843397e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42675,-0.015863880635997,0.00213161922059414,-0.0200418543083616,-0.0116859069636325,1.05036536141153e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFM,Afamin,40538,0.0144070253003803,0.00193940094978527,0.0106057994388012,0.0182082511619594,1.17632940165335e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42586,-0.0254862670951123,0.00343388028287633,-0.0322166724495499,-0.0187558617406747,1.22316404811089e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42669,0.0475612273362292,0.00642360650735528,0.0349709585818129,0.0601514960906455,1.39841637214701e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42572,0.0449218649232296,0.00607775844949786,0.0330094583622138,0.0568342714842454,1.54155340534927e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40222,-0.0548699800387887,0.00743554146729053,-0.0694436413146782,-0.0402963187628993,1.70414427349083e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2,Brorin,42455,-0.0295436100181784,0.00400690988279496,-0.0373971533884565,-0.0216900666479002,1.76501441235024e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40526,-0.0265151091994204,0.00359667956334174,-0.0335646011435702,-0.0194656172552706,1.79648437125634e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42612,0.0340362494900924,0.00462798874687087,0.0249653915462255,0.0431071074339593,2.02849807043641e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,40526,-0.0377763078023488,0.00513779273660313,-0.0478463815660909,-0.0277062340386067,2.07729643297757e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42745,-0.0289100205211617,0.003933629683131,-0.0366199347000985,-0.0212001063422249,2.1041265796746e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,42369,0.0570217870672583,0.00776089704268266,0.0418104288636003,0.0722331452709163,2.14120616400183e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42678,-0.0179854203970539,0.00245235747454119,-0.0227920410471547,-0.0131787997469532,2.36245927170494e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPN,Asporin,40510,-0.0200673136162332,0.00273703678023291,-0.0254319057054897,-0.0147027215269767,2.42633047774245e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42678,-0.0316153153657962,0.00431335175380123,-0.0400694848032466,-0.0231611459283458,2.43903348129555e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42678,-0.0234930944245248,0.00320726909277031,-0.0297793418463546,-0.017206847002695,2.52546650559895e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42678,-0.019641142741091,0.00268253170775873,-0.0248989048882981,-0.0143833805938839,2.58398536186364e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42637,-0.0247998119933656,0.00339022969168269,-0.0314446621890636,-0.0181549617976675,2.71787200826526e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42586,-0.0202315812221574,0.00276851610899628,-0.0256578727957901,-0.0148052896485247,2.87065072527271e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42586,-0.0197734103784561,0.00271028487424973,-0.0250855687319856,-0.0144612520249267,3.13832767882709e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42447,-0.0154792218954195,0.00212630396887786,-0.0196467776744201,-0.0113116661164189,3.52964155089936e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSN,Gelsolin,40487,-0.0137553918413777,0.00189469474725494,-0.0174689935459974,-0.010041790136758,4.12664147039093e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40526,-0.0149764330398133,0.00206546298744627,-0.019024740495208,-0.0109281255844186,4.41023530978078e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42565,-0.0273047114603531,0.00376640360779105,-0.0346868625316236,-0.0199225603890827,4.41136242820988e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42680,-0.0371289775241547,0.0051259648195638,-0.0471758685704997,-0.0270820864778096,4.61597937874525e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42617,-0.0196960677750061,0.00272273849471003,-0.0250326352246377,-0.0143595003253744,4.94696027686759e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42586,-0.0271188091383882,0.0037575218872042,-0.0344835520373084,-0.0197540662394679,5.5923827840212e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42650,-0.0421471827665865,0.00584696320772056,-0.0536072306537188,-0.0306871348794542,5.96365805077992e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42369,-0.0270306693485313,0.00375320339546355,-0.0343869480036399,-0.0196743906934227,6.25448908140078e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,40538,-0.0219983323958152,0.00306081618300722,-0.0279975321145094,-0.0159991326771211,7.03459784789295e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42586,0.0972425042893199,0.0135337706762521,0.0707163137638658,0.123768694814774,7.06712438462345e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42704,-0.0141294189031857,0.00196809900893776,-0.0179868929607037,-0.0102719448456677,7.37719487244363e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,40448,-0.046152963854007,0.00645761265556041,-0.0588098846589054,-0.0334960430491086,9.41393770436498e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40482,-0.0139663834632303,0.00195524638789384,-0.0177986663835022,-0.0101341005429583,9.69139910838506e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42586,-0.0475873146028059,0.00667057152158963,-0.0606616347851215,-0.0345129944204902,1.02563767678583e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40448,-0.0810854292402543,0.0113684873450631,-0.103367664436578,-0.0588031940439306,1.04630603926952e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42721,-0.0197073190998717,0.00276496861930726,-0.025126657593714,-0.0142879806060295,1.07386520141793e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42653,-0.0358049537369073,0.00502842404378798,-0.0456606648627318,-0.0259492426110829,1.12982738668431e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42753,-0.0177158032667042,0.00248813973735968,-0.0225925571519292,-0.0128390493814792,1.13278625587617e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,40526,-0.0226201820406569,0.00317771496245211,-0.028848503367063,-0.0163918607142507,1.15803807015903e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42654,0.0233142879363258,0.00327706404436234,0.0168912424093756,0.029737333463276,1.18098524517868e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPTC,Opticin,42586,-0.0321153392256898,0.00451477493995457,-0.0409642981080007,-0.0232663803433788,1.18981012126719e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42345,-0.0359693553483606,0.00506888912529663,-0.045904378033942,-0.0260343326627792,1.34900318457023e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42610,-0.0508947288868222,0.00719024064918076,-0.0649876005592164,-0.0368018572144279,1.53179660239105e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40282,-0.0169997195970155,0.00241385736820103,-0.0217308800386895,-0.0122685591553415,1.99921645226371e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,42345,-0.0378888929445989,0.00538433823411726,-0.0484421958834688,-0.0273355900057291,2.06345984973395e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42753,-0.0277413083057716,0.00394628686461561,-0.0354760305604182,-0.020006586051125,2.16839969793244e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42593,-0.0635644157842257,0.00906692859051368,-0.0813355958216325,-0.0457932357468188,2.48699386207878e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42680,-0.0204887100714067,0.00292610023363968,-0.0262238665293404,-0.0147535536134729,2.6417847718003e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42710,-0.0351756967483143,0.00503393357919235,-0.0450422065635313,-0.0253091869330973,2.92486132821755e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,40538,0.0245525897458889,0.00351885286743336,0.0176556381257195,0.0314495413660583,3.17348991856597e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,40526,-0.0188881934779209,0.00270751395974956,-0.0241949208390301,-0.0135814661168118,3.20141620218456e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42710,-0.0156372844898574,0.00224263120649951,-0.0200328416545965,-0.0112417273251184,3.25262537793313e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C3,Complement C3,39988,-0.0319862496684333,0.00458711218113056,-0.0409769895434492,-0.0229955097934174,3.28231322001818e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42720,-0.0233130041638922,0.00334794767724079,-0.0298749816112841,-0.0167510267165003,3.47558920185597e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42662,-0.0189407978535669,0.00272405172421156,-0.0242799392330215,-0.0136016564741122,3.73626922303328e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RETN,Resistin,42597,-0.0292538562672562,0.00421032468328228,-0.0375060926464895,-0.0210016198880229,3.87272964718603e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGN,Mimecan,42610,-0.0299817037837219,0.00431578270191658,-0.0384406378794784,-0.0215227696879654,3.90365177314665e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39955,-0.0154934459697623,0.00223327752785605,-0.0198706699243602,-0.0111162220151645,4.21919307496694e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42678,-0.0189648928471306,0.002736025659135,-0.0243275031390352,-0.013602282555226,4.35185479655822e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,40282,-0.0221225243288336,0.00319684106033191,-0.0283883328070842,-0.015856715850583,4.76152545223592e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42586,-0.0226179975619202,0.00327508230627683,-0.0290371588822227,-0.0161988362416176,5.20686550401453e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40448,-0.0759179888209028,0.0109947181876138,-0.0974676364686258,-0.0543683411731797,5.29252335362173e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42599,-0.0323613916354821,0.00468871534887325,-0.0415512737192736,-0.0231715095516905,5.35906350833638e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42494,-0.0268319458046951,0.00389364471643707,-0.0344634894489118,-0.0192004021604785,5.78091288747878e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42635,0.0229202879814133,0.00332881340076018,0.0163958137159233,0.0294447622469032,6.01748299163685e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42610,-0.0358704950934864,0.00521166840317781,-0.0460853651637149,-0.0256556250232579,6.13256271615296e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,42301,-0.0234247993044663,0.00340490952561572,-0.0300984219746731,-0.0167511766342595,6.26969551001774e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42239,-0.0270078144647478,0.00392584603613695,-0.0347024726955763,-0.0193131562339194,6.28083665696333e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42565,-0.0309912247609713,0.00450914887791364,-0.039829156561682,-0.0221532929602605,6.56679200797945e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42710,-0.0342159269881199,0.0049804566903761,-0.043977622101257,-0.0244542318749827,6.6993831133607e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42345,-0.0348612711995681,0.00507762491265614,-0.0448134160283741,-0.024909126370762,6.91531289785442e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42586,0.054246518661336,0.00790749005631667,0.0387478381509553,0.0697451991717166,7.18128802031101e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,40510,-0.0644172062992635,0.00939739498124785,-0.0828361004625093,-0.0459983121360177,7.51292309417938e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42659,-0.0352633901003725,0.00514710954080149,-0.0453517248003434,-0.0251750554004015,7.64656942200202e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40526,-0.0154924717195103,0.00226370690384891,-0.0199293372510541,-0.0110556061879664,8.1070050661868e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,40465,-0.0435524330655689,0.00637244925284782,-0.0560424336011506,-0.0310624325299872,8.65443622771886e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42710,-0.0202960855985901,0.00297827595839857,-0.0261335064770513,-0.014458664720129,9.84567083516664e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,40448,-0.0228358389517178,0.00335251537192403,-0.0294067690806889,-0.0162649088227467,1.01472786153403e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,40510,-0.0421754087511804,0.00619556244688397,-0.0543187111470729,-0.0300321063552878,1.04435164911408e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42586,-0.025075027764436,0.00368522485815905,-0.0322980684864278,-0.0178519870424443,1.05927651713619e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42593,-0.0286687306895913,0.004213568855762,-0.0369273256468848,-0.0204101357322978,1.0614451614847e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42617,-0.0161223635548795,0.00237023717792666,-0.0207680284236158,-0.0114766986861433,1.07543396631401e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42546,-0.0185916106128962,0.00273339533773824,-0.0239490654748632,-0.0132341557509293,1.07827775730957e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42610,-0.0436247561136585,0.00641968051187794,-0.0562073299169393,-0.0310421823103778,1.12516324556736e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42645,-0.036855489402336,0.00542650460708765,-0.0474914384322278,-0.0262195403724442,1.15431522913984e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42710,-0.0439992444058563,0.00649129202783983,-0.0567221767804223,-0.0312763120312902,1.2673309390045e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42474,-0.01761427491628,0.00259982155465024,-0.0227099251633944,-0.0125186246691655,1.29483052460896e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42610,-0.0179164670410787,0.00264475642736684,-0.0231001896387177,-0.0127327444434397,1.30190210498626e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42369,-0.0471324445395381,0.00695814579657148,-0.0607704103008182,-0.033494478778258,1.30852282485951e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42675,-0.0446352858320282,0.00659365923120948,-0.0575588579251987,-0.0317117137388576,1.34643353290891e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,42200,-0.0179842774519566,0.00265782666150373,-0.0231936177085039,-0.0127749371954093,1.37553019106206e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42558,-0.0142683447264305,0.00210878233801735,-0.0184015581089445,-0.0101351313439165,1.3776049409397e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40198,-0.0216571230919339,0.00320051565231949,-0.0279301337704801,-0.0153841124133877,1.38388961760178e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42793,-0.0270800696821997,0.0040070227290954,-0.0349338342312267,-0.0192263051331727,1.45455297123843e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42593,-0.0376580711265387,0.00558383311324862,-0.048602384028506,-0.0267137582245714,1.60264766720788e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40222,-0.0454131558469109,0.00674152801413251,-0.0586265507546107,-0.0321997609392112,1.70524601032664e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40222,-0.0345379548010741,0.0051295771468243,-0.0445919260088497,-0.0244839835932985,1.74339051787379e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42675,-0.0183464075859944,0.00272873404549818,-0.0236947263151708,-0.012998088856818,1.84662080048846e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40482,-0.0188042276496887,0.00279861742453876,-0.0242895178017846,-0.0133189374975927,1.91631596488097e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42770,-0.0308478990312848,0.00460025747733287,-0.0398644036868572,-0.0218313943757124,2.08385836401992e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42653,-0.0539382510295014,0.00804543532539934,-0.0697073042672841,-0.0381691977917187,2.10578451241858e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42675,-0.0185262706876545,0.00276471305032606,-0.0239451082662935,-0.0131074331090154,2.15258917122223e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42637,-0.0207305509117417,0.00309427160729355,-0.026795323262037,-0.0146657785614463,2.17228977596928e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42635,-0.019706100795728,0.00294277149565452,-0.0254739329272109,-0.0139382686642451,2.22040070449419e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42610,-0.015470201295854,0.00231147697426877,-0.0200006961654208,-0.0109397064262872,2.27672659454293e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42759,-0.0185358288137081,0.00277073323667567,-0.0239664659575924,-0.0131051916698238,2.3213736474674e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40510,-0.0394409118555652,0.00590838868327802,-0.0510213536747901,-0.0278604700363403,2.58071974237945e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42310,-0.0355377418316767,0.00532745576140474,-0.04597955512403,-0.0250959285393234,2.64839245596443e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42753,0.0188222801294874,0.00282431646189281,0.0132866198641775,0.0243579403947973,2.76079776307913e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42635,-0.0514352636527663,0.00772767135577089,-0.0665814995100772,-0.0362890277954554,2.9232460137184e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,42459,-0.0367712897710097,0.00553726112901778,-0.0476243215838846,-0.0259182579581349,3.24358057265912e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42675,-0.021381365733399,0.00322047220883012,-0.027693491262706,-0.015069240204092,3.27460105729396e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40222,-0.0558470427007836,0.00843160165437177,-0.0723729819433523,-0.039321103458215,3.67018221348898e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42593,-0.0262772602539023,0.00397023400768504,-0.034058918908965,-0.0184956015988396,3.76497015359763e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,40198,-0.0198370534203819,0.00299813620112157,-0.0257134003745802,-0.0139607064661836,3.84982253393316e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42612,-0.110435672861705,0.0166950911532351,-0.143158051522046,-0.0777132942013641,3.86004517790312e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42635,-0.0546315086755254,0.00826840973516548,-0.0708375917564498,-0.0384254255946011,4.06253653284818e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42710,-0.0303101515653301,0.00458886171255606,-0.03930432052194,-0.0213159826087202,4.11951772741877e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42667,-0.0195885796217295,0.00297095929782623,-0.0254116598454689,-0.0137654993979901,4.46030163590906e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42579,-0.0131252141945993,0.00199309118849329,-0.0170316729240462,-0.0092187554651525,4.70739496645232e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42564,-0.0167758448475025,0.00254813959062139,-0.0217701984451204,-0.0117814912498846,4.7644473823266e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,40282,-0.0366827437408246,0.00557678617811839,-0.0476132446499366,-0.0257522428317125,4.99095258027345e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,40266,-0.0194000341360859,0.00295304017669027,-0.0251879928823988,-0.013612075389773,5.27444103012393e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,42453,-0.0159308339323669,0.00242719151192648,-0.0206881292957428,-0.011173538568991,5.45199618228884e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,42475,-0.0214689453149415,0.00327200120688572,-0.0278820676804375,-0.0150558229494454,5.52777496325996e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40316,-0.00862348614353723,0.00131544460176833,-0.0112017575630032,-0.00604521472407131,5.78844485848278e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42585,-0.038691801317631,0.00590378126874648,-0.0502632126043741,-0.0271203900308879,5.81708633059753e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42564,-0.0275840160638972,0.004210914178114,-0.0358374078530007,-0.0193306242747938,5.94034150110111e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42635,-0.0172556943835897,0.00263770232326105,-0.0224255909371814,-0.012085797829998,6.29240408358937e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42637,-0.0217390114485133,0.00332651343872114,-0.0282589777884067,-0.0152190451086198,6.58702535952901e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42691,-0.0153803089000802,0.00235726257431333,-0.0200005435457343,-0.0107600742544261,7.05932600547762e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42586,-0.0534754059316533,0.00819773121134862,-0.0695429591058966,-0.03740785275741,7.12978651932887e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42494,-0.0344889804102412,0.00528948933954677,-0.0448563795157528,-0.0241215813047295,7.27083419423396e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42369,-0.0229812613800046,0.0035262393352456,-0.029892690477086,-0.0160698322829233,7.4231605073914e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42593,-0.0299857108089963,0.00461126627385087,-0.039023792705744,-0.0209476289122486,8.16854548965874e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POSTN,Periostin,40526,-0.0243688115862137,0.00374903912389446,-0.0317169282690468,-0.0170206949033806,8.36836157763904e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,40198,-0.0258260617859992,0.00397402177772015,-0.0336151444703307,-0.0180369791016677,8.45066895411513e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40503,-0.0312391540423432,0.00481087885639015,-0.0406684766008679,-0.0218098314838185,8.74134957176207e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,40198,-0.0165760137159752,0.00255300337141898,-0.0215799003239564,-0.011572127107994,8.79129708253173e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,40282,-0.0328422200582243,0.00507572494147377,-0.0427906409435129,-0.0228937991729357,1.01830712555606e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42610,-0.0156945962037521,0.00243303255610996,-0.0204633400137276,-0.0109258523937766,1.15206299508221e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40531,-0.0255208810926622,0.00396840047931391,-0.0332989460321175,-0.0177428161532069,1.31844099603213e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,40198,-0.0276331092976282,0.00430035095953979,-0.0360617971783262,-0.0192044214169302,1.36616250064375e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42619,-0.0580242882391944,0.00903843156973332,-0.0757396141158717,-0.0403089623625171,1.41108222942185e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40170,-0.0245455459026549,0.00382399544511661,-0.0320405769750835,-0.0170505148302264,1.42998017312351e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,42369,0.0282689046533168,0.00440880774723371,0.0196276414687388,0.0369101678378949,1.48604839762798e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40222,-0.0198841162301283,0.00310456718893773,-0.0259690679204462,-0.0137991645398103,1.56699391676e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42635,-0.021210919214005,0.00331333636071075,-0.0277050584809981,-0.0147167799470119,1.58781790349939e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,40448,-0.0708219198016441,0.0110733155508112,-0.0925256182812341,-0.0491182213220542,1.66117734914345e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,40282,-0.066635785556987,0.0104295477367437,-0.0870776991210045,-0.0461938719929694,1.73513493621162e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42369,-0.0241928551550659,0.00378877562709228,-0.0316188553841667,-0.016766854925965,1.7668505567937e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42753,-0.0305206642954669,0.00478010901798026,-0.0398896779707082,-0.0211516506202256,1.77063179366529e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42356,-0.0343655116118989,0.00538773865251796,-0.0449254793708341,-0.0238055438529637,1.84852911571258e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42586,-0.0456390824157214,0.00718078850464874,-0.059713427884833,-0.0315647369466099,2.14174827132111e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42596,-0.0253412824384296,0.00399524428471605,-0.033171961236473,-0.0175106036403861,2.32780218537917e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2,Complement C2,42662,-0.0141405902685886,0.0022305991285073,-0.0185125645604629,-0.00976861597671424,2.38066314862751e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42369,-0.0284521452380633,0.00448880198644373,-0.037250197131493,-0.0196540933446336,2.39618528157042e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42580,0.0385509073691044,0.0060877858562657,0.0266188470908236,0.0504829676473852,2.48926964928382e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42720,-0.0670107656227253,0.010586128820545,-0.0877595781109934,-0.0462619531344571,2.52812390384357e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42678,-0.0212790700658454,0.00336533426048719,-0.0278751252164003,-0.0146830149152905,2.64590277835562e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42579,-0.0178012079111484,0.0028173989528428,-0.0233233098587203,-0.0122791059635765,2.72809510911221e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42705,-0.0371315390119948,0.00587932054512393,-0.0486550072804377,-0.0256080707435519,2.77512712545641e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42356,0.0498922055682732,0.00790015519545561,0.0344079013851802,0.0653765097513662,2.78227451221863e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MME,Neprilysin,42586,0.049848239345563,0.00789441865497483,0.0343751787818124,0.0653212999093137,2.7983932383664e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40531,-0.0442840968646821,0.00701761983788531,-0.0580386317469373,-0.0305295619824269,2.88667538882618e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,42333,-0.0359658594221941,0.00572564757063622,-0.0471881286606411,-0.0247435901837471,3.4581686958239e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40366,-0.0208973185232294,0.00333062709307674,-0.0274253476256598,-0.0143692894207989,3.64232388962879e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,42369,-0.0209322695104547,0.00335741658660259,-0.0275128060201958,-0.0143517330007137,4.66654538895844e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42494,-0.0209066535612995,0.00335555609142255,-0.0274835435004877,-0.0143297636221113,4.79096826810061e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,40538,-0.0309359258223357,0.00497163143546168,-0.0406803234358406,-0.0211915282088309,5.06578860799145e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42586,-0.0142187320583708,0.00228670731071988,-0.0187006783873818,-0.00973678572935987,5.18512267356887e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42345,-0.0287436552800538,0.00462950049836735,-0.0378174762568538,-0.0196698343032538,5.49960825498948e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42710,-0.0172285776195504,0.00277499455008372,-0.0226675669377144,-0.0117895883013863,5.50547803534101e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,40374,-0.0595113413389981,0.00958458779496358,-0.0782971334171268,-0.0407255492608695,5.51912548559476e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40482,-0.0247953972245226,0.00399346577818961,-0.0326225901497743,-0.016968204299271,5.51988860698265e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42350,-0.0331712449974695,0.00535270739854435,-0.0436625514986164,-0.0226799384963226,5.92310315540199e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPS,Colipase,42589,-0.04396000068693,0.00709663104037144,-0.057869397526058,-0.030050603847802,6.01856582585565e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,40234,-0.0210209484464845,0.00339907667831497,-0.0276831387359819,-0.0143587581569872,6.45802547483078e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,40450,-0.0235930318148489,0.00381680752297832,-0.0310739745598864,-0.0161120890698114,6.57547208237609e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42635,-0.0149297738305474,0.00241701007119582,-0.0196671135700913,-0.0101924340910036,6.72321219912269e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42635,-0.0199034598077147,0.00322512127445562,-0.0262246975056477,-0.0135822221097817,6.96401673852035e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40448,-0.0531580332095478,0.00862310354615305,-0.0700593161600077,-0.0362567502590878,7.30790688884235e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,40482,-0.0553467476235816,0.00898537132600936,-0.07295807542256,-0.0377354198246033,7.53871083076351e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42586,-0.0489691084224001,0.00797804161096659,-0.0646060699798947,-0.0333321468649056,8.59332966908817e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42586,-0.0203009200693929,0.00331080547686509,-0.0267900988040484,-0.0138117413347373,8.93801299451734e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40208,-0.0331613537160131,0.00541465331127989,-0.0437740742061217,-0.0225486332259045,9.41472033625817e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42675,-0.0168264534643495,0.00275183806826663,-0.0222200560781521,-0.011432850850547,9.94584516282841e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40510,-0.0217618979771529,0.00355902857006313,-0.0287375939744766,-0.0147862019798291,1.00015996662796e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42753,-0.0211332719893054,0.00345761588710658,-0.0279101991280343,-0.0143563448505765,1.01028188400913e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40461,0.0506673258868551,0.00830079946861423,0.0343977589283712,0.066936892845339,1.06909941402501e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42793,-0.0172140070674923,0.00282062028651442,-0.0227424228290605,-0.011685591305924,1.06980846524572e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42494,-0.0153045581818299,0.00250988874347017,-0.0202239401190314,-0.0103851762446283,1.10582994240135e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42494,-0.0216712010150749,0.00355456864201125,-0.028638155553417,-0.0147042464767329,1.11265213390087e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42610,-0.0143526382872376,0.00235831198243492,-0.0189749297728101,-0.00973034680166518,1.18935791831042e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42594,-0.0192125234139171,0.00315697650816119,-0.0254001973699131,-0.0130248494579212,1.19120509866806e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42603,-0.054104149748318,0.00889617218614129,-0.0715406472331549,-0.0366676522634811,1.22121947509617e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42610,-0.0191244012019502,0.00314654983147084,-0.0252916388716331,-0.0129571635322674,1.250703377308e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42554,-0.019315953316543,0.00318428462958921,-0.0255571511905378,-0.0130747554425481,1.34655111604917e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40481,-0.0451927103676093,0.00745402368371663,-0.0598025967876939,-0.0305828239475247,1.37996292780509e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSG,Basigin,42745,-0.0128381154307537,0.00211808859489108,-0.0169895690767402,-0.00868666178476721,1.38713036797807e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,40481,0.0322949972018609,0.00534282841563306,0.0218230535072201,0.0427669408965017,1.54560054680515e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,42292,-0.0334940779907866,0.00554612435270285,-0.0443644817220842,-0.022623674259489,1.59087404569433e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42635,-0.0227405110458994,0.00376956627465263,-0.0301288609442185,-0.0153521611475802,1.655189265131e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42753,-0.0321572258164603,0.00534318938178103,-0.0426298770047511,-0.0216845746281694,1.80739793759315e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40282,-0.0175924761259176,0.00292383718250157,-0.0233231970036206,-0.0118617552482145,1.83389185092532e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42593,0.019414207674544,0.00323047443864856,0.0130824777747929,0.0257459375742952,1.90682032862866e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42586,-0.0449405471206575,0.00749591968015183,-0.0596325496937551,-0.0302485445475599,2.08290820110238e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REN,Renin,42635,0.0499233304781294,0.00834147945720316,0.0335740307420112,0.0662726302142476,2.21967647394479e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,40538,-0.0177368094676554,0.00296335792979962,-0.0235449910100627,-0.0119286279252482,2.22418035375617e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,40481,-0.0442758184389997,0.00741115856979539,-0.0588016892357987,-0.0297499476422008,2.38181429064473e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42745,-0.030535952070657,0.00511424497578892,-0.0405598722232033,-0.0205120319181107,2.42051006681298e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42610,-0.0249957334101097,0.0041936168815566,-0.0332152224979606,-0.0167762443222587,2.57898219485546e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42678,-0.0328058624260497,0.00550552406477361,-0.043596689593006,-0.0220150352590934,2.60565217199859e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42547,-0.0236837981744543,0.00397583048615803,-0.0314764259273241,-0.0158911704215846,2.63463977357619e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40198,-0.0509302973889274,0.00855389278165441,-0.0676959272409701,-0.0341646675368848,2.69576615418025e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42214,0.0586022544734205,0.0098861951901458,0.0392253119007347,0.0779791970461062,3.15010875304181e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42586,-0.0122997442412608,0.00207663787864027,-0.0163699544833957,-0.00822953399912587,3.2404560279936e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42675,-0.0748418034386754,0.0126376435679604,-0.0996115848318778,-0.050072022045473,3.2552996067608e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42593,-0.0468624530358086,0.00791879824790477,-0.0623832976017019,-0.0313416084699152,3.34095537800777e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40510,-0.0563332718773898,0.00953045522622467,-0.0750129641207902,-0.0376535796339895,3.50123690635492e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42691,0.0358583636321778,0.0060722820418365,0.0239566908301783,0.0477600364341774,3.60571866813751e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42586,-0.0184040066811046,0.00312362888704693,-0.0245263192997166,-0.0122816940624926,3.91028291713895e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42415,0.0473373225961236,0.00803468741159123,0.0315893352694048,0.0630853099228424,3.91733109929511e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42651,-0.0219704507514054,0.00373424830645149,-0.0292895774320504,-0.0146513240707605,4.11227449295198e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42593,-0.015711586602747,0.0026721735669154,-0.0209490467939012,-0.0104741264115929,4.20790926486632e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42635,-0.0155171178615395,0.00264085788504356,-0.0206931993162249,-0.0103410364068541,4.30803499191609e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42733,-0.0197390155078128,0.0033597225474725,-0.0263240717008589,-0.0131539593147666,4.32275753202703e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42593,-0.0207727448185122,0.00353758733642897,-0.0277064159979129,-0.0138390736391114,4.40745268833432e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42720,-0.0363066861639997,0.00619831659572729,-0.0484553866916252,-0.0241579856363742,4.80784753006372e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42710,-0.025662131333411,0.00439538910814543,-0.0342770939853761,-0.017047168681446,5.39078476592069e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40481,-0.064176546868253,0.0109966130645967,-0.0857299084748625,-0.0426231852616434,5.4930038059175e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42586,-0.0411946837523914,0.00707657173970645,-0.055064764362216,-0.0273246031425667,5.97375394257672e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,42487,-0.0200735689315428,0.00345403986113483,-0.0268434870593671,-0.0133036508037185,6.32896784099325e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42665,-0.0156964065898785,0.00270487531134318,-0.0209979622001111,-0.0103948509796458,6.66017155420189e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42530,-0.0257661626323089,0.00444045740910369,-0.0344694591541521,-0.0170628661104656,6.67808619542018e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42678,-0.0158798007261509,0.00274563454249244,-0.0212612444294361,-0.0104983570228657,7.47162182083794e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42593,-0.0338544064797842,0.00585816439608309,-0.045336408696107,-0.0223724042634613,7.68120895598667e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40282,-0.0351420124981723,0.00608574329425096,-0.0470700693549042,-0.0232139556414404,7.92634401099638e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40448,-0.0164580687149231,0.00285260703371479,-0.0220491785010041,-0.0108669589288422,8.16114297743845e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,40510,0.0148702320261024,0.00257892095164323,0.00981554696088163,0.0199249170913231,8.32652149398356e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42688,-0.0166618217099486,0.00289171055286387,-0.0223295743935618,-0.0109940690263354,8.49754173488416e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42720,-0.019548287756294,0.00339526336080985,-0.0262030039434814,-0.0128935715691067,8.72138791084419e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,42440,-0.0158130387793499,0.00274920996795147,-0.0212014903165348,-0.010424587242165,9.02234704685096e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42793,-0.0212120037420709,0.00369710229977746,-0.0284583242496347,-0.0139656832345071,9.81504564819035e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42356,-0.0513666609629438,0.0089724897416318,-0.0689527408565421,-0.0337805810693455,1.05750426662549e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42655,-0.0516448604997244,0.00903567406251959,-0.0693547816622628,-0.0339349393371861,1.11595202724206e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42736,-0.0236868241322453,0.00414725656741357,-0.0318154470043758,-0.0155582012601147,1.14376065681824e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40510,-0.0291996902896624,0.00511250940440421,-0.0392202087222946,-0.0191791718570301,1.14860139307485e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42587,-0.02146114418681,0.0037604311440702,-0.0288315892291876,-0.0140906991444324,1.17354819712751e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42637,-0.0135868181678858,0.00238658254658662,-0.0182645199591955,-0.008909116376576,1.27435111513194e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40472,-0.0380562960884746,0.0066978540435478,-0.0511840900138283,-0.0249285021631209,1.36535109322074e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,40538,-0.0107628414723778,0.00189531861359279,-0.0144776659550197,-0.00704801698973597,1.39102014531011e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C5,Complement C5,40538,-0.00833395050932477,0.00146852498048498,-0.0112122594710753,-0.00545564154757422,1.42047794417841e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40222,-0.0244336218598198,0.00430678012590316,-0.03287491090659,-0.0159923328130496,1.43607648881721e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,42369,-0.0260562945318715,0.00459812715400405,-0.0350686237537194,-0.0170439653100235,1.48607685722968e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,40526,-0.0274807108263419,0.00485107717385781,-0.0369888220871032,-0.0179725995655806,1.50722923364021e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,40198,-0.00959305459698394,0.00169467558324386,-0.0129146187401419,-0.00627149045382598,1.54527243370482e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42720,-0.0188406604596856,0.00333601626607037,-0.0253792523411835,-0.0123020685781877,1.65928955046669e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42639,-0.0209690172508216,0.00371367781791312,-0.0282478257739313,-0.0136902087277118,1.67130989106205e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42577,-0.0602384125604294,0.0107077878871179,-0.0812256768191805,-0.0392511483016782,1.88500458165484e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,40198,-0.0162074248809535,0.00288575743111069,-0.0218635094459304,-0.0105513403159765,1.99765405945819e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42460,-0.0320130148722937,0.00570098639788183,-0.0431869482121421,-0.0208390815324453,2.00107355903118e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,42369,-0.0332293899683513,0.00592089311473968,-0.0448343404732411,-0.0216244394634615,2.0377004476485e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,42310,0.028519228272947,0.00508455826832192,0.018553494067036,0.0384849624788579,2.07627745463852e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40526,-0.0325697433125821,0.00580892398124524,-0.0439552343158227,-0.0211842523093414,2.10868003612559e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,42474,-0.0185424818712921,0.00330990559239352,-0.0250298968323834,-0.0120550669102008,2.15956273069962e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLU,Clusterin,40538,-0.0172370321993809,0.0030781181101561,-0.0232701436952869,-0.011203920703475,2.19514230143161e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAX,Protein max,42310,-0.0570060218443291,0.0101836654655498,-0.0769660061568068,-0.0370460375318514,2.21456950508782e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,42261,-0.0252524249531518,0.0045136091762114,-0.0340990989385261,-0.0164057509677774,2.2540563476979e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42688,-0.0260910243186164,0.00467039579446197,-0.0352450000757619,-0.016937048561471,2.36214178007689e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42610,-0.0320870954889723,0.00574538625088598,-0.0433480525407089,-0.0208261384372358,2.38453409421716e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42753,-0.0496979445954983,0.00892915657959398,-0.0671990914915025,-0.0321967976994941,2.65895309144946e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42500,-0.0158587207578139,0.00284961334093866,-0.0214439629060537,-0.0102734786095742,2.66884421474736e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40448,-0.0487769872259233,0.0087672625989504,-0.0659608219198661,-0.0315931525319805,2.70403809841101e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40450,-0.0227721349700361,0.00409654146628841,-0.0308013562439614,-0.0147429136961108,2.77714213575609e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42617,-0.0282747629142756,0.00508967655691778,-0.0382505289658344,-0.0182989968627167,2.82381283758175e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42610,0.0221317365137909,0.0039845654022642,0.0143219883253531,0.0299414847022288,2.83920070465885e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,42310,-0.0243187454685556,0.00438309053215377,-0.032909602911577,-0.0157278880255342,2.94033076835365e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_A,,40481,-0.0178978147077866,0.00323490078657956,-0.0242382202494825,-0.0115574091660907,3.2232531351732e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42593,-0.0296751266254702,0.00536916648940001,-0.0401986929446943,-0.0191515603062462,3.31928463663209e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42655,-0.0170534976766871,0.00309082934275326,-0.0231115231884835,-0.0109954721648907,3.5030546007414e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40222,-0.0215235259339939,0.00390371218421686,-0.0291748018150589,-0.0138722500529288,3.59474769014555e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40222,-0.0345496758557929,0.0062733050932191,-0.0468453538385023,-0.0222539978730834,3.72311864337339e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,40515,-0.0119083715847254,0.00216316960182492,-0.0161481840043022,-0.00766855916514852,3.77094089112411e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42720,-0.0220120687959213,0.00400905090217849,-0.0298698085641911,-0.0141543290276514,4.07808703966055e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42593,-0.020802953891053,0.00378983328619927,-0.0282310271320036,-0.0133748806501025,4.11222957189487e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42544,-0.0151486294105127,0.00276114187214887,-0.0205604674799245,-0.00973679134110095,4.17765051758765e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40115,-0.0329386746665574,0.00600431845622597,-0.0447071388407604,-0.0211702104923545,4.20706783450483e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDK,Midkine,42637,-0.0272057972897662,0.00496705333410776,-0.0369412218246174,-0.017470372754915,4.39748290358386e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40481,-0.0192581099847532,0.00351882871265647,-0.0261550142615599,-0.0123612057079465,4.522542127647e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42637,-0.0113706521726476,0.00208414505057597,-0.0154555764717765,-0.00728572787351865,4.9619237277874e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42458,-0.0220586027589926,0.00405319177713932,-0.0300028586421857,-0.0141143468757995,5.35375955604272e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42688,-0.0190786379678149,0.0035096555819329,-0.0259575629084034,-0.0121997130272264,5.5423856662727e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42356,-0.0167618757190827,0.00308619183932419,-0.0228108117241581,-0.0107129397140073,5.69551175545188e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,42310,-0.0241523723577169,0.00444749085454779,-0.0328694544326306,-0.0154352902828033,5.71779687671743e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40510,-0.01509335923557,0.00278092508630736,-0.0205439724047324,-0.00964274606640758,5.83409549755592e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40448,-0.0728500513450456,0.0134278107539159,-0.0991685604227207,-0.0465315422673704,5.90519527862437e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40481,-0.0191091063623799,0.00352370734772242,-0.0260155727639158,-0.012202639960844,5.9811358309277e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42793,-0.0158988247080123,0.00294009323662671,-0.0216614074518006,-0.0101362419642239,6.49571434650491e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40222,-0.0509901902643327,0.0094359646522123,-0.0694846809826688,-0.0324956995459966,6.65968127802968e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,40448,-0.0187452502245187,0.003470399847267,-0.025547233925162,-0.0119432665238754,6.74437627110533e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42593,-0.0351662867743135,0.00651792917908374,-0.0479414279653177,-0.0223911455833094,6.95660023716925e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI3,Elafin,42445,-0.0298722769353027,0.00554084077786169,-0.0407323248599116,-0.0190122290106938,7.11529908229672e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42710,-0.0158246149669902,0.00293646673891258,-0.0215800897752589,-0.0100691401587216,7.20399521028119e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40482,-0.0551503022903529,0.0102362025343066,-0.0752132592575939,-0.0350873453231118,7.27709728308584e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42189,-0.0632201844543619,0.0117453899119763,-0.0862411486818355,-0.0401992202268884,7.47124309061656e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42635,-0.0240603103493471,0.00447331499892108,-0.0328280077472324,-0.0152926129514618,7.63110666686572e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,42436,-0.017891437116985,0.00333093800456168,-0.0244200756059259,-0.0113627986280441,7.94966290875803e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40450,-0.0220177877970911,0.00409926949406306,-0.0300523560054547,-0.0139832195887275,7.97943061398687e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,40420,-0.0377187545451624,0.00702661480278042,-0.0514909195586121,-0.0239465895317128,8.12077268591218e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42617,-0.013443051606784,0.00250571470902258,-0.0183542524364682,-0.0085318507770997,8.23126225481133e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42635,-0.0196721066523214,0.00366680642558464,-0.0268590472464673,-0.0124851660581755,8.23296824712223e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40448,-0.0274391885822863,0.00511890588288862,-0.037472244112748,-0.0174061330518246,8.46964920405404e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,40198,-0.0489023654720199,0.0091234104571155,-0.0667842499679662,-0.0310204809760735,8.48581306056588e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,40482,-0.0241852261602555,0.0045122635705822,-0.0330292627585967,-0.0153411895619144,8.49135761767298e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42720,0.018934254160901,0.00354103455898649,0.0119938264252875,0.0258746818965145,9.08295500917866e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40510,0.0436108307157049,0.00815845973410608,0.0276202496368569,0.0596014117945528,9.19339129699743e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42675,-0.0402946785840526,0.00753992367112823,-0.0550729289794639,-0.0255164281886412,9.23080262346559e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42720,-0.0138491705325034,0.00259558933116743,-0.0189365256215916,-0.00876181544341528,9.67350809970301e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42753,-0.037558908368334,0.00704142344946496,-0.0513600983292853,-0.0237577184073826,9.76193936677045e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42637,-0.0177242442933288,0.00332864239052556,-0.0242483833787588,-0.0112001052078987,1.02709730968783e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42635,-0.0244292342004012,0.00459009747792957,-0.0334258252571432,-0.0154326431436593,1.04189848523911e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42710,-0.0121416232728017,0.0022819146817019,-0.0166141760489375,-0.00766907049666602,1.04958100533077e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42586,-0.00792250313288945,0.00148917216057513,-0.0108412805676167,-0.00500372569816219,1.05396445625132e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42593,-0.02477350445224,0.00467098673774627,-0.0339286384582227,-0.0156183704462573,1.15284340546956e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42635,-0.0163782942299331,0.00308911563271397,-0.0224329608700525,-0.0103236275898137,1.16394807201126e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,40526,-0.0247505879706084,0.00466961488862472,-0.0339030331523128,-0.0155981427889039,1.17752053368878e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42457,-0.0179386082894,0.00338502504187673,-0.0245732573714784,-0.0113039592073216,1.18043311825268e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42593,-0.0251620698415172,0.00475005838014802,-0.0344721842666073,-0.0158519554164271,1.19444567332147e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40282,-0.0455492497927717,0.00859971795036193,-0.0624046969754811,-0.0286938026100623,1.20238332659022e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40481,-0.0137980512460323,0.00261121570560739,-0.0189160340290228,-0.0086800684630418,1.28643657637194e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42753,-0.0265566857539654,0.00502994844350573,-0.0364153847032367,-0.0166979868046942,1.31383619336613e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42688,0.0237160308492507,0.00449351826149149,0.0149087350567274,0.0325233266417741,1.32746835671152e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42753,-0.0241510556099675,0.00458361888559665,-0.033134948625737,-0.0151671625941981,1.3927520702741e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42557,-0.0180482378614755,0.00342638960326443,-0.0247639614838738,-0.0113325142390772,1.4050119831847e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42369,-0.0433727520042262,0.0082389832815234,-0.0595211592360121,-0.0272243447724403,1.42909732805721e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,40439,-0.0148369750990654,0.00281992161847956,-0.0203640214712853,-0.00930992872684546,1.4552434954311e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39939,-0.0545275445910755,0.0103753197242453,-0.0748631712505963,-0.0341919179315547,1.50448164286932e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42442,-0.0246380666696561,0.00470626152682632,-0.0338623392622357,-0.0154137940770765,1.67355712182274e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42673,0.0237612721383037,0.00454189715732971,0.0148591537099374,0.0326633905666699,1.70591220440646e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40481,-0.0423232249539822,0.00811790220199296,-0.0582343132698884,-0.026412136638076,1.88518623299079e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42586,-0.0213172932687725,0.00409071976288365,-0.0293351040040244,-0.0132994825335205,1.90476968303924e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42593,-0.0197492358334458,0.00379078196140852,-0.0271791684778065,-0.0123193031890851,1.91842974616027e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42667,-0.0197141145724688,0.00378763617921546,-0.0271378814837311,-0.0122903476612065,1.96996596592413e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40450,-0.027932879233108,0.00537321304109229,-0.0384643767936489,-0.0174013816725671,2.04377456260486e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40510,-0.0162913442303361,0.00313482044023432,-0.0224355922931954,-0.0101470961674769,2.06169512577485e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42356,-0.0176927088355629,0.00340672617027842,-0.0243698921293086,-0.0110155255418172,2.09496563675269e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40282,-0.0628798606740135,0.012114699889822,-0.0866246724580647,-0.0391350488899624,2.13580765703414e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,40450,-0.0582886723395537,0.0112492000495714,-0.0803371044367136,-0.0362402402423939,2.2381753445806e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,40168,-0.0147855647623114,0.00285812207352542,-0.0203874840264212,-0.00918364549820154,2.34210266103047e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,40383,-0.0158754379443626,0.00307323692667974,-0.0218989823206549,-0.00985189356807032,2.43654391306728e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42356,-0.0176480787066713,0.00342478084578089,-0.0243606491644018,-0.0109355082489407,2.5998773336771e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,40482,-0.0143773350578875,0.00279161822225167,-0.0198489067735008,-0.00890576334227421,2.6462332555763e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42610,-0.0598845272963712,0.0116756855413466,-0.0827688709574106,-0.0370001836353318,2.95354552406105e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,40526,-0.0449087142935114,0.00880500719043596,-0.0621665283867659,-0.0276509002002569,3.44486625949132e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40198,-0.0418526555327221,0.00820685956922886,-0.0579381002884107,-0.0257672107770336,3.45824019298123e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40510,-0.0140959331376896,0.00276648707973624,-0.0195182478139726,-0.00867361846140655,3.53904352084617e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42610,-0.0122365083458606,0.00240190822264361,-0.0169442484622421,-0.00752876822947911,3.54421315069244e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40481,-0.0372661404927756,0.00731792597128183,-0.051609275396488,-0.0229230055890632,3.59176423023818e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42793,-0.0149360318679894,0.00293512237852014,-0.0206888717298888,-0.00918319200608988,3.65285820455299e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42494,-0.0217559792817303,0.00427648029827208,-0.0301378806663436,-0.0133740778971171,3.68036011234873e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,40115,0.0382151754106768,0.00752837804130546,0.0234595544497181,0.0529707963716355,3.91503149909933e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40481,-0.0488893569686314,0.00963980333381034,-0.0677833715028997,-0.0299953424343632,4.00719809734094e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42793,-0.0135097806286789,0.00268282337719529,-0.0187681144479817,-0.00825144680937614,4.82308489834906e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,40467,-0.0166971603084987,0.00332169371945333,-0.0232076799986272,-0.0101866406183702,5.06653229115375e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42673,-0.0299592382364255,0.00596114609225169,-0.0416430845772388,-0.0182753918956122,5.07894751936477e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42635,0.0212213206145431,0.00422813526522563,0.0129341754947009,0.0295084657343854,5.25855193953007e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42569,-0.0512099882720916,0.0102052957127173,-0.0712123678690176,-0.0312076086751656,5.28878189795015e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40427,-0.0336727991048965,0.00672396076285458,-0.0468517622000915,-0.0204938360097016,5.58682939090775e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42675,-0.0532330640035124,0.0106359840490893,-0.0740795927397274,-0.0323865352672974,5.65677584393547e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42753,-0.0276570826285514,0.00552685471149026,-0.0384897178630723,-0.0168244473940305,5.68191304583708e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40526,0.0249895096209424,0.00500175012418855,0.0151860793775328,0.0347929398643519,5.93577959407123e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42356,-0.0270192983879655,0.00540987285907934,-0.037622649191761,-0.01641594758417,5.97623085711256e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRN,Progranulin,42551,-0.0119230112859665,0.00239203183044887,-0.0166113936736463,-0.00723462889828673,6.2910466510861e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,42461,-0.0297726197211526,0.00598694504742182,-0.0415070320140994,-0.0180382074282058,6.67753710538152e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40510,-0.0436574065798766,0.00878626805637826,-0.060878491970378,-0.0264363211893752,6.83459165071889e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40282,0.0129645805644838,0.00261328686853268,0.00784253830215979,0.0180866228268079,7.11627692677938e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42688,-0.0148856204943111,0.0030070049561934,-0.0207793502084502,-0.00899189078017209,7.49885177688992e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42710,-0.0104819537959495,0.00212171255154196,-0.0146405103969717,-0.00632339719492724,7.89247782535989e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42793,-0.0115795324668319,0.00234905588781304,-0.0161836820069455,-0.00697538292671834,8.3437467958541e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,40198,-0.0214042320613455,0.00434373781741585,-0.0299179581834805,-0.0128905059392104,8.44553655965989e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42593,-0.0285244218630691,0.00579379746382514,-0.0398802648921664,-0.0171685788339719,8.61240000600595e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42590,-0.0209945823611534,0.00426648308269927,-0.029356889203244,-0.0126322755190629,8.72082838991487e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42704,-0.0224886824882264,0.00457167682309683,-0.0314491690614962,-0.0135281959149566,8.79520869055941e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42568,-0.013684684375506,0.00278545543004168,-0.0191441770183877,-0.0082251917326243,9.07976422378925e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,40268,-0.0100647746985404,0.00204908365077644,-0.0140809786540622,-0.00604857074301856,9.15145118609021e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,40282,-0.0173179370170168,0.0035271493008268,-0.0242311496466373,-0.0104047243873963,9.24234842897996e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40482,-0.0199987792477458,0.00407403112501098,-0.0279838802527673,-0.0120136782427242,9.28968149657519e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42733,-0.0172356292144941,0.00351834694374495,-0.0241315892242342,-0.010339669204754,9.75452433089193e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42606,-0.045475606622013,0.00928735496151223,-0.0636788223465769,-0.027272390897449,9.8691129124375e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,42345,-0.0206109142596149,0.00421056360817859,-0.0288636189316449,-0.0123582095875848,9.94476765376467e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42593,-0.0199179500768462,0.00407523335557643,-0.027905407453776,-0.0119304926999164,1.03275076900899e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42586,-0.0151768297405756,0.00310847094352263,-0.0212694327898799,-0.00908422669127119,1.0600606836605e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42675,-0.0137434572279616,0.00282190554795525,-0.0192743921019539,-0.00821252235396932,1.12707723541436e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,40013,-0.0383729407974886,0.00787873554209313,-0.0538152624599911,-0.0229306191349861,1.1292448281705e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42586,-0.0414169982869856,0.00852837578066965,-0.0581326148170981,-0.0247013817568731,1.20904699260997e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42356,-0.01013247229911,0.00208667592128791,-0.0142223571048343,-0.00604258749338566,1.21282316590648e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40481,-0.0280213887567414,0.00577031757117316,-0.0393312111962408,-0.016711566317242,1.21310626318015e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42793,-0.0193281882605912,0.00398412605901642,-0.0271370753362634,-0.011519301184919,1.2401461795567e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42586,-0.0102630108962906,0.00211813079661534,-0.0144145472576566,-0.00611147453492448,1.27826941142993e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42610,0.03881215198055,0.00801222203833382,0.0231081967854157,0.0545161071756843,1.28595721677452e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,40510,-0.0245088263763849,0.0050622315328704,-0.0344308001808108,-0.0145868525719589,1.30562913622579e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42599,0.00935254604162231,0.00193551034168495,0.00555894577191982,0.0131461463113248,1.36608173026473e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42635,-0.023120671590468,0.00478988401652442,-0.0325088442628559,-0.0137324989180801,1.40143975356724e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGMN,Legumain,42675,-0.0167478887951783,0.00347098206857897,-0.0235510136495931,-0.00994476394076351,1.41454267440275e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42673,-0.0163885526360901,0.00339981525239205,-0.0230521905307785,-0.00972491474140169,1.44815896378133e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42710,-0.017604179354593,0.00365636245573564,-0.0247706497678349,-0.0104377089413512,1.49039904655271e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40481,-0.0226539618191402,0.00470933594059966,-0.0318842602627156,-0.0134236633755649,1.52548989023104e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,40181,-0.019588155180707,0.00407953401016518,-0.0275840418406308,-0.0115922685207832,1.59506278653856e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42593,-0.0222858089312331,0.0046439093639862,-0.0313878712846461,-0.0131837465778202,1.61233975634107e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42489,-0.0472189127306044,0.00985005424805331,-0.0665250190567889,-0.0279128064044199,1.65446456614709e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,40301,-0.0600774193063511,0.012537697224518,-0.0846513058664064,-0.0355035327462958,1.67479832501333e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42753,-0.00407987589109033,0.000851903884465606,-0.00574960750464291,-0.00241014427753774,1.69279903583276e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40489,-0.0105039520157152,0.00219483066615651,-0.014805820121382,-0.00620208391004848,1.72492431480376e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42635,-0.0271762630927141,0.00568193264527574,-0.0383128510774546,-0.0160396751079737,1.74595699065323e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42675,-0.0547028707732639,0.0114448987705544,-0.0771348723635505,-0.0322708691829773,1.77434163077504e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40450,-0.0281704742796702,0.00589545319774455,-0.0397255625472495,-0.0166153860120909,1.78983127042367e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40510,-0.0451192588034203,0.00944870858240127,-0.0636387276249268,-0.0265997899819138,1.81800489422878e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42437,-0.0177364782782504,0.00371500739677659,-0.0250178927759325,-0.0104550637805683,1.8228277266068e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40481,-0.0287032590073519,0.00601167828815471,-0.0404861484521351,-0.0169203695625687,1.82342596607378e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42688,-0.0155786897703755,0.00327187302443811,-0.0219915608982741,-0.00916581864247677,1.94254147167749e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40482,-0.0494454606446001,0.0104035095069576,-0.069836339278237,-0.0290545820109631,2.03128116321092e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40282,-0.0547332889405869,0.0115266410743128,-0.07732550544624,-0.0321410724349339,2.07583442156666e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,40481,-0.0223217814429616,0.00470441475610848,-0.0315424343649342,-0.013101128520989,2.11211781533934e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42675,-0.0138883530051288,0.00292993312342186,-0.0196310219270356,-0.00814568408322194,2.15732202771977e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40188,-0.0162307633802248,0.00342593606746131,-0.0229455980724489,-0.00951592868800059,2.18956640866366e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,42356,-0.0386443228589,0.00816760387354495,-0.0546528264510481,-0.0226358192667519,2.25278483450264e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42720,-0.0372434018571569,0.00787619809189063,-0.0526807501172625,-0.0218060535970512,2.28353464668432e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,42275,-0.0224308061787665,0.00475074065384339,-0.0317422578602995,-0.0131193544972334,2.36496179487155e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42542,-0.0150544525350419,0.0031927334845618,-0.021312210164783,-0.00879669490530076,2.43888141825654e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42593,-0.0253503254854208,0.00538227549204114,-0.0358995854498215,-0.0148010655210202,2.5024654467244e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,42345,-0.0247496979514301,0.00525862468771047,-0.0350566023393426,-0.0144427935635176,2.54580084040979e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40481,-0.0332572150774608,0.00706578895607535,-0.0471061614313685,-0.0194082687235531,2.54634899873203e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,40115,0.0356713962500555,0.00757911158080146,0.0208163375516846,0.0505264549484263,2.55052094843132e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40531,-0.0125263855067339,0.00266240810314569,-0.0177447053888995,-0.00730806562456838,2.56982362370851e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40222,-0.0278674223500428,0.00592649288359366,-0.0394833484018863,-0.0162514962981992,2.60522541499155e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42688,0.053415234772912,0.0113884872447741,0.0310937997731547,0.0757366697726693,2.75501700880919e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,42332,-0.0230617231782627,0.00491798108029007,-0.0327009660956312,-0.0134224802608941,2.76945510291295e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42793,-0.0103797792717216,0.00221781447727605,-0.0147266956471826,-0.00603286289626052,2.89383333537022e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,42436,-0.0193710848996653,0.00414295842983194,-0.0274912834221359,-0.0112508863771947,2.95895605237829e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42586,-0.0240543550850551,0.00514645409895498,-0.0341414051190069,-0.0139673050511034,2.98317199148853e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42345,-0.0351738420169038,0.00752650557860871,-0.0499257929509769,-0.0204218910828307,2.99295954363831e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40222,-0.0128900943832464,0.00275839225330459,-0.0182965431997234,-0.00748364556676937,3.00278207915915e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39872,-0.0111258490065621,0.00238252908819204,-0.0157956060194185,-0.00645609199370574,3.05223063950036e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42586,0.0180791961089851,0.00387239688221959,0.0104892982198348,0.0256690939981355,3.06001037125195e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42781,-0.0207495814665434,0.00444538771730396,-0.0294625413924592,-0.0120366215406277,3.07553527202391e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,40448,-0.0343158363776459,0.00735645575314854,-0.048734489653817,-0.0198971831014748,3.1259146303473e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42688,-0.0266795164157327,0.00572573509985206,-0.0379019572114427,-0.0154570756200226,3.19885513871784e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40448,-0.0345807678553311,0.0074247547836532,-0.0491332872312914,-0.0200282484793708,3.2374353627137e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,40282,-0.0183989463039212,0.00395270391971648,-0.0261462459865655,-0.0106516466212769,3.28096582757227e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42617,-0.0181650632695769,0.00390421345084579,-0.0258173216332346,-0.0105128049059191,3.3077645248065e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42637,-0.0153503365708694,0.00330278926226131,-0.0218238035249015,-0.00887686961683722,3.38864549769299e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40182,-0.0378423140729805,0.00814173173624818,-0.053800108276027,-0.0218845198699341,3.39161271947353e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42586,-0.0300011621439481,0.00645572992795869,-0.0426543928027471,-0.017347931485149,3.3965515035293e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42793,-0.0141478844507499,0.0030453930520047,-0.0201168548326791,-0.00817891406882069,3.42156768865692e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42593,-0.0219945184780409,0.00473445645677831,-0.0312740531333263,-0.0127149838227554,3.42272025182252e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42635,-0.0340792513043136,0.00734458136469462,-0.048474630779115,-0.0196838718295121,3.51608236004951e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,40222,-0.0345896630275569,0.00745453828355622,-0.0492005580633271,-0.0199787679917867,3.52284238943213e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42610,-0.0209955132666923,0.00452837032410732,-0.0298711191019426,-0.012119907431442,3.57806221567591e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,40165,-0.0202137026296262,0.00436017421711369,-0.028759644095169,-0.0116677611640833,3.59341202116531e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42720,-0.0178816618594488,0.00386744894618337,-0.0254618617939682,-0.0103014619249294,3.80568655323917e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,40418,-0.0205518424451403,0.00444483258164128,-0.0292637143051572,-0.0118399705851234,3.81051938840633e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42753,-0.0296723910733047,0.00642440340102821,-0.04226422173932,-0.0170805604072894,3.89703188756504e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,42124,-0.0151834000025702,0.00328844932739486,-0.0216287606842641,-0.00873803932087629,3.92715563174972e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42569,-0.0298261866192097,0.00646872785577001,-0.0425048932165189,-0.0171474800219005,4.04784640415172e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD248,Endosialin,40526,-0.0182876814655515,0.00397024490383633,-0.0260693614770707,-0.0105060014540323,4.14593221002599e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42586,-0.014560950621098,0.00316300175984603,-0.0207604340703962,-0.00836146717179977,4.19223145982829e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40482,-0.014413481030654,0.00313891676089051,-0.0205657578819994,-0.00826120417930863,4.44051749672504e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40448,-0.0133013768259037,0.00289749310734166,-0.0189804633162934,-0.00762229033551409,4.46653609687793e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40510,-0.0401885351689305,0.00876744416123328,-0.0573727257249477,-0.0230043446129133,4.61409483752087e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,40101,-0.0242323569318812,0.00529905232954313,-0.0346184994977857,-0.0138462143659767,4.86176438325526e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40510,-0.0329914999038354,0.00721524343503286,-0.0471333770364998,-0.018849622771171,4.87116448352727e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42710,0.0163449077773723,0.0035789018766243,0.00933026009918867,0.0233595554555559,4.99083342892663e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42777,-0.0105906293582324,0.00232521551436554,-0.0151480517663889,-0.00603320695007593,5.29200393607199e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,40115,-0.0257770390071416,0.00568072171096084,-0.0369112535606248,-0.0146428244536583,5.7496015095277e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,42356,-0.0172075573891287,0.00379476071027855,-0.0246452883812747,-0.00976982639698276,5.82342074361533e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42586,-0.0184920318978447,0.00408398714614174,-0.0264966467042825,-0.0104874170914069,6.00765213491965e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42793,-0.0122775457162336,0.00271179965841425,-0.0175926730467255,-0.00696241838574165,6.02058234608531e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,42356,-0.0208839874510451,0.00464232887923043,-0.0299829520543368,-0.0117850228477535,6.89876252534836e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40531,-0.0119053476183788,0.00264844882266306,-0.0170963073107984,-0.00671438792595917,7.01888272949852e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40526,-0.0276182074199941,0.00614722254017529,-0.0396667635987377,-0.0155696512412505,7.09906029198045e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40482,-0.042344863068302,0.00942668917937735,-0.0608211738598817,-0.0238685522767224,7.12520538333403e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42793,-0.0137157036060065,0.00306485487467609,-0.0197228191603716,-0.00770858805164136,7.69756874458038e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42407,-0.0208848440908422,0.00467380270494577,-0.0300454973925359,-0.0117241907891485,7.9428190834475e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40499,-0.0206886698886633,0.00463270776685328,-0.0297687771116957,-0.0116085626656309,8.05498838022079e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42793,-0.0284259767858202,0.00637630791364683,-0.040923540296568,-0.0159284132750725,8.33658425902724e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42593,-0.0251927006652162,0.00565274445917525,-0.0362720798051997,-0.0141133215252327,8.38983475592706e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42494,-0.0173219444428237,0.0038986624516761,-0.0249633228481089,-0.00968056603753858,8.94098835043677e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42314,-0.0126266532626787,0.0028422554107782,-0.018197473867804,-0.00705583265755339,8.96572433800845e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,40448,0.044330687639428,0.00998970980057052,0.0247508564303098,0.0639105188485463,9.18173830723966e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40510,-0.0115617441046896,0.00260635217738488,-0.0166701943723639,-0.00645329383701519,9.25168225936992e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,40282,-0.0295543301377853,0.0066634006114688,-0.0426145953362641,-0.0164940649393064,9.28200669788468e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42593,-0.0306288222725728,0.00691469292393766,-0.0441816204034906,-0.017076024141655,9.51882720152562e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40510,-0.0143687989071187,0.00324583478483207,-0.0207306350853895,-0.0080069627288478,9.65183396656991e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,40482,-0.0182769154188795,0.00412993480396578,-0.0263715876346524,-0.0101822432031065,9.71337943794717e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,40282,-0.0193657665537394,0.00437884509692376,-0.0279483029437099,-0.0107832301637688,9.84609942207439e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,40282,0.0143623201501393,0.00325347850659801,0.00798550227720722,0.0207391380230714,1.02224710218273e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,42444,-0.0165533965174631,0.00375171907597079,-0.0239067659063658,-0.00920002712856033,1.03125617711515e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,42474,-0.0140802299924411,0.00319422155345051,-0.0203409042372041,-0.00781955574767806,1.05133033218003e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42705,-0.0126716838287144,0.00287619451036142,-0.0183090250690228,-0.00703434258840601,1.06248872549432e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42677,-0.0289239254132538,0.00657328332449629,-0.0418075607292665,-0.0160402900972411,1.0896902399846e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42356,-0.0308979678685029,0.00703588858750505,-0.0446883095000128,-0.017107626236993,1.13460259088877e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,42369,-0.0392483876174118,0.00893798609131502,-0.0567668403563892,-0.0217299348784343,1.13611346680429e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42610,-0.0128425961900143,0.00292970723193864,-0.018584822364614,-0.00710037001541457,1.17634462634754e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,42438,-0.0204703036053314,0.00467110535495523,-0.0296256701010436,-0.0113149371096192,1.18322934809644e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42678,-0.00936796827627069,0.00213968276278483,-0.013561746491329,-0.00517419006121243,1.20562388737719e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40448,0.0419811525345289,0.00960686425241226,0.0231516985998009,0.060810606469257,1.25410701839832e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42599,-0.0129281888679439,0.00295908818211217,-0.0187280017048838,-0.00712837603100408,1.25767895360811e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40448,-0.0128853577781993,0.00295188277646004,-0.0186710480200609,-0.00709966753633759,1.28180088569365e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42369,-0.020768979806047,0.00476535160240516,-0.0301090689467612,-0.0114288906653329,1.32050888345764e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42678,-0.0104678258025009,0.00240233767422653,-0.0151764076439849,-0.00575924396101694,1.32620274021423e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,40481,-0.0289374469115072,0.00664639070539784,-0.041964372694087,-0.0159105211289274,1.3494060492215e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,40510,-0.028720589304184,0.00660184165910466,-0.0416601989560291,-0.0157809796523388,1.37086127378821e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40198,-0.0184807509615293,0.00424993200120135,-0.026810617683884,-0.0101508842391747,1.38316678037595e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42602,-0.0170760736720748,0.00393160975823163,-0.0247820287982088,-0.0093701185459408,1.41403533128107e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40448,-0.00910353989004762,0.00209951182899617,-0.0132185830748801,-0.00498849670521511,1.46343426231628e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42345,-0.024355588214846,0.00561855629862608,-0.0353679585601531,-0.0133432178695389,1.46945148999711e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42475,-0.00986808799637007,0.00228012280127141,-0.014337128686862,-0.00539904730587812,1.51655872179801e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42793,-0.0175941797711675,0.0040687822677808,-0.0255689930160179,-0.00961936652631714,1.54184871987975e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40450,-0.0243995690685282,0.00564274249918762,-0.0354593443669359,-0.0133397937701205,1.54500629971884e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELE,E-selectin,42793,0.0212981474090398,0.00493558757611698,0.0116243957598506,0.0309718990582291,1.60570320010892e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42653,-0.0234374281068678,0.00543438910235407,-0.0340888307474818,-0.0127860254662538,1.62348913204419e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40450,-0.0343891790063413,0.00798339069637017,-0.0500366247712268,-0.0187417332414558,1.66442463665713e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42793,-0.0142626437072135,0.00331918426273652,-0.0207682448621771,-0.00775704255224994,1.74302927520452e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42720,-0.0234874039002474,0.00546803905510602,-0.0342047604482552,-0.0127700473522396,1.75597262299321e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42586,-0.0374341335982886,0.00873451804830895,-0.0545537889729742,-0.0203144782236031,1.83380255693314e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42356,-0.0313873839896044,0.00732452677856613,-0.045743456475594,-0.0170313115036148,1.83836305645058e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42662,-0.0117646793606369,0.00275007526655056,-0.017154826883076,-0.0063745318381978,1.89925685628001e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,42356,-0.032357929290673,0.00757040839851622,-0.0471959297517648,-0.0175199288295812,1.93118951487107e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,40135,-0.0460169996733961,0.0107724959291082,-0.0671310916944482,-0.0249029076523439,1.95617707997204e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42635,-0.02790118914064,0.00653616639138307,-0.0407120752677508,-0.0150903030135292,1.97929255742409e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,40433,-0.0248609144563002,0.00582943339372072,-0.0362866039079928,-0.0134352250046076,2.01787588810664e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42593,-0.0256396181168161,0.00601374102096831,-0.0374265505179139,-0.0138526857157182,2.02622599081606e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40282,0.0159308552964993,0.00374024557398291,0.00859997397149281,0.0232617366215058,2.06752799080701e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,40282,-0.0351579933720502,0.00825749741100746,-0.0513426882976248,-0.0189732984464756,2.08236764467433e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COCH,Cochlin,40510,-0.0194163196699773,0.00456260104022227,-0.0283590177088129,-0.0104736216311417,2.10227147419983e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42345,-0.0452792079728287,0.0106584291667728,-0.0661697291397035,-0.024388686805954,2.16971758146163e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,40115,-0.0296995716892631,0.00699705283521164,-0.0434137952462779,-0.0159853481322483,2.20810258038558e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42635,-0.0146622684487128,0.00345891944862566,-0.0214417505680191,-0.00788278632940652,2.26043414018077e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,42345,-0.0214443439072697,0.00506153835894597,-0.0313649590908038,-0.0115237287237356,2.28348932626149e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42793,-0.0133872947028857,0.00316152299894202,-0.019583879780812,-0.0071907096249593,2.30623007970143e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,42187,0.0164545583466792,0.00388773384519236,0.00883460001010218,0.0240745166832562,2.32768382267067e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42586,0.0145468343066028,0.00343912682173704,0.00780614573599818,0.0212875228772074,2.3544911271358e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,40222,-0.0363863763018677,0.00860604698565928,-0.0532542283937599,-0.0195185242099755,2.37677662833162e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40448,-0.0597944290607966,0.0141467590467371,-0.0875220767924013,-0.0320667813291919,2.38990681537055e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42610,-0.0111547534836581,0.00264788047625613,-0.0163445992171201,-0.00596490775019608,2.5397306457258e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42610,-0.0141398034432253,0.00335878161396189,-0.0207230154065906,-0.00755659147985996,2.57260787316229e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40481,-0.0513690938682935,0.0122098233644905,-0.0753003476626948,-0.0274378400738922,2.60560113497886e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42635,-0.0211317149348903,0.00502993930343743,-0.0309903959696276,-0.0112730339001529,2.67232806614838e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40482,-0.0276499932132805,0.00658353184304642,-0.0405537156256515,-0.0147462708009095,2.69116199097943e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40328,-0.022824947770455,0.00543572111079317,-0.0334789611476096,-0.0121709343933004,2.7010406548932e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40222,-0.0417846321886962,0.00995503493376467,-0.0612965006588749,-0.0222727637185174,2.72190324840784e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42675,-0.016073581240803,0.00383221827853979,-0.023584729066741,-0.00856243341486503,2.75431448864313e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,40526,-0.033752540895334,0.0080491971920465,-0.0495289673917451,-0.0179761143989229,2.77039648664819e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40526,0.0191448486963064,0.00457013077828607,0.0101873923708657,0.0281023050217471,2.82153265610069e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42583,-0.0290923113733446,0.00695519347892416,-0.042724490592036,-0.0154601321546533,2.89751721350719e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42753,-0.0149129829735056,0.00356537062397022,-0.0219011093964872,-0.00792485655052394,2.89841154437978e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40526,-0.0134948519171636,0.00322803712371586,-0.0198218046796467,-0.00716789915468052,2.93037645560472e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40469,-0.0166657941637349,0.00399196490665704,-0.0244900453807827,-0.00884154294668708,3.00443039848387e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,40538,-0.0281141213658434,0.00673800597058296,-0.041320613068186,-0.0149076296635008,3.03561994509366e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,40222,0.0211827707988524,0.00509488916968105,0.0111967880262775,0.0311687535714272,3.23968595393356e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,42482,-0.0415863459426759,0.0100075356544527,-0.0612011158254033,-0.0219715760599486,3.26604761631145e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,40282,-0.0448972039352876,0.0108102391026078,-0.0660852725763988,-0.0237091352941764,3.3029818505247e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42688,-0.0122446700540605,0.0029489536962741,-0.0180246192987577,-0.00646472080936326,3.31306424285745e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,40510,-0.0288136604229366,0.00694510164992311,-0.0424260596567859,-0.0152012611890873,3.36703430596693e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40482,-0.0968689927402006,0.0233573103931745,-0.142649321110823,-0.0510886643695786,3.38930587007523e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40282,-0.0286691849450654,0.00691561646497322,-0.0422237932164129,-0.0151145766737179,3.41488272933107e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,42369,-0.0228225061975069,0.00550701045426295,-0.0336162466878622,-0.0120287657071515,3.4303737758959e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40450,-0.0353213559714915,0.00852372065952691,-0.0520278484641642,-0.0186148634788187,3.43962714051563e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42569,-0.0348395806587945,0.00842555375045221,-0.0513536660096809,-0.0183254953079082,3.57136976462196e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42586,-0.0327675194595503,0.00793028304925658,-0.0483108742360932,-0.0172241646830074,3.61888223830736e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,42345,0.0305929174481381,0.00741268091506431,0.016064062854612,0.0451217720416641,3.69621917416855e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42672,-0.0152243609397318,0.00369187824634784,-0.0224604423025736,-0.00798827957689006,3.74997922984915e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40450,-0.0316857198770974,0.00768817657814676,-0.0467545459702651,-0.0166168937839298,3.79346403229908e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,40198,-0.0160855897108787,0.00390429590181905,-0.023738009678444,-0.00843316974331333,3.81692616851646e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,40135,-0.0199954004355701,0.0048568805674787,-0.0295148863478283,-0.0104759145233118,3.86784626889877e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,40481,-0.0126547993424202,0.00307477892333289,-0.0186813660321527,-0.00662823265268771,3.88787614600575e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40510,-0.0148146052563328,0.0036081509328983,-0.0218865810848135,-0.00774262942785218,4.05623030636152e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB2,Calretinin,42310,-0.0128313251356311,0.00312600063650571,-0.0189582863831823,-0.00670436388807993,4.07273549094848e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40282,-0.033725573689329,0.00821921631843388,-0.0498352376734594,-0.0176159097051986,4.10285038923222e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42494,-0.0224826289185864,0.00548240056007884,-0.0332281340163409,-0.0117371238208318,4.14042615513731e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42610,-0.0473244477851605,0.0115703073928582,-0.0700022502751626,-0.0246466452951583,4.33586229201343e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42759,-0.0132906388397082,0.00324960324234665,-0.0196598611947076,-0.00692141648470873,4.34000789898609e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42657,0.0258688968955714,0.00634214413993695,0.013438294381295,0.0382994994098478,4.55121226540839e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42635,-0.0328998052786422,0.00806746069806476,-0.0487120282468491,-0.0170875823104353,4.56694727394096e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42625,-0.0262748234066685,0.0064513241969574,-0.038919418832705,-0.013630227980632,4.6721902212148e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40448,-0.0384840089690946,0.00944984508999928,-0.0570057053454932,-0.019962312592696,4.68400836849263e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42680,-0.0274454625150276,0.00675121827173925,-0.0406778503276365,-0.0142130747024186,4.82510710920505e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPL,Periplakin,40198,-0.0132154778912324,0.00325162757133579,-0.0195886679310506,-0.00684228785141425,4.85189039241822e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42710,-0.0227338742491757,0.0055947638416152,-0.0336996113787415,-0.0117681371196099,4.86322923657423e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFI,Complement factor I,40538,-0.00773736416568234,0.00190645988238877,-0.0114740255351643,-0.00400070279620036,4.97205251895474e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,40526,-0.011054829082513,0.00272569315286961,-0.0163971876621375,-0.00571247050288861,5.03005177783267e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42494,-0.0271911997263416,0.0067053214695472,-0.0403336298066542,-0.0140487696460291,5.03840323617958e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40481,-0.0263944525584075,0.00651711050526474,-0.0391679891487264,-0.0136209159680887,5.15548907158626e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42678,-0.0375800095411623,0.00928172698849482,-0.0557721944386122,-0.0193878246437125,5.17649901076163e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40482,-0.0323345193625168,0.00798574405906534,-0.0479865777182849,-0.0166824610067488,5.17738641544138e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,42310,-0.0153623148563041,0.00379819028449016,-0.0228067678139048,-0.00791786189870337,5.27033802980707e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40481,-0.0333738765482876,0.00825417278396136,-0.0495520552048518,-0.0171956978917233,5.30603676529434e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42675,-0.0484704792461727,0.0119921242585734,-0.0719750427929766,-0.0249659156993688,5.33235619936407e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40510,-0.0286144739031768,0.00707949958191223,-0.0424902930837247,-0.0147386547226288,5.33757873355352e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42657,0.0262293713708846,0.00649606571002176,0.0134970825792419,0.0389616601625272,5.42694818303388e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,40282,-0.0213180979068427,0.00528979582852452,-0.0316860977307508,-0.0109500980829346,5.61395149328306e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40301,-0.0146159848459808,0.00363141860568554,-0.0217335653131245,-0.00749840437883718,5.73853391356016e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,40429,-0.0167603262355664,0.00416830930387279,-0.0249302124711571,-0.00859043999997574,5.83568735429822e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42604,-0.0442909630352855,0.0110176583673366,-0.0658855734352652,-0.0226963526353059,5.85169925724687e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40481,-0.0185476234987815,0.00461457705469849,-0.0275921945259905,-0.00950305247157244,5.87368141483134e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40450,-0.0367735499116729,0.00915702442212358,-0.0547213177790351,-0.0188257820443107,5.96078863624313e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40181,-0.0215859704810467,0.00537707954938667,-0.0321250463978446,-0.0110468945642488,5.99826330930596e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,40282,-0.0325462430752324,0.00812112625238043,-0.048463650529898,-0.0166288356205667,6.17395190383435e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELN,Elastin,40510,-0.0142894255485502,0.00357010038687506,-0.0212868223068253,-0.00729202879027508,6.30690259051674e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40482,-0.0349152062055727,0.00872430010852592,-0.0520148344182835,-0.0178155779928619,6.31936342763097e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42662,-0.00977389902436578,0.00244485343098101,-0.0145658117490886,-0.00498198629964301,6.42899655470466e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42673,-0.00945516720324343,0.00236596137272948,-0.0140924514937932,-0.00481788291269365,6.46737971652213e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40518,-0.00987717143005709,0.00247467068794544,-0.0147275259784302,-0.00502681688168402,6.6124387432599e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40482,-0.0177034452526755,0.00443624404222342,-0.0263984835754334,-0.00900840692991762,6.6312298580545e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42753,-0.0224271705873275,0.00562063651197683,-0.0334436181508021,-0.0114107230238529,6.6379359031918e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42675,-0.00975119904194537,0.00244818390811968,-0.0145496395018599,-0.00495275858203081,6.83985433368189e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42617,-0.0156593904755101,0.00393219162685923,-0.0233664860641541,-0.00795229488686597,6.85949923014299e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40198,0.0265782683406496,0.0066739069516716,0.0134974107153733,0.0396591259659259,6.86574463159738e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40481,-0.0258975834068239,0.00650464944969874,-0.0386466963282334,-0.0131484704854144,6.89411443092776e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42345,-0.0148518046826686,0.00373352847417507,-0.0221695204920518,-0.00753408887328549,6.9883341539635e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40135,-0.0381951240427434,0.00962170290606258,-0.057053661738626,-0.0193365863468607,7.24280375364114e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40450,-0.0188645434340849,0.00475241332332355,-0.0281792735477991,-0.00954981332037075,7.24814230310199e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40481,0.0173115730035283,0.00436345179226899,0.00875920749068109,0.0258639385163755,7.31093018606992e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42793,-0.0197584827779285,0.00498736509341399,-0.0295337183610199,-0.00998324719483707,7.47953300282312e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40481,-0.0289132672215878,0.0073056581443329,-0.0432323571844803,-0.0145941772586954,7.61531964667449e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40481,-0.0174968248939585,0.00442203042996454,-0.026164004536689,-0.00882964525122796,7.64446138044531e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42581,0.0262024394820618,0.00662408654668718,0.013219229850555,0.0391856491135687,7.67264277949886e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42494,-0.0232826214812269,0.00588641293641652,-0.0348199908366032,-0.0117452521258505,7.68300298443622e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42586,-0.0205996252414428,0.00521041118403005,-0.0308120311621417,-0.0103872193207439,7.73958056351919e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40448,-0.0228493514875841,0.00577947478276,-0.0341771220617937,-0.0115215809133745,7.74765289201786e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,40268,0.0226004032163194,0.0057216881519819,0.0113858944384348,0.0338149119942039,7.865084150571e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42310,-0.0280786904230587,0.00711428994736818,-0.0420226987199003,-0.014134682126217,7.96152792600978e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42586,-0.0321531084859819,0.00815082570066235,-0.0481287268592801,-0.0161774901126837,8.02848435850008e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,42433,-0.0289199925472361,0.00733188579076277,-0.0432904886971311,-0.014549496397341,8.0407801263487e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42617,-0.0112637316376153,0.00285820921118026,-0.0168658216915286,-0.00566164158370197,8.16098428767116e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40481,-0.0308212335161519,0.00782627355881747,-0.0461607296914342,-0.0154817373408697,8.25974547846975e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40450,-0.0211895325224627,0.00538090896998481,-0.0317361141036329,-0.0106429509412924,8.26900564928288e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42520,-0.0221569953380179,0.00564035612993086,-0.0332120933526824,-0.0111018973233534,8.59808762008452e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42675,0.0245889128322079,0.00626127278415412,0.0123168181752659,0.03686100748915,8.63889622951153e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42643,-0.0106063104312006,0.00270109548500321,-0.0159004575818069,-0.00531216328059431,8.65597571929193e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42291,-0.0179651755468825,0.00457513217599361,-0.0269324346118299,-0.00899791648193497,8.65602071636453e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40448,-0.0179264962438905,0.00456728503303549,-0.0268783749086401,-0.00897461757914095,8.72539065900885e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42675,-0.0398067808433469,0.0101479693256166,-0.0596968007215554,-0.0199167609651383,8.80199863278921e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40301,-0.0145705861125421,0.00372326061342548,-0.0218681769148561,-0.00727299531022817,9.15508029670647e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42793,-0.00620490758798063,0.00158817260112946,-0.00931772588619437,-0.0030920892897669,9.39217722446008e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,42276,-0.0283305798450295,0.00726041611858642,-0.0425609954374589,-0.0141001642526001,9.5855195913511e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40450,0.0145002668581378,0.00371677823486622,0.00721538151779997,0.0217851521984755,9.62342068479838e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,40448,-0.013785384912353,0.00353552026891696,-0.0207150046394303,-0.00685576518527579,9.71073031324752e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40135,-0.0179948162293177,0.00461617164394783,-0.0270425126514554,-0.00894711980717994,9.74839016054901e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40482,-0.0178745978642917,0.00458843857560635,-0.0268679374724802,-0.00888125825610329,9.85320697840649e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42552,-0.0226377730972241,0.00581521814740815,-0.0340356006661441,-0.0112399455283041,9.95549693722412e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEXN,Nexilin,40531,-0.0261192599768596,0.00671906301409774,-0.0392886234844911,-0.012949896469228,0.000101927746987439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40222,0.0140685365998324,0.00362039333798756,0.00697256565737674,0.021164507542288,0.000102542143299044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,40510,-0.0172145880051449,0.00443161043661901,-0.0259005444609182,-0.00852863154937165,0.000103124815967638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42345,-0.0213730266105719,0.00550330737550241,-0.0321595090665566,-0.0105865441545872,0.000103395342648268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42793,-0.00999042252931731,0.00257318797058986,-0.0150338709516734,-0.00494697410696118,0.00010387340258037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40222,-0.0185251570150815,0.0047735827758925,-0.0278813792558308,-0.00916893477433223,0.000104734260218516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42586,-0.0211617509425265,0.00546119460693075,-0.0318656923721108,-0.0104578095129422,0.000107163252763846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42356,-0.0159251017869927,0.00411188036357031,-0.0239843872995905,-0.00786581627439486,0.000108046801978453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,40282,-0.0108934435528937,0.00281272064436058,-0.0164063760158404,-0.00538051108994693,0.000108156818063053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTR,Transthyretin,40423,0.00952153384245665,0.0024597800160365,0.00470036501102511,0.0143427026738882,0.000109053483677584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,42302,-0.040658486585359,0.0105081923567669,-0.0612545436046222,-0.0200624295660959,0.000109713624494536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42586,-0.034958143861649,0.00904985823367545,-0.0526958659996529,-0.0172204217236452,0.000112604745975748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40222,-0.0243920474458008,0.00632155593496242,-0.0367822970783271,-0.0120017978132744,0.000114710934924864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40198,-0.0285286069778758,0.00739455940162217,-0.0430219434050552,-0.0140352705506963,0.000114945762094599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40448,-0.0167257999199973,0.00434313931264678,-0.0252383529727849,-0.00821324686720957,0.000118247176216895
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42593,-0.0237381137636287,0.00616483300282524,-0.0358211864491662,-0.0116550410780913,0.000118391842722215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42474,-0.0152061164510691,0.00395480475843653,-0.0229575337776047,-0.00745469912453348,0.000121128472291133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,40282,-0.0275215406231724,0.00716065465045804,-0.0415564237380702,-0.0134866575082747,0.000121999350943394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42310,-0.0142967941459836,0.00372530956997868,-0.0215984009031418,-0.00699518738882539,0.000124751057939478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,40336,-0.0128035169056937,0.00333796083847211,-0.0193459201490991,-0.00626111366228841,0.000125882054215651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40438,-0.0102450063561484,0.00267184446901268,-0.0154818215154132,-0.0050081911968835,0.000126541398847288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,40198,-0.0133188928003079,0.00347457625130684,-0.0201290622528693,-0.00650872334774655,0.000127169537001903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42635,-0.0139849173127773,0.00365205849016354,-0.0211429519534979,-0.0068268826720568,0.000129078827883868
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42296,-0.0210749144375,0.00550451620185797,-0.0318637661931417,-0.0102860626818584,0.000129443211391243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42678,-0.0215332255797836,0.00562511645145735,-0.03255845382464,-0.0105079973349272,0.000129746463363517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40222,-0.0268847912949348,0.00703811351984603,-0.040679493793833,-0.0130900887960365,0.000134245565038727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,40282,-0.034994347916369,0.00916307163453162,-0.052953968320051,-0.017034727512687,0.000134689612756247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,40450,-0.0133589144261804,0.00349807141557519,-0.0202151344007078,-0.00650269445165303,0.000134747401178367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40538,-0.00688354271552218,0.00180367391032739,-0.0104187435797639,-0.0033483418512805,0.000136131835620372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,42345,-0.0144126294087781,0.00377743112282067,-0.0218163944095067,-0.00700886440804963,0.000136552826613107
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,40461,-0.0270541307852918,0.00709823721268559,-0.0409666757221556,-0.0131415858484281,0.000138924609847274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42494,-0.0334898711249564,0.00879041954042772,-0.0507190934241948,-0.0162606488257181,0.000139696806208216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,40531,-0.0216393120302454,0.00568121692088153,-0.0327744971951733,-0.0105041268653176,0.000140310482848433
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42601,-0.0129151120775097,0.00339240288155947,-0.0195642217253663,-0.00626600242965318,0.00014124962528808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42593,-0.0300952405286619,0.00790678890320133,-0.0455925467789365,-0.0145979342783873,0.000141716026986541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42610,-0.0139923841755566,0.00367789588657851,-0.0212010601132505,-0.00678370823786272,0.000142748292464228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42793,-0.0152311238076019,0.00400373526926836,-0.0230784449353679,-0.00738380267983595,0.000142869492478612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40222,-0.0124244226172428,0.00327189270858018,-0.0188373323260599,-0.00601151290842565,0.000147053509651605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40198,-0.0111632027762177,0.00294217532397406,-0.0169298664112069,-0.00539653914122852,0.000148913622657613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42593,-0.0440222647012078,0.0116091751867832,-0.0667762480673029,-0.0212682813351128,0.000150080654219645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MENT,Protein MENT,40282,0.00858592270680096,0.00226434636487543,0.00414780383164512,0.0130240415819568,0.000150359584337007
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,42310,-0.0225436112403257,0.00594713182093146,-0.0341999896093513,-0.0108872328713,0.000150914550518449
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42494,-0.0212358176516058,0.00560428232433691,-0.0322202110073062,-0.0102514242959055,0.000151791895872745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40450,-0.0258285691692939,0.00682262857374181,-0.0392009211738278,-0.01245621716476,0.000154059478987213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,42310,-0.016916891471421,0.00447200220286545,-0.0256820157890373,-0.00815176715380471,0.000155734847800328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40481,-0.017612610592739,0.00466444080893042,-0.0267549145782426,-0.00847030660723533,0.000160228210147504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42345,-0.0159931385864931,0.00423607009624812,-0.0242958359751394,-0.00769044119784678,0.000160411369136321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42593,0.0100879703753989,0.00267361221984316,0.00484769042450632,0.0153282503262915,0.00016188628334757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,42369,-0.0189599976439555,0.00502565082386471,-0.0288102732587304,-0.00910972202918069,0.000162233140280195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40481,-0.0283479513065402,0.00751918455772715,-0.0430855530396854,-0.013610349573395,0.000164025296884405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40448,-0.0231998364657207,0.00615580361224263,-0.0352652115457162,-0.0111344613857251,0.000164888815164174
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42345,-0.0109835097815902,0.0029182608055709,-0.0167033009605091,-0.00526371860267122,0.000168133689871123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42678,-0.0262000328660057,0.00697804241903282,-0.03987699600731,-0.0125230697247014,0.00017432060400659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42561,-0.0278387601131254,0.00742088184646484,-0.0423836885321965,-0.0132938316940543,0.000176586750953486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40198,-0.0214121019450129,0.00571233054088657,-0.0326082698051506,-0.0102159340848752,0.00017887685380103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,40531,-0.00817339682737326,0.00218159559726004,-0.0124493241980029,-0.00389746945674359,0.000180191996671947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40456,-0.0210377164375539,0.00563014536009005,-0.0320728013433304,-0.0100026315317774,0.000187431792947518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,40510,-0.0331593999158682,0.00888116169864057,-0.0505664768452038,-0.0157523229865327,0.000189628882605083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,42447,-0.0245594289118308,0.00657885218710561,-0.0374539791985578,-0.0116648786251038,0.00018993834570105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40526,0.00849179463331598,0.00227555274609647,0.0040317112509669,0.0129518780156651,0.000191083249081984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42710,-0.0212442017174335,0.00570523951731633,-0.0324264711713735,-0.0100619322634935,0.000197176439459244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42586,-0.0251988633159769,0.0067775188489031,-0.038482800259827,-0.0119149263721269,0.000201619343109448
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,40266,-0.0369262782419585,0.00993649282762646,-0.0564018041841064,-0.0174507522998107,0.000203214451287996
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42369,-0.023808050428526,0.0064108985584801,-0.036373411603147,-0.0112426892539051,0.00020510683831298
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,42331,-0.0183424000616706,0.00493961954601857,-0.028024054371867,-0.00866074575147415,0.000205402234018987
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42720,0.0451587388137319,0.0121621458368736,0.0213209329734596,0.0689965446540041,0.000205593374590073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42753,-0.022029932025208,0.00593325406953767,-0.0336591100015018,-0.0104007540489141,0.000205670415454468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,40481,-0.0197544492202617,0.00533711058622799,-0.0302151859692685,-0.00929371247125481,0.000215486119429187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,40448,-0.0210203990524982,0.00569087189311703,-0.0321745079630076,-0.00986629014198881,0.000222057095871797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42586,-0.0197423245406009,0.00534514459467257,-0.0302188079461591,-0.00926584113504267,0.000222062830398018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAYN,Layilin,42475,-0.0136304484211146,0.00369071054190099,-0.0208642410832406,-0.0063966557589887,0.000222357394612484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40115,-0.0129631427415276,0.00351029521986492,-0.0198433213724628,-0.00608296411059234,0.000222798785912737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40181,-0.0432805905947325,0.0117264826857801,-0.0662644966588615,-0.0202966845306035,0.000224594186461982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40222,-0.0200403718716364,0.0054365776595871,-0.0306960640844271,-0.00938467965884569,0.000228709245268719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42593,0.0265325977392343,0.0072001147956006,0.0124203727398571,0.0406448227386114,0.000229582064609603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TF,Serotransferrin,40538,0.00766410307207855,0.0020805311465107,0.00358626202491757,0.0117419441192395,0.000230919624869079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,40448,-0.0364910278782724,0.00991538010223667,-0.0559251728786563,-0.0170568828778885,0.000234098232790475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40531,-0.00950484464289914,0.0025841359293047,-0.0145697510643364,-0.00443993822146192,0.000236016824881511
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42678,-0.012867618268859,0.00349898486514897,-0.019725628604551,-0.006009607933167,0.000236419536204222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40482,-0.0353504135450788,0.00961961008921794,-0.0542048493199459,-0.0164959777702116,0.000239111726415066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40481,-0.0189304085623874,0.00515843626373048,-0.0290409436392991,-0.00881987348547562,0.000243862524301121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42688,-0.0113351902648928,0.00308901451594123,-0.0173896587161376,-0.005280721813648,0.000243945472796583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42494,-0.0103795222216736,0.00283123843498923,-0.0159287495542525,-0.00483029488909473,0.000247264335659389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42675,-0.0308424972174118,0.00841331919626703,-0.0473326028420951,-0.0143523915927284,0.000247404274499273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40282,-0.0214393355431164,0.00584935572853726,-0.0329040727710494,-0.00997459831518334,0.000248253171808739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,40450,-0.0122214692043014,0.00333447649313732,-0.0187570431308506,-0.00568589527775228,0.000248297504163791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40531,-0.0187548268324681,0.00511936559602161,-0.0287887834006705,-0.00872087026426577,0.000249920158584118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,40198,-0.0178379098883114,0.004875689622609,-0.027394261548625,-0.00828155822799773,0.000254840263510305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCN,Decorin,42356,-0.00858078440607912,0.00234646223472686,-0.0131798503861438,-0.00398171842601448,0.000256276219175592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40222,-0.0115334800529726,0.00316360035132886,-0.0177341367415771,-0.00533282336436798,0.000267910674494808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42745,-0.0187169415404238,0.00513670223043071,-0.028784877912068,-0.0086490051687796,0.000269681184238128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42635,-0.023061544386907,0.00632931753782639,-0.0354670067610467,-0.0106560820127672,0.000269856313940601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42660,0.0286851537849013,0.00787447283439236,0.0132511870294923,0.0441191205403103,0.000270697892093402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40481,-0.0145129871027444,0.00398515501155269,-0.0223238909253876,-0.00670208328010107,0.000271990208170814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42593,-0.0140556613048151,0.00386351496682951,-0.0216281506398009,-0.00648317196982927,0.000275741607516366
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,40198,-0.0118162841802814,0.00325207204055503,-0.0181903453797692,-0.00544222298079353,0.000280915411182068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41746,0.0148918210777567,0.0041093168074599,0.00683756013513526,0.0229460820203781,0.000291321837404337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,40482,-0.0275384827199773,0.00762116836310085,-0.0424759727116549,-0.0126009927282996,0.000303498058142769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42438,-0.0102426533189694,0.00283502427629262,-0.0157993009005029,-0.00468600573743587,0.000303914867457237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,40510,-0.0106404643095094,0.00294506866657968,-0.0164127988960056,-0.00486812972301324,0.000304013882353216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,40450,-0.0126518207939605,0.00350303997849513,-0.0195177791518109,-0.00578586243611001,0.000305556535880355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40515,-0.00644852974194021,0.00178736279915814,-0.00995176082829016,-0.00294529865559026,0.000310080054874755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42678,-0.0194626252959801,0.00539819479040024,-0.0300430870851645,-0.0088821635067956,0.000312802791160549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40510,-0.0246064024606148,0.00682883804189651,-0.0379909250227319,-0.0112218798984976,0.000315541709580965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40482,-0.0171325924389185,0.00475851262495905,-0.0264592771838383,-0.00780590769399879,0.000319079301789047
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42586,-0.0145583188837972,0.00404372325820791,-0.0224840164698847,-0.00663262129770967,0.000319089090559394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42494,-0.0330849450712757,0.00920745834033955,-0.0511315634183413,-0.0150383267242102,0.00032772501754654
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42710,-0.0124305458221617,0.00346112740850743,-0.0192143555428363,-0.00564673610148718,0.000329980630936013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,40222,0.0219208339843263,0.00610463616080947,0.00995574710913973,0.0338859208595129,0.0003310335163775
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42345,-0.0166741475379917,0.00464718628528491,-0.0257826326571502,-0.00756566241883332,0.000334422944836746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40450,-0.0180351004750966,0.00503053959093545,-0.0278949580733301,-0.00817524287686313,0.000338346103472697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40282,-0.0132148593676346,0.00369184218791248,-0.0204508700559431,-0.00597884867932616,0.000345754868937225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42586,-0.0086940434159093,0.00243214431073663,-0.0134610462649531,-0.0039270405668655,0.000351942176930127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42610,-0.0116227012751863,0.00325301804402044,-0.0179986166414663,-0.00524678590890621,0.000354289984387862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40115,-0.0113746642293348,0.00318446293711476,-0.0176162115860797,-0.00513311687258987,0.000355891024176438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42291,-0.019605252283439,0.00549448763459961,-0.0303744480472542,-0.00883605651962374,0.000360771067194799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,42369,-0.0108586108130009,0.00304627997886852,-0.0168293195715832,-0.00488790205441863,0.000365773566784819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,40481,-0.0359143425986005,0.0100774430062969,-0.0556661308909425,-0.0161625543062586,0.000366984562746697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42610,0.0108125893832362,0.00303446289674371,0.00486504210561855,0.0167601366608539,0.000367544324133001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40538,-0.00907975905312486,0.00254831456613662,-0.0140744556027526,-0.00408506250349708,0.00036808234238302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42710,-0.0107062931581393,0.00300734931488413,-0.0166006978153122,-0.0048118885009664,0.000372066732045673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,40222,0.0216428989432936,0.00607915502740059,0.00972775508958848,0.0335580427969988,0.000372157438726892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40531,-0.0162838081573665,0.00457518785523679,-0.0252511763536306,-0.00731643996110238,0.000373569699915887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,40282,-0.015721896867494,0.00443315410709281,-0.0244108789173959,-0.00703291481759211,0.000392090742954617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFB,Complement factor B,40343,-0.0111804523544456,0.00315548478029052,-0.0173652025238151,-0.00499570218507619,0.000396948453329116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42584,-0.0187169093989757,0.00528900380444202,-0.0290833568556821,-0.00835046194226938,0.00040325943592521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42617,-0.0094265018879499,0.00266517543713035,-0.0146502457447254,-0.00420275803117442,0.000406193818891333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,40198,-0.00923755715180297,0.0026158050747196,-0.0143645350982534,-0.00411057920535255,0.00041499572509775
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42586,-0.0203950905273391,0.00577994684275598,-0.0317237863391408,-0.0090663947155374,0.000419172342063475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40481,-0.024655948847992,0.00699377219754166,-0.0383637423551736,-0.0109481553408103,0.000424495940100168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42635,-0.0269612146640897,0.00764947739046558,-0.0419541903494023,-0.0119682389787772,0.000425560887651753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40222,-0.0208166800481641,0.00590961848705549,-0.0323995322827928,-0.00923382781353531,0.000429212652448681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40012,0.0110720981209233,0.00314418850199767,0.00490948865700786,0.0172347075848387,0.000430963545279155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42593,-0.0409243069322633,0.0116310646544445,-0.0637211936549746,-0.018127420209552,0.000435374822337731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42666,-0.0379288468518536,0.0107885071841099,-0.059074320932709,-0.0167833727709981,0.000440084826072815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42479,-0.0161954193769138,0.0046071237640065,-0.0252253819543665,-0.00716545679946105,0.000440721672838698
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,40498,-0.0149951579156049,0.00427734477259927,-0.0233787536698994,-0.00661156216131029,0.000457145040203501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40448,-0.0199326509452709,0.00568781639655715,-0.0310807710825229,-0.0087845308080189,0.000459335567739271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40526,0.0116474744418986,0.00332393584867029,0.00513256017850481,0.0181623887052923,0.000459884789507549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42635,-0.00970221279383776,0.00277119568090578,-0.0151337563284131,-0.00427066925926244,0.00046485737753578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42510,-0.0114971799406946,0.00328584028359493,-0.0179374268965406,-0.00505693298484848,0.000468518630290505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42777,-0.00975972726797782,0.00278931327978735,-0.015226781296361,-0.00429267323959461,0.000468552148672748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40282,-0.0280725029440421,0.00802435535186295,-0.0438002394336935,-0.0123447664543907,0.000469872156071037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42753,-0.0332269633314135,0.00952235408752829,-0.051890777342969,-0.0145631493198581,0.000485707717826601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42593,-0.0376083569136116,0.0107780808479728,-0.0587333953756383,-0.0164833184515849,0.000485775731571474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42651,-0.0155609362558885,0.0044653039649881,-0.0243129320272652,-0.00680894048451187,0.000493971537613589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40282,-0.0292042091506057,0.00839596646428022,-0.045660303420595,-0.0127481148806165,0.000506424454761697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40481,-0.020611896319463,0.00592600108702373,-0.0322268584500295,-0.00899693418889649,0.000506670478996571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40198,-0.0305134582240645,0.0087734722206444,-0.0477094637765275,-0.0133174526716015,0.000507268675268646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42369,-0.0134331375426532,0.00386857430969519,-0.0210155431896558,-0.00585073189565066,0.000517531864075544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,40482,-0.0252082382789725,0.00726526010354924,-0.039448148081929,-0.010968328476016,0.000522995118245217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40282,-0.0105462502555177,0.00304419600366174,-0.0165128744226947,-0.00457962608834066,0.000533465216214609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,40510,-0.0108680731200191,0.00313828435277856,-0.017019110451465,-0.00471703578857309,0.000536040811326241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42593,0.0118533753102207,0.00342352773034214,0.00514326095875012,0.0185634896616913,0.000537195665148076
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40198,-0.0164829046939127,0.00476758513558499,-0.0258273715596593,-0.00713843782816611,0.000547708330229685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,40266,0.0125701404552059,0.00363611427941437,0.00544335646755375,0.0196969244428581,0.000548224142610755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42657,-0.0234854254250889,0.00679755302029679,-0.0368086293448706,-0.0101622215053072,0.000552024709700267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42593,-0.0186016696244234,0.00538617314038997,-0.0291585689795878,-0.00804477026925906,0.000554874108551903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42645,-0.0153937425251582,0.00446088662458786,-0.0241370803093504,-0.00665040474096599,0.000560590159301134
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,42345,-0.0250383463143472,0.00725942144123199,-0.0392668123391619,-0.0108098802895325,0.000564257154385208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40115,-0.0230612761331809,0.00668617216713561,-0.0361661735807667,-0.0099563786855951,0.000564581967617235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,42352,-0.0298666976952497,0.00866129786441636,-0.0468428415095058,-0.0128905538809936,0.000565906390925346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,40450,-0.0154834785331092,0.00449002371321444,-0.0242839250110095,-0.00668303205520887,0.000565944612371801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42635,-0.022475218453399,0.00651844852569721,-0.0352513775637655,-0.00969905934303246,0.000566610070977344
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42610,-0.00775054242300269,0.00224944498239123,-0.0121594545884895,-0.00334163025751588,0.000571673652816679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42593,-0.0140987330210991,0.00409566143249698,-0.0221262294287932,-0.00607123661340505,0.000578427705416774
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40450,-0.0134925782621922,0.0039226287840072,-0.0211809306788463,-0.00580422584553809,0.000584519249484156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,42474,-0.0170753555497377,0.00496460594468714,-0.0268059832013245,-0.0073447278981509,0.000584756881421081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42678,-0.0267605872844568,0.00782097399414891,-0.0420896963129887,-0.011431478255925,0.000624285020536074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42356,-0.0363903668855182,0.0106482564910993,-0.0572609496080729,-0.0155197841629635,0.000633914468785861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40448,-0.0132538138407101,0.00388354785104268,-0.0208655676287538,-0.00564206005266647,0.000645230317348305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,40181,-0.0162690439615027,0.00476829756145274,-0.0256149071819501,-0.00692318074105537,0.000647398308449342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',40115,-0.0144369557448344,0.00423279556819705,-0.0227332350585007,-0.00614067643116823,0.000650219847530334
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42345,-0.024483820354164,0.00717891673178641,-0.0385544971484653,-0.0104131435598626,0.000650346569076775
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40510,-0.035341158659712,0.0103661992469341,-0.0556589091837028,-0.0150234081357211,0.000653645649767051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42688,-0.0329949909708478,0.00968063539101847,-0.051969036337244,-0.0140209456044515,0.000655480845953313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40301,-0.0244509974083421,0.00718919000468381,-0.0385418098175223,-0.0103601849991618,0.000673571072529014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42345,-0.0255065087235946,0.00750276392341663,-0.0402119260134912,-0.010801091433698,0.000676812426208179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,42345,-0.0159694605149668,0.00470008237911186,-0.025181621978026,-0.00675729905190752,0.000681568229205641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42586,-0.019616658063602,0.00577415171126478,-0.030933995417681,-0.00829932070952301,0.000682466024102443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,40198,-0.0186980059339828,0.0055070672330817,-0.0294918577108229,-0.00790415415714264,0.000688020533363955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42720,-0.0196652879435436,0.00579435570844425,-0.0310222251320943,-0.00830835075499286,0.000691102561599353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42635,-0.0128203977909098,0.00377845278392382,-0.0202261652474005,-0.00541463033441914,0.000693239080442833
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42668,-0.00988773571738794,0.00291426585295336,-0.0155996967891765,-0.00417577464559935,0.000693625806266691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42688,-0.00998638313141461,0.00294809074123036,-0.0157646409842261,-0.0042081252786031,0.0007075817568492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2,Prothrombin,40538,-0.00491461820236941,0.00145127263840425,-0.00775911257364175,-0.00207012383109707,0.000710513805013014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42635,-0.00577507258630384,0.00170800190092694,-0.00912275631212065,-0.00242738886048703,0.000723791552000491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42770,-0.0101641698735987,0.00300739485590224,-0.0160586637911671,-0.00426967595603029,0.000727624568555873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,42310,-0.0227915187032107,0.00674793727959613,-0.0360174757712191,-0.00956556163520231,0.000733463510325665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42678,-0.0203470875416389,0.00602624992338931,-0.0321585373914819,-0.00853563769179582,0.000736459256444238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40282,-0.00764298351015454,0.00226714041933645,-0.012086578732054,-0.0031993882882551,0.000750971482727851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,40282,-0.00960842531756629,0.00285347869388126,-0.0152012435575736,-0.00401560707755902,0.000761752471013254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,40198,-0.0098596016384468,0.00292882975138041,-0.0156001079511524,-0.0041190953257412,0.000764179196865665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42635,-0.00905204617207921,0.00269408941436105,-0.0143324614242269,-0.00377163091993155,0.000781692274872426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,42345,-0.0185459710943363,0.0055200524285343,-0.0293652738542635,-0.00772666833440903,0.000782361065189589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40448,-0.0231065660272636,0.0068782107494091,-0.0365878590961055,-0.0096252729584218,0.000783752775621122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42748,-0.00903892203192623,0.00269218802237161,-0.0143156105557746,-0.00376223350807788,0.0007887766311553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42678,-0.00957647998460208,0.00285560865246274,-0.0151734729434291,-0.0039794870257751,0.000799962787542686
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40510,-0.0171524193772591,0.0051178481036195,-0.0271834016603534,-0.0071214370941649,0.000806409817672338
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40538,-0.0051402447243715,0.00153383938864729,-0.0081465699261202,-0.00213391952262281,0.000807168924092415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40448,-0.016686875047411,0.00498164616130053,-0.02645090152356,-0.00692284857126193,0.00081173483528819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42345,-0.017248397953309,0.00515631963041176,-0.027354784428916,-0.00714201147770189,0.000824833836387874
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42610,-0.0248152915925742,0.00741974662572953,-0.039357994979004,-0.0102725882061443,0.000826589465794519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40482,-0.0140597462146886,0.0042040305046988,-0.0222996460038983,-0.00581984642547895,0.000827444369232737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40448,-0.0166132211623071,0.00498419191699571,-0.0263822373196187,-0.00684420500499545,0.000861356076795719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42345,-0.0243989280495331,0.00733478084436096,-0.0387750985044806,-0.0100227575945857,0.000881944853200317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,42345,-0.0273073131948115,0.00821148388308516,-0.0434018216056584,-0.0112128047839646,0.000885007512344406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40450,0.0168037498293315,0.00505536076665427,0.00689524272668911,0.0267122569319738,0.000890365040026918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40482,-0.0169584915125458,0.0051157495930857,-0.0269853607149938,-0.00693162231009786,0.000919459991138135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42653,-0.0285070501021479,0.00859994363944598,-0.045362939635462,-0.0116511605688338,0.000919526977524941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40222,-0.0271079477861076,0.00818015755532817,-0.0431410565945508,-0.0110748389776644,0.000923120109889979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42688,-0.0221161469492599,0.00667527847986582,-0.0351996927697969,-0.00903260112872293,0.000924967516947991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40481,-0.0213596316970556,0.00644846472242911,-0.0339986225530167,-0.00872064084109456,0.000928034220712025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40510,-0.0250168399711032,0.007563129400476,-0.0398405735960362,-0.0101931063461702,0.000943465394588311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42675,-0.014732242685079,0.0044547694108426,-0.0234635907303305,-0.00600089463982752,0.000945232689990894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBN1,Drebrin,40198,-0.0160863776249373,0.00486939954248258,-0.0256304007282032,-0.00654235452167146,0.000957685902959668
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42494,-0.0188570454429599,0.00571212320544765,-0.0300528069256372,-0.00766128396028247,0.000965146853274416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42793,-0.0104290920307266,0.00316219174837231,-0.0166269878575363,-0.00423119620391684,0.000976058736488705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40115,-0.0217520853824851,0.00660278380799745,-0.0346935416461601,-0.00881062911881012,0.000989527175919136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42675,-0.013539005403377,0.00411303470754582,-0.0216005534301668,-0.00547745737658718,0.000998286493231803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42678,-0.019391354463919,0.0058912409141344,-0.0309381866556225,-0.00784452227221562,0.000998905022077099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,40198,-0.0263267800051015,0.00799890861524228,-0.0420046408909763,-0.0106489191192266,0.00100040723151628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42610,-0.0165669379496075,0.00503417833765188,-0.0264339274914051,-0.00669994840780979,0.00100127941075694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,40222,-0.0104836029578736,0.00318600054069246,-0.0167281640176308,-0.00423904189811641,0.00100315787059431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,42369,-0.0362091586345348,0.0110198386998809,-0.0578080424863013,-0.0146102747827683,0.00101953248371285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,40282,-0.0180661723006347,0.00550004712011401,-0.0288462646560582,-0.00728607994521127,0.0010239658404729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42458,-0.00953340136470567,0.00290719533600382,-0.0152315042232732,-0.00383529850613818,0.001043539503532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40198,-0.0128870154270314,0.00393006628366364,-0.0205899453430121,-0.00518408551105062,0.00104468235805559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40301,-0.0289068373727592,0.00885922377272716,-0.0462709159673045,-0.011542758778214,0.00110608200969622
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42612,-0.0103487692491741,0.00317318619705209,-0.0165682141953962,-0.00412932430295203,0.00111172353741142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42369,0.0189046530854553,0.00580414379660034,0.00752853124411866,0.030280774926792,0.00112843112443583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42753,-0.0242231610747021,0.00744344372412062,-0.0388123107739785,-0.0096340113754257,0.00113952711721508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42586,-0.01768789802459,0.00544260249370573,-0.0283553989122532,-0.00702039713692676,0.00115731729199995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42675,-0.0182052213428214,0.00560238850060194,-0.0291859028040012,-0.00722453988164163,0.00115872529304165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42733,-0.0218139955770578,0.00672302500878146,-0.0349911245942695,-0.00863686655984619,0.00117872306724823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42763,-0.0174245434758855,0.00537797038560619,-0.0279653654316736,-0.00688372152009736,0.0011982390657153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40510,-0.0103224635585111,0.00318611753405996,-0.0165672539252686,-0.00407767319175359,0.00119948468762453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42710,-0.00736159052508479,0.00227239035314534,-0.0118154756172496,-0.00290770543291993,0.00119995180186197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42593,0.0163547455568908,0.00504990255906473,0.00645693654112389,0.0262525545726576,0.00120399491238034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40181,-0.0172410399245905,0.00532798139569378,-0.0276838834601503,-0.00679819638903072,0.00121600989667021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,42475,-0.0235196938353768,0.00726866740599078,-0.0377662819511187,-0.00927310571963485,0.0012161467800317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40079,-0.0133452676830057,0.00412720874322757,-0.0214345968197317,-0.00525593854627968,0.00122654285549062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,42458,-0.0211111288992865,0.00653204194752961,-0.0339139311164445,-0.00830832668212844,0.00123255628627087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40115,-0.0156507074827366,0.00484442211156639,-0.0251457748214068,-0.0061556401440665,0.00123868132308479
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42678,-0.0137833786873616,0.00426678451284553,-0.0221462763325388,-0.00542048104218435,0.00123917776631364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40482,-0.0199234405691978,0.00617387061719369,-0.0320242269788974,-0.00782265415949815,0.00125426837496947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42635,-0.0268637810505716,0.00833947233944224,-0.0432091468358784,-0.0105184152652648,0.00127922861949403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,42369,-0.0150567868931965,0.00467487003147608,-0.0242195321548897,-0.00589404163150341,0.0012814686729856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42635,-0.0248511137883957,0.00771656480539567,-0.0399755808069712,-0.00972664676982016,0.00128276328989527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,40222,-0.03675626511505,0.0114136052325152,-0.0591269313707797,-0.0143855988593202,0.00128387171347352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPSE,Heparanase,40407,-0.0292989043831688,0.00909962553714048,-0.0471341704359641,-0.0114636383303734,0.0012864893662949
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40301,-0.0329420654773153,0.0102353587407977,-0.0530033686092788,-0.0128807623453517,0.0012925222447779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42675,-0.0285574904628673,0.00889381199314153,-0.0459893619694247,-0.0111256189563099,0.00132612144865771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42593,-0.0180048515951511,0.00560981040731204,-0.0290000799934827,-0.00700962319681947,0.00133265630451175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42310,-0.00878786648229731,0.00274054551992932,-0.0141593357013588,-0.00341639726323585,0.00134630091479931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40222,-0.0151815851583862,0.00474203971195185,-0.0244759829938118,-0.00588718732296056,0.00137107342133303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42720,-0.012305844792655,0.00384646366671387,-0.0198449135794142,-0.00476677600589587,0.00138097665526165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42710,-0.00945319869007642,0.00295528638095264,-0.0152455599967436,-0.00366083738340925,0.00138346987447357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARTN,Artemin,42369,-0.0139619234161851,0.00436495212128646,-0.0225172295739065,-0.0054066172584636,0.00138402728576071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42494,-0.024527912491381,0.0076697308271703,-0.0395605849126348,-0.00949524007012718,0.00138701268117087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42610,-0.0121116646959008,0.00378969994027818,-0.019539476578846,-0.00468385281295556,0.00139697497510333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40407,-0.0338249209174505,0.010583926686735,-0.0545694172234511,-0.01308042461145,0.00139793194144996
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40222,-0.00654581839679734,0.00205094221055929,-0.0105656651294935,-0.00252597166410113,0.00141876384886848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40222,-0.0294159107468304,0.00922742535478742,-0.0475016644422137,-0.011330157051447,0.0014372090426544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42369,-0.016477200749649,0.00517378109489047,-0.0266178116956343,-0.00633658980366365,0.00145216290375427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40382,-0.0184365376648203,0.0057952294640496,-0.0297951874143575,-0.00707788791528305,0.00147000910092702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42635,-0.00897093163740494,0.00282307701799509,-0.0145041625926753,-0.00343770068213457,0.00148777064883537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42586,-0.00821922388572528,0.00259221639522016,-0.0132999680203568,-0.00313847975109377,0.00152397944452251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,40482,0.0218463489279209,0.00689623477678845,0.00832972876541553,0.0353629690904263,0.00153971440539655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FN1,Fibronectin,40538,-0.00820664907358484,0.00259774678509953,-0.0132982327723799,-0.00311506537478975,0.00158650152689032
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42593,-0.0215676586659211,0.00682867919853535,-0.0349518698950504,-0.00818344743679178,0.00158993281213248
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40135,-0.0229085630063702,0.00726349335280055,-0.0371450099778593,-0.00867211603488115,0.0016152250233232
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,40198,-0.0166316777606176,0.0052802658285337,-0.0269809987845436,-0.00628235673669152,0.00163830618630029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42619,-0.0150501276476954,0.00478706654431986,-0.0244327780745623,-0.00566747722082848,0.0016706739505344
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42610,-0.0173209958455,0.00551343077025368,-0.0281273201551972,-0.00651467153580279,0.0016839259853974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42475,-0.0291531301172053,0.00928081480652709,-0.0473435271379984,-0.0109627330964122,0.00168611951512906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,40450,-0.00811069429141578,0.00258192816389463,-0.0131712734926492,-0.0030501150901823,0.00168616890107311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40181,-0.0186279197744647,0.00593225680905345,-0.0302551431202095,-0.00700069642871996,0.00169333962404323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42345,-0.0142505884966151,0.00453947346297707,-0.0231479564840501,-0.00535322050918003,0.00169749651829921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40448,-0.0233838575853868,0.00746208413186765,-0.0380095424838474,-0.00875817268692623,0.00173066572935428
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42736,-0.00950404480042162,0.00303793812743647,-0.0154584035301971,-0.00354968607064613,0.00176102236051284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42593,-0.0134797509982306,0.00430877006822373,-0.0219249403319491,-0.00503456166451211,0.00176110528609289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPART,Spartin,40282,-0.0233453447924679,0.00746577882419942,-0.0379782712878988,-0.00871241829703703,0.00177068454889431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,40032,-0.013305944113997,0.00425567715543632,-0.0216470713386522,-0.0049648168893418,0.00177287731984539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40510,-0.0271254862899572,0.00868696537398207,-0.0441519384229621,-0.0100990341569524,0.00179743501284455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,42331,-0.0226649989744836,0.00726227057536353,-0.0368990493021961,-0.00843094864677104,0.00180674923773447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42720,-0.0140304326937715,0.00449642202739795,-0.0228434198674715,-0.00521744552007154,0.00181013217892747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42793,0.0119584145879125,0.00384430193178346,0.00442358280161689,0.0194932463742081,0.00187039674081916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42558,-0.0219534472757963,0.00706439913109759,-0.0357996695727476,-0.00810722497884501,0.00188997840423299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,42345,-0.0117908964779682,0.00380465659811432,-0.0192480234102722,-0.0043337695456641,0.00194538852699443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,40181,-0.0195432968965923,0.0063059982503459,-0.0319030534672702,-0.0071835403259143,0.00194560477266857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42593,-0.0187476041434233,0.00606130777245687,-0.0306277673774388,-0.00686744090940788,0.0019855381010558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42494,-0.0107715358785726,0.00348479431658159,-0.0176017327390725,-0.00394133901807272,0.00199888769837542
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40115,-0.0122033016414856,0.00394830497259948,-0.0199419793877806,-0.00446462389519059,0.00200140683806692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42586,-0.0253459307315937,0.00821155043504591,-0.0414405695842836,-0.00925129187890369,0.0020285993676333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42602,-0.0326687153397338,0.0105840037393486,-0.0534133626688571,-0.0119240680106106,0.00202864323165796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42612,-0.00949173059491601,0.00307679934013174,-0.0155222573015742,-0.0034612038882578,0.00204009626486266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,42310,-0.0115496941360971,0.00374512827010025,-0.0188901455454936,-0.00420924272670061,0.00204713674762873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40282,-0.0110074971643852,0.00357232535310188,-0.0180092548564649,-0.00400573947230555,0.00206586251735589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,42335,-0.0118963127894444,0.00386624852819647,-0.0194741599047095,-0.00431846567417929,0.00209549715731672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,40448,-0.0180026462496218,0.00585438206297798,-0.0294772350930587,-0.00652805740618495,0.00210956095898403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSPN,Claspin,42291,-0.0104989992581599,0.00342293973708086,-0.0172079611428384,-0.0037900373734814,0.00216481463549354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40282,-0.012070793392801,0.00393524858657136,-0.0197838806224808,-0.00435770616312111,0.00216484721125937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40448,-0.0258942318797101,0.00844845408492027,-0.0424532018861538,-0.00933526187326637,0.00218209549511703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40326,-0.0024483677419173,0.00079931472188568,-0.00401502459681323,-0.000881710887021367,0.00219592121116879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40510,-0.0119722069429534,0.00391075731156002,-0.0196372912736111,-0.00430712261229578,0.00220856077414631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42586,-0.00780780054129369,0.00255175094106491,-0.0128092323857809,-0.00280636869680646,0.0022193640923839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42494,-0.0277431262009758,0.00907329160753973,-0.0455267777517536,-0.00995947465019788,0.0022350849309571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42778,-0.0105634021230006,0.00346080483630815,-0.0173465796021645,-0.00378022464383659,0.00227536455681473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40181,-0.0165155908230063,0.00541597809858556,-0.027130907896234,-0.00590027374977863,0.00229829665375948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42586,0.0277794956364109,0.00911795974208011,0.00990829454193391,0.0456506967308879,0.00231835098560725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,40181,-0.0143231015233644,0.0047041783837897,-0.0235432911555922,-0.00510291189113655,0.00233416094615735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,42369,-0.0185876934025891,0.00611334811154384,-0.030569855701215,-0.00660553110396318,0.00236642005723212
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42585,-0.0199735165356072,0.00657961217451281,-0.0328695563976523,-0.00707747667356212,0.00240464693458012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40481,-0.010667478638772,0.00351431068740807,-0.0175555275860918,-0.00377942969145215,0.00240732422331959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42310,-0.0119705904689956,0.00394688224553057,-0.0197064796702355,-0.00423470126775569,0.00242670712907625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,42345,-0.011876506810544,0.00392560648750107,-0.0195706955260461,-0.00418231809504189,0.00248789025535597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42586,-0.0338997025820079,0.0112145537308169,-0.055880227894409,-0.0119191772696068,0.00250895514222074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42494,-0.0229317766614465,0.00758701626945931,-0.0378023285495867,-0.0080612247733062,0.00251171111085765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42753,-0.0105260262233036,0.00348271555872803,-0.0173521487184106,-0.00369990372819669,0.00251278864298379
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,42291,0.0179225942745813,0.00593203438849818,0.00629580687312484,0.0295493816760377,0.00252158214149196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42593,-0.0105730951261947,0.00350110025996856,-0.0174352516357331,-0.0037109386166563,0.00253305194497259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42586,-0.0195942364052293,0.00649362802010399,-0.0323217473246331,-0.00686672548582544,0.00255385057103436
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40448,-0.0140447343394433,0.00465645208620341,-0.023171380428402,-0.00491808825048465,0.0025654611453604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42793,0.0183297208177966,0.00608039175919092,0.00641215296978241,0.0302472886658108,0.00257824724702086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42587,-0.0231242292690512,0.00767568904839809,-0.0381685798039115,-0.00807987873419099,0.00259453962538818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40481,-0.0341379134047549,0.0113386676485888,-0.056361701995989,-0.0119141248135208,0.00261178153524792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42494,-0.0113887193036554,0.00379011716878547,-0.0188173489544749,-0.00396008965283584,0.00266210232298428
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42542,-0.0146782790656541,0.00488857350213511,-0.0242598831298389,-0.00509667500146926,0.00268206950840828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42589,-0.025372627913678,0.00845399024720079,-0.0419424487981915,-0.00880280702916444,0.0026935959002869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42494,-0.0233588421372031,0.00779174834264438,-0.0386306688887861,-0.00808701538562014,0.00272353717933722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,40222,-0.0154910756899232,0.00517310624411335,-0.0256303639283853,-0.00535178745146099,0.00275468640915838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42356,-0.0148190000085648,0.00495016556047542,-0.0245213245070966,-0.00511667551003297,0.00276185485599351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42635,-0.0303187799677694,0.0101543247267992,-0.0502212564322958,-0.0104163035032429,0.00283347309436664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42710,-0.0380982714772445,0.0127766396175244,-0.0631404851275923,-0.0130560578268967,0.0028700488628653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40198,-0.0257964612726154,0.00865828845004227,-0.0427667066346982,-0.00882621591053252,0.0028944879832537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42475,-0.0213198556366102,0.00715937362446598,-0.0353522279405636,-0.00728748333265693,0.00290760389905983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0080623816513549,0.00271138173996982,0.00274807344101405,0.0133766898616958,0.00295032176995954
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40181,-0.0208276004625583,0.00700963129430337,-0.0345664777993929,-0.00708872312572366,0.00297200151045751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,42356,-0.0157176549934955,0.00531101148946744,-0.0261272375128516,-0.00530807247413927,0.00308740998834841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,42345,-0.0230038824321998,0.00777732233034272,-0.0382474341996716,-0.0077603306647281,0.00310378952785908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42345,-0.0170623465027876,0.00577088057184935,-0.0283732724236123,-0.00575142058196284,0.00311575701472439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42710,-0.0180563209408757,0.00611137266051396,-0.0300346113554831,-0.00607803052626835,0.00313671067874801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42740,-0.0150818476537588,0.00511076289293084,-0.0250989429239032,-0.00506475238361432,0.00317292125115449
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40282,-0.0202927176156027,0.0068869056595899,-0.0337910527083988,-0.00679438252280646,0.0032199320310614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42675,-0.00793324981975208,0.0026948291395819,-0.0132151149333326,-0.00265138470617156,0.00324680017848495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42593,-0.0143559898470918,0.00487859663038302,-0.0239180392426426,-0.00479394045154111,0.00325976444462593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40482,-0.0108873880706776,0.00370477343757777,-0.0181487440083301,-0.00362603213302521,0.00330210189269703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42635,0.0181613009359262,0.00618943015697478,0.00603001782825563,0.0302925840435968,0.00334926056892113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39982,-0.0140819717122941,0.00480131392326504,-0.0234925470018936,-0.0046713964226946,0.00336473587467218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42586,-0.0289387911564795,0.00990086958858192,-0.0483444955501001,-0.00953308676285897,0.00347419928109618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40450,-0.00978079281326565,0.00335102175821909,-0.0163487954593751,-0.00321279016715623,0.00352134601111491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42585,-0.0183171483781523,0.00628267539212486,-0.030631192146717,-0.00600310460958756,0.00355706330996286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40301,-0.0108600432197305,0.00372588747256986,-0.0181627826659675,-0.0035573037734936,0.00356680568113587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40510,-0.0137719093966353,0.00472710023544777,-0.0230370258581129,-0.00450679293515764,0.00358221847771253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40198,-0.0258234253831733,0.00886494102783173,-0.0431987097977235,-0.00844814096862308,0.00358713750895939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42568,-0.00722229595646016,0.00248221977188888,-0.0120874467093624,-0.00235714520355796,0.00362474218296969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40301,-0.0198232532798997,0.0068258485069513,-0.0332019163535242,-0.00644459020627512,0.00368983402523866
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40222,-0.0147681445377635,0.00508869843890652,-0.0247419934780203,-0.00479429559750672,0.00371349857481116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42568,-0.0249807772709851,0.0086149839893632,-0.041866145890137,-0.00809540865183326,0.0037414057368651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,42369,-0.0136755596172514,0.00471773316762108,-0.0229223166257887,-0.0044288026087141,0.00375263954882834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40276,0.013141741179292,0.00453479697584657,0.00425353910663268,0.0220299432519512,0.00376313252227664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,42345,-0.0121181436328334,0.00418261970685642,-0.020316078258272,-0.00392020900739484,0.00377056803559665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42675,-0.0080022335629498,0.00276278402979941,-0.0134172902613566,-0.00258717686454295,0.00378031704020563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,40197,-0.0197033177043543,0.00680348299270526,-0.0330381443700566,-0.00636849103865199,0.00378620290876797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42494,-0.0280120359143192,0.00967299120962175,-0.0469710986851778,-0.00905297314346054,0.00378686071012297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42635,-0.00879786629969226,0.00303874784702726,-0.0147538120798657,-0.00284192051951883,0.00379493965118061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42753,-0.0211539701702454,0.00731897192702357,-0.0354991551472116,-0.00680878519327921,0.00385494036477162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40510,-0.00854591126394751,0.0029570030654732,-0.014341637272275,-0.00275018525562004,0.00385902393403632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40448,-0.0129719882350385,0.00448855415041069,-0.0217695543698434,-0.00417442210023351,0.00385959712378733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42793,-0.00891740763722324,0.0030908802662894,-0.0149755329591505,-0.00285928231529601,0.00391940892453109
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42586,-0.0540224589111581,0.018733902330443,-0.0907409074788265,-0.0173040103434898,0.00393692096932704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42753,-0.00746553916378176,0.00259134946737328,-0.0125445841198334,-0.00238649420773013,0.00397104587946548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,40059,-0.0124414615469455,0.00432235391755819,-0.0209132752253596,-0.00396964786853145,0.00400478205493689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,40450,-0.0230546786217638,0.00801304382282196,-0.0387602445144948,-0.00734911272903277,0.00402047154642025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42653,-0.0308006528022304,0.010706484455108,-0.0517853623342421,-0.00981594327021878,0.00402333012695637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,40382,-0.00843512511058353,0.00293921835432326,-0.0141959930850571,-0.00267425713610993,0.00411431999201443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,42369,-0.0082506706924909,0.00287684958088155,-0.0138892958710187,-0.00261204551396306,0.00413792115782031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,40301,0.0152476443129393,0.00532177726311018,0.0048169608772433,0.0256783277486352,0.00417605209558925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40135,-0.0165486107270367,0.0057835641592053,-0.0278843964790791,-0.00521282497499436,0.00422684679238532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,42475,-0.0176156331744134,0.00615760805923923,-0.0296845449705223,-0.00554672137830451,0.00423244233005504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40181,-0.0119732127650814,0.00418521006754414,-0.0201762244974679,-0.00377020103269485,0.0042331850448388
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42662,-0.00894244227995148,0.00313084662412006,-0.0150789016632268,-0.00280598289667616,0.00429349898762961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40450,-0.0139489657148751,0.00488553448154426,-0.0235246132987018,-0.00437331813104832,0.0043094265770679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42586,-0.0247845607649048,0.00869321112178229,-0.0418232545635981,-0.00774586696621151,0.00436451769148924
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,42356,-0.017152540552591,0.00602218730520001,-0.0289560276707831,-0.00534905343439903,0.00440320510526331
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,40008,-0.0108871873052858,0.00382362911663212,-0.0183815003738847,-0.00339287423668681,0.00441687678277486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,40181,-0.00644117601304536,0.0022649490864317,-0.0108804762224515,-0.00200187580363922,0.00446542866684506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40198,-0.021945582876539,0.00774455886139057,-0.0371249182448646,-0.00676624750821353,0.00460994684495186
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40135,-0.0178053695531866,0.00628576564202606,-0.0301254702115577,-0.00548526889481553,0.00462483838244782
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,40482,-0.0192563833919525,0.00680104303229652,-0.0325864277352537,-0.00592633904865129,0.00464286128728846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,40222,-0.0166317438848122,0.00587660796382954,-0.0281498954939181,-0.00511359227570628,0.00466087541910367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,42345,-0.00785008491804375,0.00277422874538498,-0.0132875732589983,-0.00241259657708919,0.00466701367163825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,40115,-0.0110673486636513,0.00391614083081175,-0.0187429846920423,-0.00339171263526025,0.0047206255303748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42635,-0.0102505604568517,0.00363587424891671,-0.0173768739847285,-0.00312424692897497,0.00482013715205406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40448,-0.0175375710763982,0.00622158586862815,-0.0297318793789093,-0.00534326277388699,0.00482837113398966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42720,0.0166594271137107,0.0059129102034727,0.0050701231149042,0.0282487311125172,0.00484743283516245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42345,-0.0123799954357995,0.00439543097531581,-0.0209950401474185,-0.00376495072418054,0.00486132667396816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42494,-0.0199220036966642,0.00708426377877286,-0.033807160703059,-0.00603684669026939,0.00492838081975598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,40482,-0.0227965823843035,0.00811508836528973,-0.0387021555802713,-0.0068910091883356,0.00497563277060205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42494,-0.0188668994553167,0.00672892402607838,-0.0320555905464303,-0.00567820836420309,0.00505694247809431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42586,0.0220063176735412,0.00784943304721203,0.00662142890100559,0.0373912064460768,0.00506153075909717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,40481,-0.00977351859933591,0.00348796277299517,-0.0166099256344064,-0.00293711156426538,0.00508622328079747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,40181,-0.035313287640542,0.0126079382884783,-0.0600248466859595,-0.0106017285951245,0.00510529561256406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,40198,-0.00800344785710031,0.00286389460417899,-0.0136166812812911,-0.00239021443290948,0.00520534506038824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,40450,-0.0152220776386854,0.00544902661745345,-0.0259021698088942,-0.00454198546847667,0.00522225545449238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42697,-0.0112559356662218,0.00403121701312297,-0.0191571210119429,-0.00335475032050082,0.00524257320066721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,40482,-0.0101582235755755,0.00363818266090061,-0.0172890615909407,-0.00302738556021028,0.0052452840139163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,40135,-0.0109112399563481,0.00390865341950849,-0.0185722006585847,-0.00325027925411142,0.00525456030662561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42593,-0.0225034943586993,0.00806221649828319,-0.0383054386953344,-0.00670155002206425,0.00525825721420998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42710,-0.00774196472440578,0.00277369903972472,-0.0131784148422662,-0.00230551460654532,0.00525857406070603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40181,-0.0188673688791942,0.00676105367678683,-0.0321190340856964,-0.00561570367269201,0.0052701830355401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40115,-0.014292725774157,0.00512572831388757,-0.0243391532693766,-0.00424629827893732,0.00530561014596097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42753,-0.0253556765676089,0.00909671601108859,-0.0431852399493425,-0.00752611318587528,0.00532159764414791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42586,-0.0123830776275115,0.00444643361665529,-0.0210980875161559,-0.00366806773886713,0.00536118170568584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42617,-0.0102936781634251,0.00369926555544944,-0.017544238652106,-0.0030431176747442,0.00539959907457139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLN,Promotilin,42593,-0.0240029903291928,0.00863022320732373,-0.0409182278155474,-0.00708775284283833,0.00542221398560617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42635,-0.0170757668684768,0.00614046448267498,-0.0291110772545198,-0.00504045648243386,0.00542907108494353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40301,-0.018933264254699,0.00680930221766926,-0.0322794966013307,-0.00558703190806721,0.00543666527319746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42310,-0.0137898836800923,0.00496132886125409,-0.0235140882481503,-0.00406567911203427,0.00545245617122535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,40135,-0.00970320885795756,0.003492857572097,-0.0165492096992677,-0.00285720801664745,0.00547853614134291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40448,-0.0150939478313956,0.00543429915746191,-0.025745174180021,-0.00444272148277029,0.00548638604854038
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42675,-0.0230394756350624,0.00829969419595834,-0.0393068762591408,-0.00677207501098408,0.00551178010198169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42678,-0.0245864691598344,0.0088614830859798,-0.0419549760083548,-0.00721796231131393,0.00553572493590624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42593,-0.0224056525109404,0.00808866243514857,-0.0382594308838316,-0.00655187413804919,0.00561322359023011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40526,-0.0106922710091261,0.00386010724049623,-0.0182580812004987,-0.0031264608177535,0.00561576316481763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42593,-0.0179022806899114,0.00646651104392014,-0.0305766423359949,-0.00522791904382796,0.00563991840463777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42291,-0.0130651421295393,0.00472053509583855,-0.0223173909173829,-0.00381289334169576,0.00565283643700749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42593,-0.0136898162751849,0.00494820688406003,-0.0233883017679426,-0.00399133078242725,0.00567180799965275
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42593,-0.026562752989233,0.00961271390819699,-0.0454036722492991,-0.00772183372916685,0.00572993179798965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42700,-0.0059413414896166,0.00215049253769847,-0.0101563068635056,-0.00172637611572759,0.0057388617054593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,42369,-0.0375931004634528,0.0136120795198166,-0.0642727763222933,-0.0109134246046123,0.00575728931193872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42345,0.0136406041222356,0.00493922187463431,0.00395972924795231,0.0233214789965188,0.00575826744150754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40526,-0.0110404645157207,0.00400034390136393,-0.018881138562394,-0.00319979046904737,0.00579156935937548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,40282,0.0104415253701373,0.00378364969352124,0.00302557197083564,0.0178574787694389,0.00579593941285759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42635,-0.0340651664334858,0.0123477731939543,-0.0582668018936362,-0.00986353097333543,0.0058090622939177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40450,-0.0185772476758541,0.00673915289825744,-0.0317859873564387,-0.00536850799526951,0.00584971899614772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,40079,-0.0216372348914709,0.00784952674753646,-0.0370223073166424,-0.00625216246629947,0.00585205685141645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,42236,-0.0188889658791463,0.00685815587681479,-0.0323309513977033,-0.00544698036058929,0.0058911207269766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42310,-0.0296629145348939,0.0107765614729128,-0.0507849750218029,-0.00854085404798483,0.00592162472795079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,40435,-0.0235535174778999,0.00855830794324904,-0.040327801046668,-0.00677923390913178,0.00593051746791352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42753,-0.0165736934623322,0.0060261586876408,-0.0283849644901082,-0.00476242243455623,0.00596212016064162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40222,-0.024484239605119,0.00890994943261644,-0.0419477404930472,-0.00702073871719074,0.00600636600342553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42586,-0.0230901680950397,0.00840912668906466,-0.0395720564056064,-0.00660827978447293,0.00604356111374794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,42475,-0.0214676433431924,0.00782165739658108,-0.0367980918404914,-0.00613719484589353,0.00606584775365154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40181,-0.0215089316396507,0.00784270037443448,-0.0368806243735423,-0.00613723890575917,0.00610644901733097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,40515,-0.00393428440391028,0.00143637091610429,-0.00674957139947468,-0.00111899740834587,0.00617143825288824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,40282,-0.0179770615359828,0.00656460583765802,-0.0308436889777925,-0.00511043409417308,0.0061821893826777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40482,-0.00605775401171553,0.00221548099114886,-0.0104000967543673,-0.00171541126906376,0.00626136168411642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,40510,-0.0197112366882044,0.0072135040474183,-0.0338497046211443,-0.0055727687552645,0.00629443120413806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,40403,-0.0128428857029988,0.00470925427676908,-0.0220730240854662,-0.00361274732053141,0.00639816246187247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42589,0.0220909607630085,0.00810552741157651,0.0062041270363185,0.0379777944896984,0.00643032951409967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OCLN,Occludin,40481,-0.0119420460736044,0.00438339081431181,-0.0205334920696555,-0.0033506000775532,0.00645204572502558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42753,-0.0205245893382309,0.00754587925319079,-0.0353145126744849,-0.00573466600197698,0.00653703879358583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40222,0.00982606698509109,0.00361244651761862,0.0027456718105586,0.0169064621596236,0.00653725691081998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40482,-0.0124382462895729,0.00457283838847166,-0.0214010095309774,-0.00347548304816845,0.00653763940822675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42593,-0.0169892189354696,0.00624985247679666,-0.029238929789991,-0.00473950808094815,0.00656949481550335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42345,-0.0222780485723041,0.00819637568857635,-0.0383429449219138,-0.00621315222269449,0.00657566315261778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,42310,-0.0189464115773893,0.00698895075962926,-0.0326447550662627,-0.00524806808851597,0.0067186303239669
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,40301,-0.0143624224999109,0.00531784513298203,-0.0247853989605557,-0.00393944603926614,0.00692783516707999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,40115,-0.0158157196667394,0.00586091733109563,-0.0273031176356868,-0.00432832169779193,0.00697586103962693
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42678,-0.0218776355775515,0.00811149648902579,-0.037776168696042,-0.0059791024590609,0.00700301315425185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,42345,-0.0173551849216729,0.00643509574409937,-0.0299679725801076,-0.0047423972632381,0.00700651919989966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42369,-0.0174119574922624,0.00646346519352132,-0.0300803492715642,-0.00474356571296065,0.00707098655851691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42602,-0.00791623838975852,0.00294293655676174,-0.0136843940410115,-0.0021480827385055,0.00715594924732829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,40282,0.0134578978114803,0.00500913196096132,0.0036399991679961,0.0232757964549645,0.00722752263385912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40198,-0.00542922077599019,0.00202352291258447,-0.00939532568465574,-0.00146311586732463,0.00730623180883477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42641,-0.0178359144484768,0.00665629796782922,-0.0308822584654221,-0.0047895704315315,0.0073809916160563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42610,-0.0131508401767651,0.00490953186739729,-0.0227735226368638,-0.00352815771666642,0.00740131945233836
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42653,0.022647305356186,0.00846799968382707,0.00605002597588494,0.039244584736487,0.00749406934498748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42688,-0.0148057244666525,0.00553605076195429,-0.0256563839600829,-0.0039550649732221,0.00749488548583539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42650,-0.0151403388011638,0.00566944352748615,-0.0262524481150367,-0.00402822948729097,0.00758258361717117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42628,-0.0483198146883433,0.0180989349397434,-0.0837937271702403,-0.0128459022064463,0.0075996756304573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42586,-0.0118444781837697,0.0044426442197936,-0.0205520608545652,-0.00313689551297427,0.00768318592865061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40481,0.0111558372785664,0.0041847891134815,0.00295365061614263,0.0193580239409901,0.00769133058284291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,40515,0.00925211552681092,0.00347893960174644,0.00243339390738789,0.016070837146234,0.00783752170207789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40481,-0.016838306331525,0.00633699484233072,-0.0292588162224932,-0.00441779644055683,0.0078916760802717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42753,-0.0090055609877936,0.00338948773431687,-0.0156489569470547,-0.00236216502853254,0.0078953065284623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,40135,-0.0192342280458833,0.00723984764420398,-0.0334243294285231,-0.00504412666324351,0.00790201150067468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,40181,0.0176015509068102,0.00662984567624332,0.0046070533813733,0.0305960484322471,0.00794472356762955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELP,P-selectin,42688,-0.0144345241119902,0.00544210162559036,-0.0251010432981474,-0.00376800492583313,0.00800199216321739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,42310,0.0164275625053237,0.00619789932059354,0.00427967983696039,0.0285754451736871,0.00804680508184636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40198,-0.00820266669464383,0.0030956796685245,-0.0142701988449518,-0.00213513454433582,0.00806750228303066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42673,-0.018709650645428,0.00706581956477546,-0.0325586569923879,-0.00486064429846814,0.00810854899886302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,40301,-0.00916165060377501,0.00346354894776298,-0.0159502065413905,-0.00237309466615956,0.00817665684557435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42364,-0.0123183491257671,0.00466874589847572,-0.0214690910867795,-0.00316760716475469,0.00833788699259058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42643,0.0126927769329461,0.00481330507829226,0.00325869897949324,0.0221268548863989,0.00837343031184213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,40181,-0.0104431336434863,0.0039662547485643,-0.0182169929506723,-0.00266927433630025,0.00847537617311841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,42310,-0.0132139958137623,0.00502235320428565,-0.0230578080941622,-0.00337018353336244,0.00852243724638049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,42291,-0.0227649744983794,0.00865954914234344,-0.0397376908173726,-0.00579225817938626,0.00857648944731986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40115,-0.0125907772269014,0.00480029634641092,-0.0219993580658668,-0.00318219638793595,0.00873016938479143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42589,0.0128339075580612,0.00489387695843272,0.0032419087195331,0.0224259063965894,0.00874009736556374
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42369,-0.010046588403763,0.0038334731889489,-0.0175601958541028,-0.00253298095342316,0.00878363825307645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42610,-0.011414697132143,0.0043590115971002,-0.0199583598624594,-0.00287103440182663,0.00883794030437878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40301,-0.0174565471250059,0.00668529423671682,-0.0305597238289709,-0.00435337042104091,0.00903500665939632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40282,-0.0135501092727077,0.0051998615444829,-0.0237418378998942,-0.00335838064552121,0.00917665078179299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42586,-0.0115990136647967,0.00445185943316154,-0.0203246581537933,-0.00287336917580006,0.00918601725922969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42593,-0.0241474555466144,0.00926886599272772,-0.0423144328923607,-0.00598047820086806,0.00919161568894612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42345,-0.015833972333022,0.0060821732014054,-0.0277550318077766,-0.00391291285826737,0.00924236943008542
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,40301,-0.00595466197062797,0.00228880757302683,-0.0104407248137605,-0.00146859912749538,0.00929012560798695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40350,0.00675766835083015,0.00260055971428523,0.0016605713108311,0.0118547653908292,0.00937432340009874
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42720,0.0109350867158302,0.00421051419140758,0.00268247890067138,0.0191876945309891,0.00941189129994955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,40135,-0.015798932922771,0.00609300933582247,-0.027741231220983,-0.00385663462455893,0.00952803212273969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42494,-0.0241168272763861,0.00930387555673239,-0.0423524233675816,-0.0058812311851906,0.0095488852096997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42720,0.0116700805136438,0.00451016506472887,0.00283015698677521,0.0205100040405124,0.00967767198101028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42586,-0.00504983921845531,0.00195268432342552,-0.00887710049236933,-0.00122257794454129,0.00971729832386115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40526,0.015986450623123,0.00618222527078331,0.00386928909238766,0.0281036121538582,0.00972562603448841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42494,-0.0144527885543734,0.00558981994378177,-0.0254088356441857,-0.00349674146456112,0.00973276376068021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42494,-0.0150643395857972,0.00583164212174321,-0.0264943581444139,-0.00363432102718053,0.00979922700505875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42635,-0.00903361234426498,0.00349759455657647,-0.0158888976751549,-0.0021783270133751,0.00981047688956853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40481,-0.00957157017178477,0.0037069579003779,-0.0168372076565255,-0.00230593268704408,0.0098338675237356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42657,0.00827407110641741,0.00321017065573245,0.00198213662118181,0.014566005591653,0.00996361515419557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42593,-0.00785751443524281,0.00305119225397052,-0.013837851253025,-0.00187717761746059,0.0100280386131967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40481,-0.0269036072964334,0.0104514861076885,-0.0473885200675029,-0.0064186945253639,0.010061540395696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42759,-0.00483408953354423,0.00187810349014843,-0.00851517237423516,-0.00115300669285331,0.0100658446135585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40301,-0.0123025593267027,0.00478261105580967,-0.0216764769960897,-0.00292864165731578,0.0101138840955828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,40053,-0.0181698780700795,0.00707526197975975,-0.0320373915504086,-0.00430236458975034,0.0102394423260384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,40222,-0.00760934700384262,0.0029719480577939,-0.0134343651971187,-0.00178432881056656,0.0104686653406979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,42310,-0.00887579130735093,0.00347280435837246,-0.015682487849761,-0.0020690947649409,0.0106055907746971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40481,-0.0100120723471276,0.00391965895682149,-0.0176946039024977,-0.00232954079175743,0.0106524845948202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40079,-0.016305882896669,0.00638914336089087,-0.0288286038840151,-0.00378316190932292,0.0107203936488664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42474,-0.00853144496809847,0.00334752951119861,-0.0150926028100477,-0.0019702871261492,0.0108274181410405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42635,0.00868122471757201,0.00340698234331856,0.00200353932466763,0.0153589101104764,0.0108431455502136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42345,-0.0164642488905591,0.00646149656036367,-0.0291287821488719,-0.00379971563224633,0.0108438099075243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40341,-0.0107745393337402,0.00423186855873934,-0.0190690017088693,-0.00248007695861108,0.0109083675376483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40115,-0.0178315677546611,0.0070091295488527,-0.0315694616704123,-0.00409367383890976,0.0109712315341721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40482,0.0211634503670092,0.00832414862069195,0.004848119070453,0.0374787816635655,0.0110221417239333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40301,-0.0162599099820695,0.00640311557135531,-0.0288100165019259,-0.00370980346221311,0.0111185984150134
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42635,-0.013540131153384,0.00533228552217215,-0.0239914107768414,-0.00308885152992661,0.0111194677241393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAST,Gastrin,40482,0.0359430490186793,0.0141739221360034,0.00816216163211271,0.0637239364052459,0.0112306017457834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40448,-0.0115206993229982,0.00454609708096722,-0.020431049601694,-0.00261034904430247,0.0112840222454628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40481,-0.0125441514508589,0.00495983065355253,-0.0222654195318219,-0.00282288336989594,0.0114474450792272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42369,0.0106462464367213,0.00421166898222382,0.00239137523156266,0.01890111764188,0.0114896420675981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,40135,-0.0112948798143638,0.00446908244865172,-0.0200542814137212,-0.00253547821500643,0.0115070644947328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40135,-0.0192249028965087,0.00761114295317992,-0.0341427430847413,-0.00430706270827606,0.0115545862566572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40481,-0.0118086307907493,0.0046913652300278,-0.0210037066416038,-0.00261355493989486,0.0118462959383422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42571,-0.00839324076244949,0.00333560801872579,-0.014931032479152,-0.00185544904574693,0.0118725349669325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42494,-0.010674555700081,0.00424282821957201,-0.0189904990104422,-0.0023586123897199,0.0118843733788659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40481,-0.0237681473102805,0.00944965816318321,-0.0422894773101195,-0.00524681731044135,0.0119089520972321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42573,-0.00828725858415706,0.00329910124701621,-0.0147534970283088,-0.0018210201400053,0.0120174477721475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42590,-0.00609269178049898,0.0024254710931119,-0.0108466151229983,-0.00133876843799967,0.0120178544341634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,42260,-0.0177656575109899,0.00707669749883782,-0.0316359846087121,-0.00389533041326781,0.0120699028532596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42710,-0.0174644359670402,0.00696220389513107,-0.0311103556014971,-0.00381851633258335,0.0121373563931089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40198,-0.00761050110240365,0.00303505823161323,-0.0135592152363656,-0.00166178696844172,0.012172094515322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40181,-0.0104875392097542,0.00418736833949021,-0.018694781155155,-0.00228029726435335,0.012274550750035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42474,-0.0216357656691822,0.00864661840619115,-0.0385831377453168,-0.00468839359304751,0.0123535495502043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40482,-0.0132659013334887,0.00530213364928655,-0.0236580832860903,-0.00287371938088704,0.0123636722769985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,40481,-0.00937063932941828,0.00374880491737104,-0.0167182969674655,-0.00202298169137103,0.0124462597212125
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40531,-0.0160355106513115,0.00642016537400803,-0.0286190347843672,-0.00345198651825574,0.0125150027145033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,40222,-0.0132115794349,0.00529001104790478,-0.0235800010887934,-0.00284315778100666,0.0125231938268265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,40115,0.0112614971607891,0.00451016589831975,0.00242157200008243,0.0201014223214959,0.0125425393616638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40222,-0.0135613997042994,0.00543444292931452,-0.0242129078457559,-0.00290989156284293,0.0125941235778112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42585,-0.00460310610574578,0.00184507519447271,-0.0082194534869123,-0.000986758724579265,0.0126145250005278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,40198,-0.014013833440376,0.00562684612166533,-0.0250424518388401,-0.00298521504191197,0.0127698768633374
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40301,-0.0127901184729316,0.00513803441508796,-0.022860665926504,-0.00271957101935918,0.0128139463733462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40135,-0.0149763332409422,0.00601838275559852,-0.0267723634419153,-0.00318030303996911,0.0128455545936038
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42698,-0.0374311854427779,0.0150477350399757,-0.0669247461211304,-0.00793762476442543,0.0128765519788105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,42310,-0.0209609087811982,0.00842807592458968,-0.037479937593394,-0.00444187996900242,0.0128936554290125
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42586,-0.0298010475279454,0.0119854510358083,-0.0532925315581296,-0.00630956349776116,0.0129150973282431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42710,-0.0155959134334589,0.00627256463923858,-0.0278901401263666,-0.00330168674055134,0.0129173705137953
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,40282,0.00687023192218904,0.00276860990753765,0.00144375650341524,0.0122967073409628,0.0130987517079658
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40450,-0.0083158673567574,0.00335397294957964,-0.0148896543379335,-0.00174208037558131,0.0131745947197394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40450,-0.0099230520558286,0.00400653920362421,-0.0177758688949321,-0.00207023521672514,0.0132743890537187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40198,0.0107448099001624,0.00433971066438581,0.00223897699796619,0.0192506428023586,0.0133039795520152
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,40181,-0.0165299918597143,0.00668112381458456,-0.0296249945363,-0.00343498918312854,0.0133709714917594
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,40249,-0.0158009260185658,0.00639018131609991,-0.0283256813981216,-0.00327617063900997,0.0134250368689121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,42341,-0.00977531407188479,0.00395403221794206,-0.0175252172190512,-0.00202541092471835,0.0134395189761889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGRN,Neugrin,40482,-0.0055748862583027,0.00225560480762685,-0.00999587168125133,-0.00115390083535406,0.0134667462506621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42578,-0.00589451834821575,0.00238697743234828,-0.0105729941156184,-0.00121604258081312,0.0135445269458555
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40282,0.0178904036249694,0.00725985598684028,0.00366108589076245,0.0321197213591763,0.0137434855332297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42345,-0.0114000566541414,0.00462798695385751,-0.0204709110837021,-0.00232920222458068,0.0137797066551217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,40531,-0.0218010900492513,0.00885162072651407,-0.0391502666732189,-0.00445191342528372,0.0137947055307867
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42345,-0.00950665199151366,0.00387442153160315,-0.0171005181934558,-0.00191278578957148,0.0141525297125675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40482,-0.00952074721987235,0.00388064177267527,-0.0171268050943159,-0.00191468934542881,0.0141664929324462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42610,-0.0105249495417038,0.00429052473792978,-0.0189343780280462,-0.00211552105536143,0.0141769841003653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42494,-0.00726640754533812,0.00296388305800004,-0.0130756183390182,-0.00145719675165805,0.0142330099387056
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42619,-0.0135091386183064,0.00551218439326931,-0.0243130200291143,-0.00270525720749857,0.0142674597487797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40115,-0.00894951185216207,0.00365277135354938,-0.0161089437051189,-0.00179007999920529,0.0142987933597189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42310,-0.0120803849649843,0.00493186852303812,-0.021746847270139,-0.00241392265982956,0.0143202848687936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42586,-0.0140961911576923,0.00576288215721336,-0.0253914401858304,-0.00280094212955409,0.0144566152571946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,40469,-0.00772722760330896,0.00316234121719092,-0.0139254163890032,-0.00152903881761475,0.0145601992462927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,42345,-0.0203640709599732,0.0083458983724968,-0.0367220317700669,-0.00400611014987948,0.0146999926753654
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40481,-0.0159183070101668,0.00652436673701492,-0.0287060658147161,-0.00313054820561761,0.0147097015260499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42610,0.00923139780139634,0.00378575132072968,0.00181132521276618,0.0166514703900265,0.0147629314810778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42494,-0.010068575279936,0.00413670621386711,-0.0181765194591155,-0.00196063110075646,0.0149477396970214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42610,-0.00648045922541287,0.00266407378462682,-0.0117020438432814,-0.00125887460754431,0.0150064251813368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40448,-0.0199351595796031,0.00820302589895408,-0.0360130903415531,-0.00385722881765311,0.0151051762222245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,40448,-0.00733813362566604,0.00302366629452989,-0.0132645195629446,-0.00141174768838745,0.0152440756653177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40135,-0.0146441912359748,0.00603879315578001,-0.0264802258213036,-0.00280815665064595,0.0153236434048311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40115,-0.00926069648000365,0.00381961238763991,-0.0167471367597779,-0.00177425620022942,0.0153450917403454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,42346,-0.0101910974254004,0.00421569435702854,-0.0184538583651764,-0.00192833648562449,0.0156445439593945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42310,-0.00933996957633207,0.00386498838239325,-0.0169153468058228,-0.00176459234684131,0.0156815800495256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42249,0.0129898261187035,0.00537707200828376,0.00245076498246728,0.0235288872549396,0.0157151583950255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40464,-0.0188650073054936,0.00782150040697816,-0.0341951481031708,-0.00353486650781639,0.0158836718187401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42635,-0.0281952081176707,0.0116910591233853,-0.0511096839995058,-0.00528073223583558,0.0158921011525576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,42310,-0.0130220107371353,0.00540649145168393,-0.0236187339824358,-0.00242528749183476,0.0160280638237127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42720,-0.00516058415091028,0.00214302224641209,-0.00936090775387798,-0.000960260547942577,0.0160496506396806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,40115,-0.00874017471524178,0.00363291004321484,-0.0158606783999429,-0.00161967103054069,0.0161521546211081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40135,-0.00781488030244911,0.00324925931285559,-0.0141834285556461,-0.00144633204925214,0.016183358566092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40510,-0.0147781684147258,0.00614496879652339,-0.0268223072559116,-0.00273402957353993,0.0161918899601472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,40181,-0.00737422377786287,0.0030673035771656,-0.0133861387891075,-0.00136230876661828,0.0162270638863746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42610,-0.00676082262140388,0.00281450493424703,-0.0122772522925281,-0.0012443929502797,0.0163131691687226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40482,-0.0165535685174548,0.00689402697418559,-0.0300658613868585,-0.00304127564805102,0.0163598660472893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLG,Plasminogen,40284,-0.00501141962719885,0.00209139456143438,-0.00911055296761024,-0.000912286286787461,0.0165820793646703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40198,-0.0132468941376821,0.00553958836223479,-0.0241044873276623,-0.00238930094770187,0.0168048913150098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40222,-0.0159185893607413,0.0066745143884133,-0.0290006375620313,-0.00283654115945119,0.017096799150123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42610,0.0124167273900899,0.00521304978494423,0.00219914981159918,0.0226343049685806,0.0172395464471851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42720,-0.00694675119141203,0.00291660434390397,-0.0126632957054638,-0.00123020667736025,0.0172422690971932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,42345,-0.0133459069154488,0.00562823892354846,-0.0243772552056038,-0.00231455862529388,0.0177428236409169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42678,-0.0160382253704916,0.00676620133128565,-0.0292999799798114,-0.0027764707611717,0.0177855215680094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,40198,-0.0145383667035393,0.00613421773821296,-0.0265614334704367,-0.0025152999366419,0.0178031054200601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40282,-0.00969620789953677,0.00409512564109519,-0.0177226541560833,-0.0016697616429902,0.0179139907514179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,40482,-0.0153080408628654,0.0064779278934989,-0.0280047795341233,-0.00261130219160758,0.01813925963884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,40482,-0.00867934027163951,0.00367394243095207,-0.0158802674363056,-0.00147841310697345,0.0181736590848223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42710,-0.013741908175805,0.00581745028508818,-0.0251441107345779,-0.00233970561703218,0.0181815439324825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42345,-0.0149126411914766,0.0063158002567934,-0.0272916096947916,-0.00253367268816151,0.0182321651570749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,40115,-0.0213109474091468,0.00902768811821185,-0.039005216120842,-0.00361667869745157,0.0182618540983916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40115,-0.00899567031940551,0.00381512097570817,-0.0164733074317935,-0.0015180332070175,0.0183962192462023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42494,-0.0246502618881285,0.010465702186497,-0.0451630381736626,-0.00413748560259443,0.0185203241841772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",40538,-0.00384870367502759,0.00163408831182983,-0.00705151676621405,-0.000645890583841127,0.0185266559131933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39869,0.0284103061537599,0.0120631140850709,0.00476660254702101,0.0520540097604988,0.0185337917252235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40135,-0.00694218901644312,0.00294813053059325,-0.0127205248564059,-0.00116385317648035,0.0185514064595215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,40301,-0.0172672567954469,0.00733438510782052,-0.0316426516067751,-0.00289186198411865,0.0185755266411372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,40135,-0.012427290448239,0.00527968966596572,-0.0227754821935319,-0.00207909870294623,0.0186006011265992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42709,-0.0102266434032965,0.00434663580527893,-0.0187460495816432,-0.00170723722494977,0.0186483058909083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40510,0.0137906038181315,0.00586246358299643,0.0023001751954585,0.0252810324408045,0.0186719239595817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40079,-0.0118603897779493,0.00504513336990543,-0.0217488511829639,-0.00197192837293464,0.0187479439110186
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,40181,0.00766042624279088,0.00326054948790462,0.00126974924649783,0.0140511032390839,0.0188198860615082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40448,-0.023422872927231,0.00997946589912851,-0.0429826260895228,-0.00386311976493908,0.0189370633109073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42562,-0.0148754097682389,0.00633962522983669,-0.0273010752187188,-0.00244974431775893,0.018969366300752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42345,-0.0113714469256174,0.00484631352432584,-0.0208702214332961,-0.00187267241793878,0.018969916811054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,40450,-0.0121667404961205,0.00518602059758237,-0.0223313408673819,-0.00200214012485907,0.0189900617766491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,42369,-0.0179352685968305,0.00764540930355956,-0.0329202708318072,-0.00295026636185375,0.0189965899966524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40531,-0.0333304289851449,0.0142114993435725,-0.0611849676985469,-0.00547589027174283,0.0190282057389197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,42356,-0.015574763806497,0.00664930905467001,-0.0286074095536502,-0.00254211805934374,0.0191794509614477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40222,-0.0232202005938823,0.00991334828241757,-0.0426503632274207,-0.00379003796034384,0.0191821386625465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42310,-0.0192669063306379,0.00822801382601947,-0.0353938134296361,-0.0031399992316398,0.0192149847902261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,40448,0.0195907754588349,0.00836726956218795,0.00319092711694651,0.0359906238007233,0.0192310762379654
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40480,-0.00904925301536453,0.00386995588187614,-0.0166343665438418,-0.0014641394868873,0.0193872482340166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42720,-0.00373168370874362,0.00159862482784999,-0.00686498837132959,-0.000598379046157646,0.0195941284827683
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40115,-0.0157143179808026,0.00673259328193899,-0.028910200813403,-0.00251843514820219,0.0196102985765137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,40198,-0.00992975939948077,0.00425782490780838,-0.0182750962187852,-0.00158442258017634,0.0197123140462648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42720,0.0190962656517282,0.00819397540866147,0.00303607385075174,0.0351564574527047,0.0197930387544613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42710,-0.015042588482928,0.00646920819920887,-0.0277222365533774,-0.00236294041247861,0.020072810167928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40181,-0.0144127574079795,0.00619883591397872,-0.0265624757993778,-0.00226303901658118,0.0200860802690522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42793,-0.0195151849277632,0.00842768542673708,-0.0360334483641679,-0.00299692149135855,0.0205946842307811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42593,-0.0137751171474943,0.00595675638832655,-0.0254503596686144,-0.0020998746263743,0.0207641318778372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42623,-0.0123824693395969,0.00535735841098357,-0.0228828918251247,-0.00188204685406912,0.0208312838520595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,40448,0.0250596676064909,0.0108557876524738,0.00378232380764221,0.0463370114053396,0.0209940779433609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42345,0.00708202985403257,0.00307430322917916,0.00105639552484141,0.0131076641832237,0.0212594396962763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42586,-0.0173281668469744,0.00753294797578264,-0.0320927448795083,-0.00256358881444038,0.0214455746930516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,40462,-0.0220101023799818,0.0095708055310025,-0.0407688812207467,-0.00325132353921686,0.0214826988043518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42555,-0.018594170965538,0.00808941165264993,-0.0344494178047319,-0.00273892412634412,0.0215440843989646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,42153,-0.00837730081250179,0.00364619745124499,-0.015523847816942,-0.00123075380806161,0.0216035863913791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42650,-0.00788074998263683,0.00343021825697476,-0.0146039777663074,-0.0011575221989663,0.0216084678851082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42662,0.00403761083873339,0.00175763097565677,0.000592654126446114,0.00748256755102066,0.0216232450022947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42310,-0.0126150362683331,0.00549407139582643,-0.0233834162041529,-0.00184665633251331,0.0216848278103005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40115,-0.0197053279138401,0.00860500713800237,-0.0365711419043247,-0.00283951392335542,0.0220412270004844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,40301,-0.012583092408094,0.00549813987392907,-0.023359446560995,-0.00180673825519307,0.022120769043945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42793,-0.00666123370813045,0.00291377934176176,-0.0123722412179835,-0.000950226198277396,0.0222628569339717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,42475,-0.0111341424368188,0.00487179554704726,-0.0206828617090314,-0.00158542316460613,0.0223033744991191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,42310,-0.0136486994439243,0.00598270848468906,-0.0253748080739148,-0.0019225908139337,0.0225432292817519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42678,0.0116412183130399,0.00511193320812318,0.00162182922511844,0.0216606074009613,0.0227860909569618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40450,-0.00814548817544724,0.00357965086301491,-0.0151616038669565,-0.00112937248393802,0.0228947870630929
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40115,-0.0106650080493843,0.0046871885575361,-0.019851897622155,-0.00147811847661351,0.0229040570068947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,42356,-0.0116799201927317,0.00514909181128778,-0.0217721401428557,-0.00158770024260763,0.0233242724355435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40222,0.0129139015468918,0.00569697236439067,0.00174783571268609,0.0240799673810975,0.0234216772916366
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42793,0.0133812322891065,0.00590758661952389,0.00180236251483968,0.0249601020633733,0.0235226454705218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,40181,-0.0180769098474445,0.00798575541878505,-0.0337289904682632,-0.00242482922662582,0.0236154187207229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42610,-0.013906316720557,0.00614589260985638,-0.0259522662358755,-0.00186036720523853,0.0236700523183406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42710,-0.0126761719205958,0.00560453873095359,-0.0236610678332648,-0.00169127600792675,0.0237274964805119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,40538,-0.00571163455731125,0.0025274208645827,-0.0106653794518933,-0.000757889662729144,0.0238484020160303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42310,-0.0133465574532046,0.00590904951734252,-0.0249282945071959,-0.00176482039921326,0.0239206470601209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,40531,0.00625209585999133,0.00276905570039306,0.00082474668722094,0.0116794450327617,0.0239743227880359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40448,-0.0126019745207509,0.00558184947957277,-0.0235423995007135,-0.00166154954078826,0.0239853168375496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40481,-0.0104557105263923,0.00463290288817199,-0.0195362001872094,-0.00137522086557522,0.024037251266006
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,40526,-0.00969461761768727,0.00429654354141314,-0.018115842958857,-0.00127339227651751,0.0240660704486704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42369,-0.0133387877094332,0.00591466422447109,-0.0249315295893965,-0.00174604582946988,0.024136727230067
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42345,-0.0269366858966413,0.0119715699619349,-0.0504009630220337,-0.00347240877124885,0.0244619417116673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42586,0.00753282373865189,0.00334998151006814,0.000966859978918331,0.0140987874983854,0.0245530946919989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42593,-0.0111878181193148,0.00497676830205144,-0.0209422839913357,-0.00143335224729399,0.0245918309890316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40057,-0.0116242404681249,0.00517696294196457,-0.0217710878343755,-0.00147739310187436,0.024763882374651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,40135,-0.00616655176928476,0.00274783565946596,-0.011552309661838,-0.00078079387673148,0.0248427475376447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40448,-0.0165552306605881,0.00738078192910918,-0.0310215632416421,-0.00208889807953414,0.024914999448891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,40135,-0.0213402059201161,0.00952432450323542,-0.0400078819464575,-0.0026725298937747,0.025071951813376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40115,0.00789984018602336,0.00352617767326622,0.000988531946421572,0.0148111484256252,0.0250888249933928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40448,-0.00775656375285312,0.00346519790003921,-0.01454835163693,-0.000964775868776274,0.0252132380650702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42635,-0.00558364788423484,0.00249740633677283,-0.0104785643043096,-0.000688731464160098,0.0253826210939633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42710,-0.0140936706058549,0.00630477067186631,-0.0264510211227129,-0.00173632008899697,0.0254075089475944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40301,-0.014210111242015,0.00636372518636376,-0.026683012607288,-0.00173720987674204,0.0255696906845991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40198,-0.00770112918952649,0.00344967565689929,-0.0144624934770491,-0.00093976490200388,0.0256071768952421
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40450,0.00865891379828371,0.00388032984976928,0.00105346729273593,0.0162643603038315,0.0256683596199092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40222,-0.0167720682735829,0.00751659936981793,-0.031504603038426,-0.00203953350873977,0.0256788171837245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,40222,0.0111753839593646,0.00501144461942752,0.00135295250528667,0.0209978154134426,0.0257693134149891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42732,0.00681441754917675,0.00305895380426986,0.000818868092807834,0.0128099670055457,0.0259171984560251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42310,-0.018590259480113,0.00835640651467802,-0.034968816248882,-0.00221170271134412,0.0261202472402298
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,40301,-0.0161171893011638,0.00724470772380491,-0.0303168164398214,-0.0019175621625062,0.0261224371631175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42586,-0.022598064027049,0.010159195631341,-0.0425100874644773,-0.00268604058962067,0.0261384838439804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42593,0.0196331963600972,0.00882668951527203,0.00233288491016405,0.0369335078100304,0.0261449334874559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,40198,-0.00612812685300448,0.00275557033246709,-0.01152904470464,-0.000727209001368976,0.0261750495452139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,40222,-0.0185983789374543,0.00837766379531062,-0.0350185999762631,-0.00217815789864546,0.0264393036632842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,40292,-0.00532952306958361,0.00240143169850582,-0.010036329198655,-0.000622716940512205,0.026485735281038
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,42310,-0.00797376806411528,0.00359494105906237,-0.0150198525398775,-0.000927683588353048,0.0265683158112323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42345,-0.00688643071046218,0.00310613898269377,-0.012974463116542,-0.000798398304382386,0.0266374748679342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42494,-0.0133285435473273,0.00602826493068285,-0.0251439428114657,-0.00151314428318893,0.0270522134912869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40222,-0.010675164121418,0.00483324934959823,-0.0201483328466306,-0.00120199539620549,0.0272164880308735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42570,0.00663206221698144,0.00300418028720577,0.00074386885405814,0.0125202555799047,0.0272882934832933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,42369,-0.0105999267980298,0.00480172522671206,-0.0200113082423855,-0.00118854535367417,0.0272945959994483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42635,-0.0143127635047337,0.00650214468336578,-0.0270569670841307,-0.00156855992533683,0.0277361632053396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40282,-0.0222108743653558,0.0101002729903094,-0.0420074094263623,-0.00241433930434926,0.0278958633832667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,40301,-0.0371228051739003,0.0168852715250409,-0.0702179373629804,-0.00402767298482021,0.0279317855776008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,40478,-0.00554904866874476,0.00252599717908408,-0.0105000031397496,-0.000598094197739953,0.0280567471820076
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42345,-0.017306133039485,0.00789343737172283,-0.0327772702880617,-0.00183499579090822,0.0283629693891173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,40482,-0.0111899719606107,0.00510562786994845,-0.0211970025857097,-0.00118294133551175,0.0284219941851976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42356,-0.0200864818646675,0.00917314923722496,-0.0380658543696284,-0.00210710935970656,0.0285632004665402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40198,-0.0170027102687645,0.00777256432758317,-0.0322369363508275,-0.00176848418670145,0.0287248918626696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40448,-0.00582206251646831,0.00266722026148627,-0.0110498142289814,-0.000594310803955217,0.0290696416663532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42586,-0.0290254616931517,0.0133005725804624,-0.0550945839508579,-0.00295633943544546,0.0291068104497356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,42310,-0.0105020825326463,0.00481462334528545,-0.0199387442894058,-0.00106542077588677,0.0291797818143013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40222,-0.00752111169197487,0.00344896177130658,-0.0142810767637358,-0.000761146620213977,0.0292275157188618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,40450,-0.00689077258709247,0.00316074475339872,-0.013085832303754,-0.000695712870430972,0.0292699225986413
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40115,-0.0109377324992674,0.00501727434055482,-0.0207715902067548,-0.00110387479177993,0.0292776425336934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40135,-0.00724116069541592,0.00332341606775872,-0.013755056188223,-0.000727265202608837,0.0293655192915715
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,42345,-0.0186835828573216,0.00857753029324751,-0.0354955422320867,-0.00187162348255647,0.0294087975417827
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40481,-0.00504691778838951,0.00231708790986206,-0.00958841009171916,-0.000505425485059864,0.0294170165565717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42586,0.0213852497397533,0.00983471024450915,0.0021092176605154,0.0406612818189913,0.0296875515107831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42678,-0.00472585992180774,0.00217806773977092,-0.00899487269175875,-0.000456847151856735,0.0300432843518103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40135,-0.0178056379279978,0.00821148304597573,-0.0339001446981102,-0.00171113115788532,0.0301510584803387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,42369,-0.0139249841533535,0.00642291493378779,-0.0265138974235776,-0.00133607088312945,0.0301752906238881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40481,-0.0167422007703649,0.00772783987608142,-0.0318887669274845,-0.00159563461324528,0.0302954810097992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42612,-0.0239008631181134,0.0110648631508033,-0.0455879948936879,-0.00221373134253897,0.0307850128459993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40286,-0.0136382312883674,0.00631755343941737,-0.0260206360296254,-0.00125582654710932,0.0308883313620728
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,40234,-0.00876896960844486,0.00406330668517044,-0.0167330507113789,-0.000804888505510784,0.0309425561934884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,40135,-0.0134035197580752,0.00621600611268546,-0.0255868917389387,-0.0012201477772117,0.0310826518828203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,40115,-0.0235378321995425,0.0109443011401165,-0.0449886624341709,-0.00208700196491403,0.0315223133965855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,40515,-0.00773677069821761,0.00360203633768513,-0.0147967619200805,-0.00067677947635475,0.0317438103892873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,40181,-0.01275869665582,0.00595136856670428,-0.0244233790465604,-0.00109401426507962,0.0320687407901619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40450,-0.0224025238252803,0.0104796744751601,-0.0429426857965941,-0.00186236185396652,0.032561619038814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40481,-0.0120757196427565,0.00565598545346414,-0.0231614511315462,-0.000989988153966812,0.0327797269833378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42720,0.00714816838104577,0.00335237335314118,0.000577516608889064,0.0137188201532025,0.033002538013424
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42310,-0.0059703694585395,0.00280539116219285,-0.0114689361364375,-0.000471802780641508,0.0333409860177894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40135,-0.0104573906088484,0.00491367866624193,-0.0200882007946825,-0.000826580423014159,0.0333411088759957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40198,-0.0211166055880753,0.00993035528565792,-0.0405801019479648,-0.00165310922818575,0.0334863115523246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42356,-0.00636395532929479,0.00299875889788279,-0.0122415227691451,-0.000486387889444522,0.0338398722759009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42793,-0.00518622008731758,0.00244568893296878,-0.00997977039593639,-0.00039266977869877,0.0339772437487014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42753,0.00990037012081063,0.00467328061419422,0.000740740116989965,0.0190600001246313,0.0341504264074386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40115,-0.0207913921532788,0.0098180470528214,-0.0400347643768087,-0.00154801992974883,0.034225486611689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,42369,-0.00676829609284597,0.00319722866741626,-0.0130348642809818,-0.000501727904710088,0.0342848303029887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,40222,-0.00599071230975333,0.00283564873745173,-0.0115485838351587,-0.000432840784347937,0.0346537833696447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40181,-0.00652944377019274,0.00309210184996008,-0.0125899633961145,-0.000468924144270969,0.0347388053754878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,40510,-0.0111088398398004,0.00526166799697217,-0.0214217091138659,-0.000795970565735001,0.0347703586292765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40450,-0.00775873447563574,0.003679397846326,-0.0149703542544347,-0.000547114696836783,0.034992795204452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,42369,-0.0129007659643878,0.00611973775427214,-0.0248954519627612,-0.000906079966014391,0.0350447536083758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,40181,-0.0122164097480557,0.00579701666832404,-0.0235785624179708,-0.000854257078140625,0.035108855728294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40481,-0.0148297693069829,0.00703887790249179,-0.0286259699958668,-0.00103356861809896,0.0351537087593168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLGN,Calmegin,40181,-0.00954734749690463,0.00453866128629896,-0.0184431236180506,-0.000651571375758676,0.0354394971619854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EZR,Ezrin,42710,-0.00488087637923628,0.00232294502887244,-0.00943384863582626,-0.000327904122646292,0.0356454973415266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42494,-0.0120288832555342,0.00573567028662107,-0.0232707970173115,-0.000786969493756919,0.0359941574589303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42424,-0.0351819814892165,0.0168061520818382,-0.0681220395696194,-0.00224192340881364,0.0363325455245682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42596,-0.00953685467167321,0.00455705742213158,-0.0184686872190511,-0.000605022124295317,0.0363888090537994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40181,-0.0171805792032434,0.00821879916902717,-0.0332894255745367,-0.00107173283195018,0.0366047934983583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,40181,-0.011137675528418,0.00533469090290449,-0.0215936696981108,-0.000681681358725181,0.0368404142975889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42705,-0.0134845937431751,0.00646074266758498,-0.0261476493716416,-0.000821538114708503,0.0368925060062963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMD,Dystrophin,40222,-0.0104843426148119,0.00502659380245335,-0.0203364664676205,-0.000632218762003365,0.0370219570638382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40531,0.0132987652216144,0.00637730948914869,0.000799238622883025,0.0257982918203459,0.0370620887401042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,40538,-0.0147961764394507,0.00709986410430794,-0.0287119100838942,-0.000880442795007097,0.0371817255713463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40482,-0.00776580298129477,0.00372645497970892,-0.0150696547415243,-0.000461951221065287,0.0371857550317063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40289,-0.00896703750888321,0.0043077650178648,-0.0174102569438982,-0.000523818073868202,0.0374020207122082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,40181,-0.0142032601138371,0.00682532447922854,-0.0275808960931251,-0.0008256241345492,0.0374602319655116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40135,-0.0129614450239964,0.0062309108991281,-0.0251740303862874,-0.000748859661705275,0.0375318198530998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,40222,0.0119351298926279,0.00574318950489193,0.000678478463039745,0.0231917813222161,0.0377198911662971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,42310,-0.0144289396084452,0.00696107497932184,-0.028072646567916,-0.000785232648974427,0.038210067349154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSPN,Persephin,42593,-0.0187778928787017,0.0090677427356065,-0.0365506686404905,-0.00100511711691298,0.0383923530043018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRNN,Cornulin,42208,-0.0139737176423201,0.00675080250226445,-0.0272052905467584,-0.00074214473788178,0.0384781793980415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42753,-0.00806790655154943,0.00390492595951703,-0.0157215614322028,-0.000414251670896047,0.0388394613907301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42562,-0.00733353733576443,0.00355171412643596,-0.0142948970235789,-0.000372177647949941,0.0389622867001335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,40282,-0.00543318328226624,0.00263373806975888,-0.0105953098989936,-0.000271056665538842,0.039143736435243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40427,-0.00832439568880521,0.00403795450609122,-0.016238786520744,-0.000410004856866415,0.0392747206682213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40135,-0.0100557213055809,0.00487856170379371,-0.0196177022450166,-0.000493740366145242,0.0393069532997968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,42345,-0.033508469576956,0.0162671334196662,-0.0653920510795018,-0.00162488807441011,0.0394289020467123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42720,-0.00803831265359351,0.00390319892363257,-0.0156885825439134,-0.000388042763273677,0.0394734429071028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40222,-0.0152847374240164,0.00742171580896764,-0.0298313004095929,-0.000738174438439779,0.0394734774711281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40450,-0.019434395591032,0.00944755296184151,-0.0379515993962414,-0.000917191785822655,0.0397012829398279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,42310,-0.011686385041237,0.00568147429748344,-0.0228220746643045,-0.000550695418169416,0.0397128586010428
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42345,-0.00823962996212326,0.00400969262752952,-0.0160986275120811,-0.0003806324121654,0.0399056618379098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,42356,-0.013585130685785,0.0066253370867767,-0.0265707913758673,-0.000599469995702682,0.0403372353239688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40079,-0.00957082330964694,0.00466974182269623,-0.0187235172821316,-0.00041812933716232,0.0404332399896412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,40383,-0.00890744316709212,0.00434882631740464,-0.0174311427492052,-0.000383743584979035,0.0405597045315053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42291,-0.008595799411992,0.00419700865365346,-0.0168219363731528,-0.000369662450831223,0.0405722929004929
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42593,-0.019955169810893,0.00974611389114458,-0.0390575530375364,-0.000852786584249587,0.0406284573129882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,42345,-0.0148844760725297,0.00727410529548466,-0.0291417224516797,-0.000627229693379808,0.0407538119326059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,40448,-0.0133730078736025,0.00654209422765136,-0.0261955125597991,-0.000550503187405802,0.0409621679663182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40222,-0.0082883500563039,0.00406278333143299,-0.0162514053859126,-0.000325294726695241,0.0413674314468271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42753,-0.00824903976539023,0.00404970029676018,-0.0161864523470402,-0.000311627183740277,0.0416743672716904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,42473,-0.00572259767565779,0.00280969518744689,-0.0112296002430537,-0.000215595108261896,0.0416966440228394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40168,-0.00976034148064427,0.00479425687071411,-0.0191570849472439,-0.000363598014044618,0.0417903597543746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40301,-0.0221478991157289,0.0108797993569997,-0.0434723058554483,-0.000823492376009559,0.0418051745424132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42710,-0.0103159422306477,0.00507314867631875,-0.0202593136362325,-0.000372570825062998,0.0420276092264859
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,40079,-0.0144601106061452,0.00711406476957441,-0.0284036775545111,-0.00051654365777937,0.0421162854406877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,42364,-0.00785658575280037,0.00387380839337145,-0.0154492502038084,-0.000263921301792324,0.0425671021513183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,40222,-0.0179515233764415,0.00885182502545652,-0.0353011004263363,-0.000601946326546702,0.0425839828237968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42676,0.00828164011572191,0.00408557323778472,0.000273916569663867,0.01628936366178,0.0426774659881399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40135,-0.0149783884991587,0.00739223193582898,-0.0294671630933835,-0.000489613904933923,0.0427650686687146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40222,-0.00783612814761978,0.00387099126320228,-0.0154232710234963,-0.000248985271743307,0.0429612107910235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42593,0.0297377409199812,0.01470390004196,0.000918096837739645,0.0585573850022227,0.0431508460436477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40282,-0.0113667973700307,0.0056326566944484,-0.0224068044911496,-0.000326790248911883,0.0436135201274178
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40115,-0.0135724228223183,0.00672598486714574,-0.026755353161924,-0.000389492482712689,0.0436251857045177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40526,-0.0279363663158518,0.0138477342939713,-0.0550779255320355,-0.00079480709966805,0.0436777150175147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42663,-0.00845839567872927,0.00419297487279555,-0.0166766264294085,-0.000240164928049999,0.0436863153751379
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40181,-0.0134731175222527,0.00669924912653776,-0.0266036458102667,-0.000342589234238667,0.0443352129897384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40450,-0.0103589371429782,0.00515207019860223,-0.0204569947322385,-0.000260879553717808,0.044387736770968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,42380,-0.00904196484294154,0.00449828506634924,-0.017858603572986,-0.000225326112897035,0.0444418272148359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,40450,-0.0161992289406545,0.00805894362298809,-0.0319947584417111,-0.000403699439597803,0.0444451239346562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42720,-0.00874133314147667,0.00435168637674599,-0.0172706384398988,-0.000212027843054526,0.0445863391508483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,42369,-0.0126410097330613,0.00629699271629543,-0.0249831154570003,-0.000298904009122207,0.0447202653654038
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40266,-0.016609468905166,0.00827537832976877,-0.0328292104315128,-0.000389727378819229,0.044763829780157
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,40482,-0.0189957671039131,0.00947956096654782,-0.0375757065983468,-0.000415827609479381,0.0451082996375203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,40482,-0.0207865464741918,0.0103744423589622,-0.0411204534977576,-0.000452639450625916,0.045133538914828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40267,0.0124034784564639,0.00621239536222121,0.000227183546510331,0.0245797733664175,0.045896419154377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,42310,-0.0103621389155644,0.00519246463240136,-0.020539369595071,-0.000184908236057709,0.0459969401761091
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40481,-0.0146994414469435,0.0073670372392662,-0.0291388344359053,-0.000260048457981787,0.0460342843854933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40115,-0.0226899366174253,0.0113784401209621,-0.0449916792545111,-0.000388193980339464,0.046164132044035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42310,-0.0164151804164313,0.00823217339960871,-0.0325502402796643,-0.00028012055319818,0.0461697141860183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBN,Nibrin,42369,-0.0103959839124993,0.00521462496152918,-0.0206166488370965,-0.000175318987902129,0.0462141105911058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42586,-0.00382432298572552,0.00191950085344436,-0.00758654465847647,-6.21013129745796e-05,0.0463526232793098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40135,-0.0146942445206338,0.00738655854513778,-0.0291718992691039,-0.000216589772163751,0.0466905141413871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42580,-0.0082174021384738,0.00413146534636197,-0.0163150742173433,-0.00011973005960433,0.0467237273376731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40450,-0.00861993806105038,0.00433734353443351,-0.0171211313885401,-0.000118744733560704,0.0469047959729862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40079,-0.0114277461275204,0.00575144887931315,-0.0227005859309741,-0.000154906324066574,0.0469547992515648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40510,-0.0142443461741666,0.00717076377420796,-0.0282990431716142,-0.000189649176718994,0.0470077316582909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,40198,-0.00600775412710784,0.00302597203252847,-0.0119386593108636,-7.68489433520415e-05,0.0471251623304056
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,40448,-0.0117746194979606,0.00593261662953135,-0.0234025480918421,-0.000146690904079162,0.0471991872567543
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40181,-0.00980456124173058,0.00494392952409692,-0.0194946631089605,-0.000114459374500626,0.0473753673130241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42593,-0.012958484522607,0.00653676152332507,-0.0257705371083242,-0.000146431936889894,0.0474547376134708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40115,-0.0128506021670196,0.00648934863178167,-0.0255697254853117,-0.000131478848727558,0.0476992970692975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42593,0.0163886190302717,0.00827881749834599,0.000162136733513597,0.0326151013270299,0.0477706646022749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,40135,-0.0110188478681924,0.00557009514932691,-0.0219362343608732,-0.000101461375511654,0.0479294598244011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,40181,-0.00534113442523579,0.00270754907875522,-0.010647930619596,-3.43382308755609e-05,0.0485567896960815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42657,-0.00979433432791599,0.00498785503846819,-0.0195705302033136,-1.8138452518331e-05,0.0495928075155231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC1,Hamartin,40198,-0.014072295806546,0.00717468462707186,-0.0281346776756068,-9.91393748510198e-06,0.0498596796128383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40079,0.0059074398356624,0.00301214663880901,3.63242359673575e-06,0.0118112472477281,0.0498804615647438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40115,-0.0191607782165167,0.00977564311434596,-0.0383210387206348,-5.17712398617753e-07,0.0500149910664169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40481,-0.00915540626451495,0.00467389321698842,-0.0183162369698122,5.42444078235373e-06,0.050156181947465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40482,-0.0108869333539231,0.00555814152879727,-0.0217808907503657,7.02404251954822e-06,0.0501682671808472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40282,-0.0102641292354947,0.00525191356864851,-0.0205578798300458,2.96213590564032e-05,0.0506837691387098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,40135,-0.0146845072018433,0.00752261183160022,-0.0294288263917797,5.98119880931332e-05,0.0509578556097046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40079,-0.0110682313493947,0.00567274599024621,-0.0221868134902773,5.03507914878729e-05,0.0510679052417456
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42678,-0.00699497153897058,0.00359283575562418,-0.014036929619994,4.69865420528112e-05,0.0515648028749641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42753,0.00582509271251066,0.00299316478517347,-4.15102664293437e-05,0.0116916956914507,0.0516595584373265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40450,-0.00856332273805079,0.00440736765527137,-0.0172017633423827,7.51178662810898e-05,0.0520463392828089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40301,-0.00769039491323688,0.00396122372829554,-0.0154543934206961,7.36035942223781e-05,0.0522327366455237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,40198,0.00884872621581859,0.00455955624618144,-8.80040266970396e-05,0.0177854564583342,0.0523203044157844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,40181,-0.0127713941145307,0.00658465089535177,-0.0256773098694202,0.000134521640358747,0.0524574813028661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,40282,-0.00416458323201652,0.0021578143239819,-0.00839389930702104,6.4732842988002e-05,0.0536322230012159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42310,-0.0146408104127501,0.00759284654572442,-0.02952278964237,0.000241168816869735,0.053847168276411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42494,0.00640538388860704,0.00332268803195258,-0.000107084654020015,0.0129178524312341,0.0539047990016201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40115,-0.0180225961920912,0.00935565672651551,-0.0363596833760616,0.000314490991879218,0.0540822482422944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,40135,-0.00904200340403597,0.00469541934586415,-0.0182450253219297,0.000161018513857766,0.0541668137030316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42593,-0.0108336147562404,0.00562706381876702,-0.0218626598410238,0.000195430328542934,0.0542167833690175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42745,-0.00712717860378715,0.00370416122498624,-0.0143873346047602,0.00013297739718587,0.054362901198381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,42475,-0.0118051870053132,0.0061392752562366,-0.0238381665075369,0.000227792496910522,0.0545144879343308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,40135,-0.00957264743155626,0.00499350387156495,-0.0193599150198236,0.000214620156711046,0.0552613900148929
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40450,-0.00626868806254004,0.00327204074330732,-0.0126818879194224,0.000144511794342306,0.0554114880811493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,40115,-0.0113119778405018,0.00590752501617642,-0.0228907268722076,0.000266771191203979,0.055538734262944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42593,-0.0105878650425945,0.00553472552030153,-0.0214359270623855,0.000260196977196498,0.0557708450422824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42720,-0.00405257154288912,0.00211864179531313,-0.00820510946170284,9.99663759246126e-05,0.0557927292578796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,42369,-0.0140933368178442,0.00738080723569771,-0.0285597189998117,0.000373045364123274,0.0562248125450844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40448,-0.00806700009184866,0.00423312391954625,-0.0163639229741593,0.000229922790461983,0.056716561754974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42345,0.0119327577368688,0.00626211339778587,-0.000340984522791488,0.0242064999965291,0.0567306572030243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42618,-0.0108517150980161,0.00569786321883174,-0.0220195270069263,0.0003160968108941,0.0568633768718725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40301,-0.0135702478203635,0.00713837012406048,-0.0275614532635221,0.000420957622795004,0.0573240872189176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,40079,-0.0147625546187245,0.00776722622565735,-0.0299863180210129,0.000461208783563934,0.0573780418606948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40510,0.00526642683877513,0.00277164875526748,-0.00016600472154912,0.0106988583990994,0.0574445847496009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42675,-0.00746633201876836,0.0039295971155745,-0.0151683423652944,0.000235678327757658,0.0574511800347689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42593,-0.00707549657050808,0.00372857016272281,-0.0143834940894448,0.000232500948428631,0.0577645476690559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42369,0.012788963765084,0.0067420401790277,-0.000425434985810323,0.0260033625159783,0.0578632261315612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42678,-0.00490988132205304,0.00259151278484862,-0.00998924638035634,0.000169483736250256,0.0581667281684673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42710,-0.00850037658241625,0.0044884968786783,-0.0172978304646257,0.000297077299793207,0.0582710846002569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,40198,-0.0181016835820313,0.00956139625945918,-0.0368420202505713,0.000638653086508706,0.0583568193945111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40450,-0.00801725783124646,0.0042364656076443,-0.0163207304222293,0.000286214759736367,0.0584579894483901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40222,-0.0134869886229432,0.00713149343080541,-0.0274647157473218,0.000490738501435439,0.0586255514144774
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40181,-0.0115404066580104,0.00610643680141094,-0.0235090227887759,0.000428209472755015,0.0588008826241352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40301,-0.0121485599991469,0.00643280870380348,-0.0247568650586018,0.000459745060307892,0.0589807060814937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,40181,-0.00905425853782671,0.00479684635801664,-0.0184560773995393,0.000347560323885896,0.0591135267641613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40450,-0.00531989303077813,0.00282012169135703,-0.0108473315458379,0.000207545484281658,0.0592660520132328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40282,-0.015306383931252,0.0081208464039721,-0.0312232428830373,0.000610475020533319,0.0594794383630224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40450,-0.00688286877499539,0.00365196226932196,-0.0140407148228664,0.000274977272875661,0.0594955208190878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERVV_1,,40115,-0.00804098278538501,0.00426812097746485,-0.0164064999012161,0.000324534330446097,0.0595964968196166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40115,0.00721512830177885,0.00383179513123826,-0.00029519015544815,0.0147254467590058,0.0597319429638741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,42369,-0.00927787761889336,0.0049359179765175,-0.0189522768528677,0.000396521615080936,0.0601756503147013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,42316,0.00908795050807674,0.00483570038102191,-0.000390022238726209,0.0185659232548797,0.0602195103331469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42310,0.0120222052447188,0.0064132488091937,-0.000547762421300887,0.0245921729107384,0.0608715037061482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40481,-0.0119669064384593,0.00640504855017868,-0.0245208015968095,0.000586988719890911,0.0617384495003057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40198,0.00518384943634983,0.00277707223847255,-0.00025921215105638,0.010626911023756,0.0619756696817079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40222,0.0103863092988669,0.00556687048592996,-0.000524756853555807,0.0212973754512896,0.0621048744622983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,42369,-0.00797925490991338,0.00427788227392739,-0.0163639041668111,0.000405394346984309,0.0621707106867098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40079,-0.0106059409253157,0.00568758638254753,-0.0217536102351088,0.000541728384477498,0.0622429953679589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42537,-0.0106612005431399,0.00572209697422541,-0.0218765106126217,0.000554109526341924,0.0624612623854223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,40282,0.0168380797806963,0.00906163896932513,-0.000922732599180982,0.0345988921605735,0.0631711401497881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42504,-0.0234700431692486,0.0126609878149876,-0.0482855792866242,0.00134549294812704,0.0638000180556244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40135,-0.00524503867841436,0.00283493744681476,-0.0108015160741713,0.000311438717342566,0.0643199357780112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42710,-0.00568602251607758,0.00307536650948469,-0.0117137408746676,0.000341695842512407,0.0644951392873022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40115,0.00661722655690132,0.00358844893981382,-0.000416133365133771,0.0136505864789364,0.0652050643777502
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40135,-0.0201225899574002,0.0109422163234048,-0.0415693339512737,0.00132415403647317,0.0659442301464604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,40510,-0.00480670123297432,0.00261878565747916,-0.00993952112163347,0.000326118655684829,0.0664623800568924
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,40301,0.00631802314854844,0.00344231614101295,-0.000428916487836942,0.0130649627849338,0.0664733333395391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42612,0.0144901438970127,0.00790206679302223,-0.000997907017310905,0.0299781948113362,0.0667183439945139
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40115,-0.00867829463147003,0.00473404700530872,-0.0179570267618751,0.00060043749893506,0.0668050733697394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,40222,0.0130867753661311,0.00716859612903309,-0.000963673046773727,0.027137223779036,0.0679420609117112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40198,-0.009643670798524,0.00528640098184602,-0.0200050167229422,0.000717675125894197,0.0681427114440013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,40079,-0.00937221371595941,0.00514437395001247,-0.0194551866579839,0.000710759226065043,0.0685070659551072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,40481,0.0086079472368601,0.00472696218972425,-0.000656898654999436,0.0178727931287196,0.0686285248429923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,42356,-0.0108521096211361,0.00596062064688109,-0.022534926089023,0.000830706846750847,0.0686851815048234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42593,-0.00993209045911809,0.00545544533470943,-0.0206247633151486,0.000760582396912384,0.0686925803623394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42593,0.018684111096909,0.0102631723551772,-0.00143170671923829,0.0387999289130562,0.0687051061089458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42610,-0.00457810519196009,0.00251803840680187,-0.00951346046929175,0.000357250085371564,0.0690675257220267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40482,-0.0156562803621546,0.00861228650919877,-0.0325363619201842,0.00122380119587498,0.0691058297798147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40301,-0.00618234410142828,0.00340336729568498,-0.0128529440009708,0.000488255798114284,0.0693149131704203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42680,-0.0129304238238169,0.00711978834079519,-0.0268852089717754,0.0010243613241417,0.0693734312967453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42369,-0.01199760247438,0.00661882593654323,-0.0249705013100047,0.000975296361244712,0.0699088593696611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,40198,-0.00748542785459723,0.00413122316092319,-0.0155826252500067,0.00061176954081222,0.0700264796556087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42610,-0.0130376776550003,0.00719968016023694,-0.0271490507690647,0.00107369545906411,0.0701834894649014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,42310,0.00756012427928516,0.00418105353538334,-0.000634740650066186,0.0157549892086365,0.0706003841047526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40301,0.00803506902287337,0.00444460309401568,-0.000676353041397359,0.0167464910871441,0.0706606260248223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,40341,0.00424016024282284,0.00234845029236715,-0.00036280233021677,0.00884312281586245,0.0710212307596766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,42016,0.00495528557968608,0.0027452581107325,-0.000425420317349616,0.0103359914767218,0.071092734371182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,40470,-0.0148009308966963,0.00820451897168713,-0.030881788081203,0.0012799262878105,0.0712583903271574
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40481,-0.0202923829716673,0.0112521352419125,-0.0423465680458157,0.00176180210248114,0.0713481367143554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40481,-0.0108552582480095,0.00602367459641069,-0.0226616604569745,0.000951143960955438,0.0715564937704508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,40082,-0.0154747502613776,0.00859100049207982,-0.032313111225854,0.00136361070309885,0.0716872788429322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,42310,-0.0108487958162402,0.00602770060156403,-0.0226630889953057,0.000965497362825352,0.0719115198635283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,40115,-0.0067788936692064,0.00376799811059951,-0.0141641699659814,0.000606382627568632,0.0720351505609565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,42356,-0.00862349578755829,0.00479744226955861,-0.0180264826358932,0.000779491060776584,0.0722761054243937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40198,-0.00962891565250512,0.00535888717033587,-0.0201323345063634,0.000874503201353193,0.072392798465484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42345,-0.0118347390743277,0.00659392663363441,-0.0247588352762511,0.00108935712759579,0.0727095041804339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,42476,-0.00811892909810996,0.00452387901826541,-0.0169857319739102,0.00074787377769024,0.0727269392143634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,40181,-0.0140902683077792,0.0078552078314981,-0.0294864756575155,0.00130593904195707,0.0728807872746297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42780,-0.0103548289492936,0.00579379057050049,-0.0217106584674746,0.00100100056888734,0.0739228128632179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42720,0.00433604636606814,0.00242850201247002,-0.000423817578373094,0.00909591031050937,0.0742055844128392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,40181,-0.00845932326689646,0.00474415596029764,-0.0177578689490798,0.000839222415286903,0.0745969811434609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42494,-0.00632178577267626,0.00355496855678809,-0.0132895241439809,0.000645952598628394,0.0753781194083661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,40198,-0.0078439718149145,0.00441165159760985,-0.0164908089462298,0.00080286531640082,0.0754294044951945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42586,-0.00686464951757049,0.00386278900976615,-0.0144357159767121,0.000706416941571164,0.0755707678814849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,40510,-0.00923012301085443,0.00520397432031719,-0.0194299126786761,0.000969666656967254,0.0761449613445326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42593,0.0165891740046775,0.00936311159598257,-0.0017625247234483,0.0349408727328034,0.076457351694267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40301,-0.0129050533727706,0.0072908229442386,-0.0271950663434783,0.00138495959793702,0.076747789122951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42675,-0.0178999202473217,0.0101155560619777,-0.0377264101287981,0.0019265696341547,0.0768257584927783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42635,-0.00501992255900341,0.00283744303233001,-0.0105813109023702,0.000541465784363414,0.0768879776963387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40198,-0.00637934942616806,0.00361556149037789,-0.0134658499473087,0.000707151094972601,0.0776899435730065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,40222,-0.012038751146973,0.00682453532277427,-0.0254148403796105,0.0013373380856646,0.0777529801573529
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40198,-0.00843533279594528,0.00478563811448121,-0.0178151835003285,0.000944517908437904,0.0779898414930218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40416,-0.0074649999422635,0.00423744885941997,-0.0157703997067266,0.000840399822199636,0.0781517598472985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42586,-0.0130728293041289,0.00745005678753085,-0.0276749406076894,0.00152928199943153,0.0793285713561614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,40135,-0.0157397763028116,0.00897221121509576,-0.0333253102843993,0.00184575767877608,0.0794104267168786
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42593,-0.0176753089399044,0.0100766791192609,-0.0374256000136558,0.00207498213384697,0.0794395295007517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,40079,-0.0101604469126505,0.00579638266792786,-0.0215213569417891,0.00120046311648807,0.079648278703561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40135,-0.00759491516995786,0.00433864530319946,-0.0160986599642288,0.000908829624313088,0.0800554688038826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,42345,-0.00542929674226884,0.00310210704073541,-0.0115094265421102,0.000650833057572569,0.0801077396894876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,40332,0.0106990237379867,0.00611495843607363,-0.00128629479671757,0.022684342272691,0.0802066400863807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40079,0.00448037617852482,0.00256133048359557,-0.000539831569322498,0.00950058392637214,0.0802780995518065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,42246,-0.0113869033636008,0.0065194741647637,-0.0241650727265376,0.00139126599933609,0.0807305417674198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,40531,-0.00428412699159913,0.00245603088439919,-0.00909794752502155,0.000529693541823283,0.0811287599788837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,40079,0.00613538269031809,0.00352309588996925,-0.000769885254021638,0.0130406506346578,0.0816286377792623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,40222,-0.00384350961064171,0.00221234405269464,-0.0081797039539232,0.000492684732639788,0.082361808302219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40115,-0.00815676912301923,0.00469782794440665,-0.0173645118940563,0.0010509736480178,0.0825416198338554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,42310,-0.00887593148834251,0.00512800832706034,-0.0189268278093808,0.00117496483269575,0.0834979249194991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,40481,-0.00613907449483012,0.00354866030503902,-0.0130944486927066,0.000816299703046355,0.0836630407604474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,42133,0.0102374960153302,0.00592646861680053,-0.00137838247359881,0.0218533745042592,0.0841162579676446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALLD,Palladin,40198,-0.00658152976760801,0.00380999608003443,-0.0140491220844755,0.000886062549259464,0.0841171960049815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42610,-0.00403623982261869,0.00234563283352421,-0.00863368017632614,0.00056120053108875,0.0853198658724268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40482,-0.00543771471185471,0.0031703385604762,-0.0116515782903881,0.000776148866678655,0.0863388993569305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40448,-0.00735565042826935,0.00428877832516809,-0.0157616559455988,0.00105035508906011,0.0863558449075292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40135,-0.00971268595733987,0.00566980475071025,-0.020825503268732,0.00140013135405221,0.0867307984851876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40510,-0.00930608311613838,0.00544475996074704,-0.0199778126392026,0.00136564640692583,0.0874447495678778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,40301,-0.00637457920833016,0.00372982036553927,-0.0136850271247871,0.000935868708126814,0.0874631825912428
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,42356,0.0236101809207593,0.013816542780274,-0.00347024292857779,0.0506906047700965,0.0875052400155455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,40135,-0.0109513947947887,0.00641141369326556,-0.0235177656335892,0.00161497604401177,0.0876444462747647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42612,-0.00718270471514126,0.0042051946276699,-0.0154248861853743,0.00105947675509175,0.0876492235163731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,40198,-0.00781465179798199,0.00457745817196562,-0.0167864698150346,0.00115716621907063,0.0878124782049785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,40301,-0.0118114704438981,0.00692536223560748,-0.0253851804256887,0.0017622395378926,0.0881220382898952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,40459,-0.0152680400540346,0.00896420731449019,-0.0328378863904354,0.00230180628236613,0.0885540117237632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,42356,-0.0176718125866001,0.0103808209911238,-0.0380182217292026,0.00267459655600254,0.0887129937185899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40481,-0.00451239726619962,0.00265330115656337,-0.00971286753306382,0.000688073000664585,0.089031981121335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40448,-0.0136405654933262,0.00803044577528693,-0.0293802392128886,0.00209910822623616,0.0894210367601576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42673,-0.00983132642842981,0.00578894069347874,-0.0211776501876481,0.00151499733078852,0.0894752630709806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40450,-0.0118041919025891,0.00695235441296917,-0.0254308065520087,0.00182242274683047,0.0895599982683253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40135,-0.00954173674532439,0.0056218047333018,-0.0205604740225959,0.00147700053194714,0.0896735217754295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,40115,0.00900259187524131,0.00530644479970542,-0.00139803993218131,0.0194032236826639,0.0898123015998179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42753,-0.0109830990736958,0.00649365703326864,-0.0237106668589024,0.0017444687115107,0.0907914204500804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40301,-0.00868686240542377,0.00513605464339743,-0.0187535295064827,0.00137980469563518,0.090798163943662
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,40482,-0.0222981452049645,0.0131873084626762,-0.0481452697918098,0.00354897938188087,0.0908874890011732
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42610,-0.0063206960980255,0.00374340737326025,-0.0136577745496156,0.00101638235356458,0.0913409502662547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40198,-0.00714513304344856,0.00423345291682366,-0.0154427007604229,0.00115243467352582,0.0914819938317052
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42356,-0.00456052002558321,0.00270667991482641,-0.00986561265864298,0.000744572607476556,0.0920290758003916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42345,0.00966326005602869,0.00574030256114932,-0.00158773296382398,0.0209142530758814,0.0923202475196686
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40481,-0.0128092396616015,0.00761384569460354,-0.0277323772230244,0.00211389789982146,0.0925264530149643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,40115,-0.00936328854314079,0.00557567217348206,-0.0202916060031656,0.00156502891688405,0.0931200210628308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,40482,-0.0169429025462902,0.0100989106867677,-0.0367367674923549,0.00285096239977452,0.0934341357003119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,40135,-0.00689198788756714,0.00411054311538572,-0.0149486523937232,0.00116467661858888,0.093637332792345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,42310,-0.00570292404038117,0.003401641812096,-0.0123701419920893,0.000964293911326997,0.0936600117005129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRTN,Neurturin,42369,-0.00804297215622161,0.00480483760506554,-0.0174604538621501,0.00137450954970686,0.0941676712500269
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42591,-0.0108092406492914,0.00646225713921443,-0.0234752646421516,0.00185678334356892,0.0944151094166634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41947,-0.00479292061943934,0.00286615652308783,-0.0104105874046915,0.000824746165812819,0.0945002271727271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42678,-0.00391513860413802,0.00234140919148495,-0.00850430061944854,0.000674023411172486,0.0945220551771503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40115,-0.0101018926473343,0.00605810167297831,-0.0219757719263718,0.00177198663170323,0.0954434297389164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42617,0.0121274441057992,0.00728725812276763,-0.00215558181482534,0.0264104700264238,0.0960961069906514
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,40448,0.0182291537109664,0.0109545671241364,-0.0032417978523409,0.0397001052742737,0.0961265152800419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42793,-0.0115996741169001,0.00697087525936216,-0.0252625896252499,0.00206324139144972,0.0961315221077419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42653,-0.0138592832093456,0.00833118052151136,-0.0301883970315079,0.00246983061281666,0.0962269241990589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,42254,-0.0111734324129118,0.0067209700950487,-0.0243465337992073,0.00199966897338362,0.0964419372471211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42356,-0.00713155527449484,0.00429234313595304,-0.0155445478209628,0.00128143727197312,0.0966449655314036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42310,-0.0107791943703337,0.00649597197241333,-0.0235112994362638,0.00195291069559644,0.097065991397022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,40181,-0.0147253456449272,0.00889398151383611,-0.032157549412046,0.00270685812219157,0.0978207038058458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42356,0.0100546274186337,0.00607595424423998,-0.00185424290007668,0.0219634977373441,0.0979842967620287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42345,-0.00779245023123989,0.00470987655647474,-0.0170238082819304,0.0014389078194506,0.0980515742033253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42610,-0.00643491722129533,0.00390918258016924,-0.014096915078427,0.00122708063583639,0.0997659757792827
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40481,-0.0148656356906773,0.00905259638441598,-0.0326087246041327,0.00287745322277798,0.100588735716252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40115,0.00557305855065846,0.00339558404626155,-0.00108228618001418,0.0122284032813311,0.100770889325653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40448,-0.0170798206608299,0.0104131600861769,-0.0374896144297366,0.0033299731080767,0.100988433042276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,40198,-0.0196865154974499,0.0120157606555134,-0.0432374063822561,0.00386437538735636,0.101368720971217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,42369,-0.0135873874784649,0.00829460356878609,-0.0298448104732857,0.00267003551635579,0.101424780581891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40176,-0.00607772882262252,0.00371610520495992,-0.013361295024344,0.00120583737909892,0.101970748046002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40481,-0.00788974487246778,0.00482526685249723,-0.0173472679033623,0.00156777815842678,0.102058098042912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42306,-0.0124053276253671,0.00759251272335939,-0.0272866525631515,0.00247599731241734,0.102306040370998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42635,-0.00487497487820955,0.00298669911107088,-0.0107289051359085,0.000978955379489376,0.102654821803658
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40181,-0.00576121927910601,0.00353988234496219,-0.0126993886752319,0.00117695011701987,0.103655980213271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42617,0.01493752382899,0.00918784864283944,-0.00307065951097531,0.0329457071689553,0.104017548029279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_DRA,,42548,-0.00585085936783167,0.00359933767485784,-0.012905561210553,0.0012038424748897,0.104071618236084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40301,-0.00585436236657413,0.00360168084836104,-0.0129136568293618,0.00120493209621351,0.104094475979631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42635,0.0119374736248069,0.00734479888160985,-0.00245833218314837,0.0263332794327623,0.104122908517938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40510,-0.00441546915380945,0.00271877586553128,-0.00974426985025076,0.000913331542631862,0.104389755115211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,42291,-0.0074502324938101,0.00459071820059506,-0.0164480401669764,0.00154757517935621,0.104636903972806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40135,-0.0143596639858674,0.00887524222630597,-0.0317551387494271,0.00303581077769232,0.105703029393975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42356,-0.00773263578739473,0.00478151987040914,-0.0171044147333966,0.00163914315860718,0.105860801628099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42356,0.00911643544251429,0.00564654009354021,-0.00195078314082452,0.0201836540258531,0.106439284651568
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40198,-0.0152123417394948,0.00942279646142552,-0.0336810228038888,0.00325633932489926,0.106465242245183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42705,-0.00329200233664022,0.00203975498603971,-0.00728992210927805,0.000705917435997622,0.106568029266515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40481,-0.00863160168664749,0.00535108932844815,-0.0191197367704059,0.00185653339711087,0.106760503608489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42635,0.0102382378338776,0.00635726904821316,-0.00222200950062023,0.0226984851683754,0.107317167301785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42586,-0.00303523214835356,0.00188917515517599,-0.00673801545249849,0.000667551155791376,0.108156034873557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40115,-0.0173179286099521,0.0107821858057839,-0.0384510127892885,0.00381515556938429,0.108267404923933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,40448,0.00877146794461687,0.00546166985748371,-0.0019334049760512,0.0194763408652849,0.108300914097999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40198,-0.0100137832807866,0.0062391162076762,-0.0222424510478319,0.00221488448625878,0.108522438453452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42635,-0.0073647046115625,0.00460774157664328,-0.0163958781017833,0.00166646887865832,0.109992431409034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,42113,-0.00761346936995855,0.00476811500704098,-0.0169589747837589,0.00173203604384177,0.110346757854318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,40115,-0.0114917563936006,0.00720195151671317,-0.0256075813663585,0.00262406857915717,0.110597057121358
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42586,0.0136904876928478,0.00858233178558848,-0.00313088260690558,0.0305118579926013,0.110692365166155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,40079,-0.00818586501442541,0.00515316716124685,-0.0182860726504692,0.0019143426216184,0.112199778779816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40448,0.00775716925010772,0.00488343609617839,-0.00181436549840191,0.0173287039986174,0.112209231506859
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,40198,-0.0110186655359579,0.00694098763111912,-0.0246230012929514,0.00258567022103553,0.112433144890841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,42369,-0.00600282307996133,0.00378497003183469,-0.0134213643423573,0.00141571818243467,0.112771662820899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,42369,-0.00862238088332397,0.00543906900094372,-0.0192829561251737,0.00203819435852573,0.112929504303934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40135,-0.00648960547504812,0.00409551494459301,-0.0145168147664504,0.00153760381635418,0.113094334709129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40448,-0.00396403572005582,0.00250493849366414,-0.00887371516763754,0.000945643727525896,0.113566254044097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42310,-0.0102417603109463,0.00647942646488496,-0.0229414361821208,0.00245791556022825,0.113980262457597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40538,-0.00262078695266074,0.00165860500485105,-0.00587165276216881,0.000630078856847321,0.114108370926496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42345,-0.00783834826311761,0.00496497571818519,-0.0175697006707606,0.00189300414452537,0.114422414420201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,40450,-0.0107994604073179,0.00684487939359736,-0.0242154240187688,0.00261650320413288,0.114652769220581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZN,Kazrin,40448,-0.0159773689231162,0.010127201789599,-0.0358266844307302,0.00387194658449781,0.114669854839907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42720,-0.00443245110572505,0.00281594691739999,-0.00995170706382902,0.00108680485237892,0.1154984692914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42593,0.0111175947724962,0.00708876677315542,-0.00277638810288839,0.0250115776478809,0.116825475549081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42663,-0.0180917232149538,0.0115471834849077,-0.0407242028453728,0.00454075641546532,0.117193117341354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,40222,-0.0067319134112284,0.00429861807143631,-0.0151572048312436,0.00169337800878677,0.117362196304982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42682,0.00469850585239293,0.00300501950487105,-0.00119133237715432,0.0105883440819402,0.117946150235048
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42356,-0.00740060058933727,0.00474166475665444,-0.01669426351238,0.00189306233370543,0.118604435523126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,42135,0.0138932182537748,0.00891532690063521,-0.00358082247147022,0.0313672589790198,0.119174261956571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42635,-0.00707111823572055,0.0045393943803365,-0.0159683312211801,0.001826094749739,0.119322511257684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40181,-0.016334405156608,0.010502934520644,-0.0369201568170703,0.00425134650385426,0.119921775057083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,42345,-0.0110039465491362,0.00708178108512198,-0.0248842374759753,0.00287634437770292,0.120246925177639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42310,-0.0117221365430363,0.00754891966761804,-0.0265180190915677,0.00307374600549503,0.120489539285742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPGN,Epigen,40450,0.00690606959278882,0.00444989115758859,-0.00181571707608483,0.0156278562616625,0.120699021264935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,40079,-0.00622103734675119,0.00401123142031481,-0.0140830509305682,0.00164097623706584,0.120953615180659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEP,Leptin,42635,0.0100079539276791,0.0064637116424449,-0.00266092089151288,0.0226768287468711,0.121566584312312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,40531,0.00742331905134097,0.00480548645451645,-0.00199543439951128,0.0168420725021932,0.12243244918732
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42291,-0.00997650981691248,0.00646990466403991,-0.0226575229584307,0.00270450332460575,0.123100877298487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,40198,-0.0058308777506189,0.00378508573687179,-0.0132496457948876,0.00158789029364981,0.12347029007746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42345,-0.00593112988302588,0.00385628136549785,-0.0134894413594017,0.0016271815933499,0.124061948988517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,42310,-0.0048673740559964,0.00316505768852458,-0.0110708871255046,0.00133613901351178,0.124110183135251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40222,0.00384606537292183,0.00250511110077753,-0.00106395238460214,0.00875608313044579,0.124741948518489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,40115,-0.00737349158293019,0.00480350688969787,-0.016788365086738,0.00204138192087764,0.124807247686205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42310,-0.00739196905685841,0.00481829707193828,-0.0168358313178575,0.00205189320414063,0.125017966953409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42369,-0.0052062970578026,0.00340074962151044,-0.0118717663159631,0.00145917220035787,0.125811615773211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42294,-0.00855402889399038,0.00559886203060551,-0.0195277984739772,0.00241974068599641,0.126582465043847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,42356,-0.00660085054234941,0.00432257360072195,-0.0150730947997644,0.00187139371506561,0.126768895964395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,40198,-0.00824583542768018,0.00540704993219604,-0.0188436532947844,0.00235198243942406,0.127283948279042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40482,0.0105130581634158,0.00689413973093517,-0.0029994557092171,0.0240255720360488,0.127305381670729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40079,0.00633538896130291,0.00415880879003934,-0.00181587626717419,0.01448665418978,0.127696150428127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40181,-0.0153123475849536,0.0100599102521563,-0.0350297716791799,0.00440507650927281,0.128008865223461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40428,-0.0058651788177557,0.00385904639863327,-0.0134289097590769,0.0016985521235655,0.128576356085524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40115,-0.00772279349618003,0.0050838516993563,-0.0176871428269184,0.00224155583455832,0.12877051311533
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40079,0.00430201478928878,0.00283373529058046,-0.00125210638024893,0.00985613595882649,0.129007448905307
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,40282,-0.00750536062652083,0.00495265844874834,-0.0172125711860676,0.00220184993302591,0.1296944298184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42753,-0.00727972490682372,0.00480402634450313,-0.0166956165420499,0.00213616672840241,0.129710075219636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40448,-0.00603869151773208,0.00398773856308678,-0.0138546591013822,0.00177727606591801,0.129974099998045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40079,0.00669308623340196,0.00443021220962618,-0.00199012969746535,0.0153763021642693,0.13087295122583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42661,-0.0072473885330133,0.00480616423690448,-0.0166674704373461,0.00217269337131948,0.131594340925718
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42586,0.00626411824753253,0.00415576265976682,-0.00188117656561044,0.0144094130606755,0.131748907688403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,42310,-0.00508316199263354,0.00337268200263905,-0.0116936187178061,0.001527294732539,0.131794449593437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,40115,-0.0183544132210541,0.0121920082992017,-0.0422507494874895,0.00554192304538127,0.132238305386265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42637,0.00379126800530466,0.00252171363724785,-0.00115129072370112,0.00873382673431045,0.132746773691341
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40135,0.0118823639344514,0.00791740704236142,-0.00363575386857696,0.0274004817374798,0.133438787269906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,42310,0.0109069073821509,0.00728090708529788,-0.00336367050503292,0.0251774852693348,0.1341534413696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40482,-0.00692075253754604,0.00462277998757774,-0.0159814013131984,0.00213989623810633,0.134395840026452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,40448,0.0388632716989103,0.0259873512036934,-0.0120719366603289,0.0897984800581494,0.13482018868386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,42356,-0.00484466339890421,0.00324070332294362,-0.0111964419118737,0.00150711511406529,0.134953562343826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40301,-0.00653469049096785,0.004371698427829,-0.0151032194095127,0.00203383842757699,0.135002479261502
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,40181,-0.00699440247809259,0.00468233266051015,-0.0161717744926925,0.0021829695365073,0.135260306076379
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42793,0.00757941411036595,0.00508041933131185,-0.00237820777900527,0.0175370359997372,0.135751835699659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42494,-0.00690661267196417,0.00462998491595941,-0.0159813831072446,0.00216815776331628,0.135797891412801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,40450,0.00586846830666228,0.00393910284189682,-0.00185217326345549,0.0135891098767801,0.136305324250298
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42717,0.0036758486903622,0.0024677008842168,-0.00116084504270273,0.00851254242342713,0.136356872784195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40482,0.0118930061070561,0.00798983829013449,-0.00376707694160749,0.0275530891557197,0.136642669970702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,40301,-0.00791336538040221,0.00532107110744108,-0.0183426647509867,0.0025159339901823,0.136996911104963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40079,-0.0208525325745094,0.0140394910626652,-0.0483699350573333,0.00666486990831444,0.137499432150809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42310,-0.00966992398517613,0.00651786220370166,-0.0224449339044314,0.00310508593407913,0.137938136012149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42635,-0.0101671706292886,0.00687837261685353,-0.0236487809583215,0.00331443969974435,0.13939479467735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40115,-0.00545901761738172,0.00369787548439517,-0.0127068535667963,0.00178881833203282,0.139903523420919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,42369,-0.00676904850224974,0.00458548344392146,-0.0157565960523358,0.00221849904783633,0.139916575963134
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,40135,-0.00637328035125037,0.00432710263150373,-0.0148544015089977,0.00210784080649693,0.14081356881565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42345,-0.00779139190796605,0.00529450999857854,-0.01816863150518,0.0025858476892479,0.141153313129665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40526,-0.00388721051550955,0.00264676051921816,-0.00907486113317713,0.00130044010215804,0.141950819592409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40181,-0.0113164909822617,0.00770693390007832,-0.0264220814264152,0.00378909946189183,0.142037289451882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40135,-0.00870988224867439,0.00595972528228923,-0.0203909438019613,0.0029711793046125,0.143918785575258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40222,-0.00610671988365434,0.00418261783470008,-0.0143046508396665,0.00209121107235782,0.144312130340753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42753,-0.00468934949452254,0.00321258114559387,-0.0109860085398865,0.00160730955084144,0.144400433767918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40115,-0.00572918187860968,0.0039382801643031,-0.0134482110006438,0.00198984724342441,0.145769418295565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40198,-0.00603188038119558,0.00415076427669952,-0.0141673783635266,0.00210361760113548,0.146197434550068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42610,-0.00639349629132226,0.00440068461237071,-0.0150188381315688,0.00223184554892434,0.14629121377811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,40115,-0.00740563966472666,0.00509760710461738,-0.0173969495897767,0.00258567026032341,0.146316954371612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,40531,0.00380999672542242,0.00262646708209727,-0.00133787875548822,0.00895787220633307,0.146914318845164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,40079,-0.00943322101113141,0.00650394433302994,-0.0221809519038701,0.00331450988160728,0.146980099527134
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,40181,-0.00969415192152179,0.00670274192113266,-0.0228315260869418,0.00344322224389823,0.148122593444991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42345,-0.00921500075260891,0.00640628935278133,-0.0217713278840603,0.00334132637884249,0.150335795597389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40481,-0.00628168633573311,0.00437182731951498,-0.0148504678819825,0.00228709521051625,0.150786631042163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,40079,-0.00879930316279161,0.00612754596981315,-0.0208092932636254,0.00321068693804217,0.151024244864461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",42310,-0.00760583262700226,0.00530039792622409,-0.0179946125624015,0.00278294730839697,0.151323758551984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENG,Endoglin,42793,-0.00243179230520774,0.00169624009192706,-0.00575642288538479,0.000892838274969303,0.151698912230154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40198,-0.00468362915789083,0.00327104965339957,-0.011094886478554,0.00172762816277233,0.152217194354474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42172,0.0119909288301486,0.00839639738732583,-0.00446601004901001,0.0284478677093073,0.153285985069342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42476,-0.0208431987915625,0.0146001761860224,-0.0494595441161665,0.00777314653304147,0.15343078484009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42610,-0.00323199998337942,0.00226832384564067,-0.00767791472083513,0.00121391475407629,0.154226535295147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41778,-0.00694942243689314,0.00487764465910517,-0.0165096059687393,0.002610761094953,0.154254385289631
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42310,-0.00566482554239758,0.00399786296436893,-0.0135006369525607,0.00217098586776553,0.156517376805544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MB,Myoglobin,42793,-0.00732256380292186,0.00517814221088472,-0.0174717225362559,0.00282659493041219,0.157346767390705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42463,-0.00493505743609058,0.00349195782151492,-0.0117792947662598,0.00190917989407867,0.157601643079655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,40135,-0.0130823188049574,0.00927103023384407,-0.0312535380632918,0.00508890045337698,0.158244579944123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIT,Vitrin,40510,-0.00529966840452064,0.00376055092923097,-0.0126703482258133,0.00207101141677205,0.158779933172723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCIN,Adseverin,40135,-0.0100332946865976,0.00712441382002411,-0.0239971457738449,0.00393055640064964,0.159071388526669
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42586,0.00291502746115481,0.00207146535537214,-0.00114504463537458,0.0069750995576842,0.159382510995211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42561,0.0092499359080571,0.0065780693418598,-0.00364308000198811,0.0221429518181023,0.159694542230429
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40386,-0.00431663272916857,0.00307013987099417,-0.0103341068763171,0.00170084141798,0.159750331705015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42593,0.00526022564037012,0.00374207011946664,-0.0020742317937845,0.0125946830745247,0.15983659858667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40135,-0.0107574586772937,0.00766468708392647,-0.0257802453617896,0.00426532800720214,0.160493436997236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40079,-0.0121063742530148,0.00862815677916949,-0.029017561540187,0.00480481303415736,0.160608375197167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42678,-0.0094971403357495,0.00677084752275234,-0.0227680014803441,0.00377372080884508,0.160743769798184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42543,0.00315771073325628,0.00225980455960768,-0.00127150620357477,0.00758692767008733,0.16233518420027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42704,-0.00376807944062273,0.00270397314917375,-0.00906786681300328,0.00153170793175781,0.163481191429242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,40482,0.00519918290720412,0.00373642749914307,-0.00212421499111629,0.0125225808055245,0.164105818436299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40135,0.00746083719035208,0.00536291404717447,-0.00305047434210987,0.017972148722814,0.164195835499619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40135,-0.00440235332164348,0.00316759778840781,-0.0106108449869228,0.00180613834363583,0.164615410090359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,40115,-0.00658151886875371,0.00473845813379222,-0.0158688968109865,0.00270585907347904,0.164873873801756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,40448,-0.00941255797139929,0.0067850133424892,-0.0227111841226781,0.00388606817987953,0.165390848750332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FURIN,Furin,42678,0.00438952799562564,0.00317306835682011,-0.00182968598374177,0.010608741974993,0.166574305920778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,40369,-0.00884452063259197,0.00639843899466098,-0.0213854610621275,0.00369641979694355,0.166909226794608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40301,-0.0102683377407979,0.0074296882571054,-0.0248305267247245,0.00429385124312866,0.16697847752748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40198,-0.0122328073313257,0.00885418395286608,-0.0295870078789432,0.00512139321629182,0.167127225661435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40450,-0.00859751482396827,0.00623104826555113,-0.0208103694244485,0.00361533977651194,0.167679869152007
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40181,0.0065144975152579,0.00472623881331681,-0.00274893055884304,0.0157779255893588,0.168117687447993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42345,-0.00442658745042499,0.00321189312887738,-0.0107218979830247,0.00186872308217468,0.168169189598989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40450,-0.00604798984085004,0.00439034065679888,-0.0146530575281758,0.00255707784647575,0.168364303389498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42494,-0.00439695256328072,0.00319853867580268,-0.010666088367854,0.00187218324129254,0.169255247981179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42494,-0.00712313757246836,0.00519420623093916,-0.0173037817851091,0.00305750664017239,0.17028524135739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42494,0.00552375168555608,0.0040281612572699,-0.00237144437869292,0.0134189477498051,0.170309684726721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40456,-0.00506923429779396,0.00369803235736257,-0.0123173777182246,0.00217890912263667,0.170467028199556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40526,-0.00401685806148546,0.00293072616884866,-0.00976108135242883,0.00172736522945792,0.170526322184999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42715,-0.00780614042450733,0.00569886900550127,-0.0189759236752898,0.00336364282627516,0.170781421724537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42345,-0.00611051063775034,0.00446462993333703,-0.0148611853070909,0.00264016403159023,0.171132443501115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42589,-0.0121985496908406,0.00892086404390368,-0.0296834432168918,0.00528634383521066,0.171517280222171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42599,-0.00236626392214829,0.00173048586810376,-0.00575801622363166,0.00102548837933508,0.171523332743592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42656,0.013667464475553,0.0100020008132936,-0.00593645711850253,0.0332713860696085,0.171813359057807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,42310,0.00604908296886955,0.00442681315802003,-0.0026274708208497,0.0147256367585888,0.171816644587853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40222,-0.00412997717711924,0.00302481620572268,-0.0100586169403357,0.00179866258609722,0.172166312270333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCT,Secretin,40181,0.00665754342564041,0.00488093739125008,-0.00290909386120974,0.0162241807124906,0.172599064636748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42742,0.00320586814821126,0.00235302740939905,-0.00140606557421088,0.00781780187063339,0.173080444194853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40282,-0.00915163882797876,0.00672102045231865,-0.0223248389145233,0.0040215612585658,0.17333784993158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42593,-0.00699489085040001,0.00514055846639317,-0.0170703854445306,0.00308060374373061,0.173623225613958
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40115,-0.00542900530543953,0.00399017082734421,-0.0132497401270342,0.00239172951615512,0.17366988428303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,40079,-0.00457116530086364,0.00336087363383296,-0.0111584776231762,0.00201614702144897,0.173822581762137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40301,-0.00584893095033015,0.00430239230330586,-0.0142816198648096,0.00258375796414934,0.174028415547387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40448,0.0107814297596266,0.00793144354495168,-0.00476419958847868,0.0263270591077319,0.174070052910737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42793,0.00775377882184813,0.00571296525761236,-0.00344363308307208,0.0189511907267684,0.17473227884766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,40282,-0.00462459540983168,0.00341143251548687,-0.0113110031401859,0.00206181232052258,0.175248717101165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,42310,-0.00887177916517566,0.00654470920263135,-0.0216994092023331,0.00395585087198179,0.175260933818176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,40135,-0.00637271903044412,0.00470413679144405,-0.0155928271416745,0.00284738908078622,0.175539441975318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,40115,-0.00631860776648838,0.00466607593786269,-0.0154641166046993,0.00282690107172249,0.175713740461717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40109,-0.00454442978707479,0.00335818189212116,-0.0111264662956323,0.00203760672148269,0.17600664139029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40526,-0.00432642363449501,0.00320297307413581,-0.0106042508598012,0.00195140359081117,0.176801724653419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,40115,-0.00835674291379661,0.00619463991476061,-0.0204982371467274,0.00378475131913419,0.177355930350548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,40198,-0.00715945677351176,0.00532398358752366,-0.0175944646050581,0.00327555105803461,0.178731887335606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40135,-0.00746573627453056,0.00556451603985684,-0.01837218771265,0.00344071516358885,0.1797313273538
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,40079,-0.00696606861468991,0.00519771668953632,-0.0171535933261811,0.00322145609680128,0.180202758095369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42720,0.00349091495848329,0.00261631083906456,-0.00163705428608325,0.00861888420304984,0.18213160035127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,40115,-0.00783963993459247,0.00589530836155646,-0.0193944443232431,0.00371516445405819,0.183608657657107
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42345,-0.00639827926857793,0.00481365761955073,-0.0158330482028974,0.0030364896657415,0.183807413084036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40448,0.00400601743547122,0.00301739715593587,-0.00190808099016309,0.00992011586110553,0.184323962216008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40198,-0.00455143543677363,0.00343179579222219,-0.0112777551895291,0.00217488431598186,0.184782858678383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42369,-0.00773854067854252,0.00584313013906541,-0.0191910757511107,0.00371399439402569,0.185398938602141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42637,0.00678427785857145,0.00513134759313575,-0.00327316342397461,0.0168417191411175,0.186149354913488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42345,-0.00482565193948665,0.00365599729258463,-0.0119914066329525,0.00234010275397923,0.186882147253023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40198,-0.00537403045530446,0.00407623683004975,-0.013363454642202,0.00261539373159305,0.187403802217748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40115,-0.00333076484613919,0.0025301572230466,-0.00828987300331053,0.00162834331103215,0.188058714823545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,40079,-0.00489494184331732,0.00372455409298558,-0.0121950678655691,0.00240518417893442,0.188794601472489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,42325,0.0076163937553267,0.00582047312116145,-0.00379173356214974,0.0190245210728031,0.190708934565513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42345,0.00767100281531517,0.00586614325636812,-0.00382663796716635,0.0191686435977967,0.191006776388941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40455,-0.0137898630363784,0.0105501541354551,-0.0344681651418704,0.00688843906911363,0.191213275713143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42356,-0.0117373840413264,0.00899952692626495,-0.0293764568168057,0.00590168873415289,0.19218059246986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42499,0.00614720504245887,0.00471454175800329,-0.00309329680322758,0.0153877068881453,0.192296455596024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40222,-0.00943757732556793,0.00724334876067682,-0.0236345408964945,0.00475938624535863,0.192625821687238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40079,-0.00531860630445667,0.00408314238703388,-0.0133215653830431,0.00268435277412974,0.192746860333416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42493,-0.0088523861646657,0.00679873091927487,-0.0221778987664445,0.00447312643711306,0.192916888563638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,40482,-0.00489490923478081,0.00378463236591294,-0.0123127886719702,0.00252297020240856,0.195911480721134
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,40198,0.00627478634840589,0.00485718280082873,-0.00324529194121841,0.0157948646380302,0.196433749323649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,40531,0.00301430778174927,0.00233661444014829,-0.00156545652094138,0.00759407208443992,0.197065803574294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40198,-0.0104914395715074,0.00813886148284918,-0.0264436080778918,0.00546072893487696,0.197406085264756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,40135,-0.0106938670301914,0.00829789839263505,-0.0269577478797561,0.00557001381937328,0.197514338203056
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40481,-0.00408301612912832,0.00317445082926607,-0.0103049397544898,0.00213890749623318,0.198395535499288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,40345,0.00349341302370559,0.00271978289735076,-0.00183736145510189,0.00882418750251308,0.199012788913958
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXN,Paxillin,42310,-0.00639682534372729,0.00498130091936149,-0.0161601751456758,0.00336652445822123,0.199105994952154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,42310,-0.00904930974248508,0.00705139456195068,-0.0228700430839084,0.00477142359893825,0.199396997133888
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40481,0.00775822840690118,0.00605301022504503,-0.00410567163418708,0.0196221284479894,0.199969293348463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40198,-0.00363558028304481,0.00284359482709017,-0.00920902614414154,0.00193786557805193,0.201094660107155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42635,0.00910639637867023,0.00712814539921426,-0.00486476860378972,0.0230775613611302,0.201438410122673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40181,0.00524550497062441,0.0041076749262265,-0.00280553788477954,0.0132965478260284,0.201628882422851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40198,-0.00588118995556927,0.00461372250759239,-0.0149240860704504,0.00316170615931182,0.202436385844381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,40115,-0.00416393894635077,0.00326840827713372,-0.0105700191695329,0.00224214127683133,0.202691957997179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42610,0.00815073748931514,0.00640873734531716,-0.00441038770750649,0.0207118626861368,0.203460393468185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42310,-0.0063707653289298,0.00501066873509609,-0.0161916760497181,0.00345014539185854,0.20359465806622
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,42356,0.00659844816479987,0.00519923457535245,-0.00359205160289093,0.0167889479324907,0.204421012701278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40301,-0.0049507612068254,0.00390413794141134,-0.0126028715719916,0.00270134915834082,0.204795783048565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,40079,0.0055713536079136,0.00439458110659884,-0.00304202536102012,0.0141847325768473,0.2049043293025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,40301,-0.00457069301259547,0.00360798692477528,-0.011642347385155,0.00250096135996408,0.205243940954242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42720,0.0079224173177366,0.00626874005454936,-0.00436431318918014,0.0202091478246533,0.206324538357243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40181,-0.0103539833934623,0.00821838670821217,-0.0264620213415581,0.0057540545546336,0.207748091733784
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40134,-0.0052340298264393,0.0041608042647081,-0.0133892061852672,0.00292114653238858,0.208441373046094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,40181,-0.00514327581495491,0.00409074863208384,-0.0131611431338392,0.00287459150392941,0.208673734515614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40115,-0.00753777333215772,0.00599544434695619,-0.0192888442521919,0.00421329758787641,0.208689952901279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40222,-0.00662715804479674,0.00527860680343486,-0.0169732273795291,0.00371891128993559,0.209333035784526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40301,-0.00692019923172984,0.00551232383264255,-0.0177243539437092,0.00388395548024956,0.209358163914199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,40135,-0.00669507760454414,0.00533869792787776,-0.0171589255431845,0.00376877033409627,0.20984494263884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,42356,-0.00595495599146038,0.0047528870716522,-0.0152706146518987,0.00336070266897793,0.210259476052673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42596,-0.0124529117887698,0.00997285932037512,-0.031999716056705,0.00709389247916548,0.21180388358329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42369,-0.00675779761017309,0.00542407617621137,-0.0173889869155474,0.0038733916952012,0.21282725133717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,40198,-0.00681067331383058,0.00547060114996837,-0.0175330515677686,0.00391170494010743,0.213173388692426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,40181,-0.00922764576383453,0.00741756654985024,-0.023766076201541,0.00531078467387193,0.213516527668096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42356,-0.00431102326455277,0.0034686820099317,-0.0111096400040189,0.00248759347491336,0.213948246896934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42593,-0.0104935501965698,0.00845788010797817,-0.0270709952082071,0.00608389481506738,0.214744506676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42356,-0.00375754068987139,0.00303167872766552,-0.00969963099609581,0.00218454961635303,0.21520996814818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,40198,-0.00322042384657482,0.00259929672243844,-0.00831504542255417,0.00187419772940452,0.215386854732512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40198,-0.00642679839338896,0.00518818254906928,-0.0165956361895648,0.00374203940278683,0.215468998331636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,40181,-0.00626116115328719,0.00508197457114312,-0.0162218313127277,0.00369950900615332,0.217963066081157
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42593,-0.0101406345883752,0.00823389063398807,-0.0262790602309918,0.00599779105424142,0.218130373341999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42610,-0.00604596205594818,0.00492226850376655,-0.0156936083233306,0.00360168421143426,0.219360518698612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42710,-0.011369224507726,0.00925803657153262,-0.02951497618793,0.00677652717247791,0.219453934235034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,40135,-0.0057737556181689,0.00470247940917945,-0.0149906152601606,0.00344310402382282,0.219544365563521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42678,0.0044452130707642,0.00362972690397198,-0.00266905166102087,0.0115594778025493,0.22072145138294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42793,-0.00552108614608527,0.00451254906108341,-0.0143656823058088,0.00332351001363822,0.221163578088652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42617,0.0353641959507991,0.028920373670544,-0.0213197364434671,0.0920481283450653,0.221421971914241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42759,0.00545398729794947,0.00446509100442626,-0.003297591070726,0.0142055656666249,0.221928278292394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42586,-0.00517012056559861,0.00424226997212368,-0.013484969710961,0.00314472857976381,0.222973624894726
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40510,0.00334626390096299,0.00275113972710837,-0.00204596996416941,0.00873849776609539,0.22388874404003
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40198,-0.00348139511860774,0.00286540878281523,-0.00909759633292559,0.00213480609571011,0.224402349842386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40510,-0.00969772334287616,0.00800717348876079,-0.0253917833808473,0.00599633669509499,0.22587110181519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40135,-0.00383869770519178,0.0031717534595334,-0.0100553344858772,0.00237793907549367,0.226199075201465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42310,-0.00625662459463666,0.00517010162166353,-0.0163900237730972,0.00387677458382387,0.226241210663274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,40115,-0.00775375325804063,0.0064108928512383,-0.0203191032464677,0.00481159673038643,0.226510266859581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40526,-0.00986223484502673,0.00815517187292319,-0.0258463717159562,0.00612190202590272,0.226564104730012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,40448,-0.00823273925278503,0.00680812919816159,-0.0215766724811817,0.00511119397561169,0.226591707954714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42593,-0.010634181793365,0.00879580790679186,-0.027873965290677,0.00660560170394705,0.2266819933137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40510,-0.00374893864243946,0.00310124563622492,-0.0098273800894403,0.00232950280456138,0.226746001873476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,42369,-0.00560354664641568,0.00463749896773745,-0.0146930446231811,0.00348595133034972,0.226948878982273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42594,-0.015507265873611,0.0128599730270755,-0.0407128130066789,0.00969828125945698,0.227894602557191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42793,-0.00643424889647919,0.00535754848786315,-0.016935043932691,0.00406654613973258,0.229784198358768
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40198,-0.0103904552034075,0.0086639163306179,-0.0273717312114186,0.00659082080460355,0.230445197999126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42593,-0.00905227811003109,0.00761639397193972,-0.0239804102950329,0.00587585407497077,0.234647521781212
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40222,-0.00504317495639758,0.0042534626514892,-0.0133799617533164,0.00329361184052126,0.235780803181159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,40198,-0.00336794403067547,0.00284460310181303,-0.008943366110229,0.00220747804887807,0.236447827409839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40198,0.00281270393023763,0.00237837788466745,-0.00184891672371058,0.00747432458418583,0.236987555306678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42369,-0.00656200270132058,0.00554901924474156,-0.017438080421014,0.00431407501837288,0.237008164713472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,40198,-0.00741723741033988,0.00627316516991421,-0.0197126411433717,0.00487816632269198,0.237082249412532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,40198,-0.00640588240259625,0.00541887311780245,-0.0170268737134891,0.00421510890829656,0.237174546965032
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,40222,-0.0068717651553737,0.00583033095329583,-0.0182992138238335,0.00455568351308612,0.238573553916367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42593,-0.00389754608630619,0.00330724029977385,-0.0103797370738629,0.00258464490125055,0.238622670544927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40450,-0.00759199197089171,0.00644442200610383,-0.0202230591028552,0.0050390751610718,0.238792880302687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40481,-0.00985301771716553,0.00836982673313161,-0.0262578781141035,0.00655184267977243,0.239137761424347
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40482,-0.00789682403518604,0.00671458681774797,-0.0210574141979721,0.00526376612759998,0.239591712060551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,40115,-0.00387780375329505,0.00329759888992714,-0.0103410975775523,0.00258549007096215,0.239641418935419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42610,-0.00385745993031226,0.00328158548962176,-0.0102893674899709,0.00257444762934638,0.239820935707905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40510,-0.00854604731332228,0.00727204865196784,-0.0227992626711792,0.00570716804453469,0.239942971314148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,40115,-0.00820596149409859,0.00699866820467618,-0.0219233511752639,0.00551142818706672,0.241020627069059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40181,0.00736698548916896,0.00628507797695213,-0.00495176734565721,0.0196857383239951,0.241166639055435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42586,0.00904186045178165,0.00772232694981393,-0.00609390036985365,0.0241776212734169,0.241670853906045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40222,-0.00969759987070312,0.00828748289964175,-0.0259410663540009,0.00654586661259471,0.241965811780762
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,40450,0.0088621544697203,0.00758269527217085,-0.00599992826373455,0.0237242372031752,0.242535533170752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42610,-0.00511037512727158,0.00437442856141586,-0.0136842551076467,0.00346350485310351,0.24273140168188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,40079,0.00472020212640821,0.00404196850861207,-0.00320205615047145,0.0126424604032879,0.242913894869106
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,42310,-0.00561779066294186,0.00482248892481434,-0.015069868955578,0.00383428762969424,0.244074505329295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,40198,-0.00710891259467655,0.00610264319940979,-0.0190700932655197,0.00485226807616663,0.244088471463943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40079,-0.00907427606104857,0.00781408517302256,-0.0243898830001728,0.00624133087807565,0.245556884710716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40482,-0.00383607503016006,0.00330348686478264,-0.010310909285134,0.00263875922481391,0.245576996574916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42369,-0.0048793316974662,0.00420358197346009,-0.013118352365448,0.00335968897051558,0.245762298178666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40181,-0.00565093569437814,0.00487867844308122,-0.0152131454428173,0.00391127405406105,0.246769947440877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42369,-0.00414232795984621,0.00357682779832037,-0.0111529104445541,0.00286825452486171,0.246843802123909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40538,0.00365719856842535,0.00316546452903193,-0.00254711190847723,0.00986150904532793,0.247974161950178
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40181,-0.00411123662103383,0.00356393285082027,-0.0110965450086415,0.00287407176657389,0.248702678746519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40135,-0.00578624152161085,0.005018648094168,-0.0156227917861801,0.00405030874295842,0.248956815365652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42720,-0.00677462448334032,0.00588168395963525,-0.0183027250442254,0.00475347607754476,0.249416575133106
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40198,-0.0045104364127847,0.00392298701024633,-0.0121994909528675,0.00317861812729811,0.25027372145617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40198,-0.00491023070188568,0.00427384715249607,-0.013286971120778,0.00346650971700661,0.250621446021402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,40526,-0.0110002710346357,0.00957644334461537,-0.0297700999900818,0.00776955792081043,0.250712111091151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,40115,-0.00531570095482181,0.00462952819363398,-0.0143895762143444,0.0037581743047008,0.250904322693444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40448,-0.0120972697624588,0.0105697458254957,-0.0328139715804305,0.00861943205551279,0.252433006123782
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42475,-0.0123280558698955,0.010793860947363,-0.0334840233267269,0.00882791158693587,0.253418133960008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,40198,0.00893826559364664,0.00783661338031668,-0.00642149663177405,0.0242980278190673,0.254070570848426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42620,0.00497671249079373,0.00437450674180392,-0.00359732072314196,0.0135507457047294,0.255281719173122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,40450,-0.00448227924605283,0.00394692862336447,-0.0122182593478472,0.00325370085574152,0.256132583726194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40181,-0.00409181690396473,0.00360412319354379,-0.0111558983633106,0.00297226455538111,0.256267918384748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,40510,-0.00709268495679833,0.00624849289624472,-0.019339731033438,0.00515436111984132,0.256356077661885
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42577,-0.00915473750711914,0.0080679934674076,-0.024968004703238,0.00665852968899975,0.256522122668673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,40181,-0.00501127880136782,0.00442550541061127,-0.0136852694061659,0.00366271180343026,0.257506544634627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42369,-0.00496875626913282,0.00439110951845302,-0.0135753309253007,0.0036378183870351,0.257844621596947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,40115,-0.00723352186488112,0.00639608554227951,-0.019769849527749,0.00530280579798671,0.258109597550103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40079,-0.00654429452894515,0.005787571971088,-0.0178879355922776,0.00479934653438733,0.258185423573361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42720,-0.00357619967283809,0.00317314385695847,-0.00979556163247669,0.0026431622868005,0.259753607298835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42612,-0.00405436388766404,0.0035975424217112,-0.011105547034218,0.00299681925888991,0.259770440586804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,40079,-0.00578835300045865,0.00516036346975797,-0.0159026654011843,0.00432595940026697,0.262016961161382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42586,-0.00369511525457008,0.00330917967628111,-0.0101811074200811,0.0027908769109409,0.264174408317829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,40079,0.00461352436675344,0.00414201721722454,-0.00350482937900666,0.0127318781125135,0.265374508813395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42438,-0.00649488681689492,0.00584478393373958,-0.0179506633270245,0.00496088969323467,0.266490449162396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40115,-0.00432689610845492,0.0038966905927713,-0.0119644096702867,0.00331061745337683,0.266849943699503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42310,0.00622564609081359,0.00561124894134176,-0.00477240183421626,0.0172236940158434,0.267237545442273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42310,-0.00325792083346163,0.00293884572930228,-0.00901805846289409,0.00250221679597083,0.267635373854801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42593,-0.00408349156587969,0.00369720833264577,-0.0113300198978654,0.00316303676610602,0.269404936038031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,40115,-0.00534515314586879,0.00486461943261942,-0.0148798072338028,0.00418950094206528,0.271887667890463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40115,-0.00588971468016882,0.0053618345466395,-0.0163989103915822,0.00461948103124461,0.272031643081879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,40301,-0.00368270329372474,0.00335763773296402,-0.0102636732503342,0.00289826666288475,0.272746589248408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42610,-0.00961666991304368,0.00877659825923332,-0.026818802501141,0.00758546267505362,0.273222210040391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEO1,Neogenin,40481,-0.00237609225496978,0.00216923020562394,-0.00662778345799271,0.00187559894805315,0.273381463650085
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,40482,-0.00595998303732663,0.005444776314765,-0.016631744614266,0.00471177853961276,0.273704735945814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,40222,-0.0050484241391575,0.00462269200820582,-0.0141089004752409,0.00401205219692591,0.274814699369094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42533,-0.00744341970213262,0.00681751500730317,-0.0208057491164468,0.0059189097121816,0.274937074590992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40079,-0.00654999882086011,0.00600219080802202,-0.0183142928045833,0.00521429516286305,0.275179123868198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40482,0.00682129849827582,0.00625223480206811,-0.00543308171377766,0.0190756787103293,0.275288405104174
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42678,0.0025038467941702,0.0022958917975821,-0.00199610112909071,0.00700379471743111,0.275478541281035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40029,-0.00354811272871769,0.00325760014117003,-0.00993300900541095,0.00283678354797558,0.276098767001363
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,40450,-0.0104480085551075,0.00959527490725856,-0.0292547473733343,0.00835873026311927,0.276234457488034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40135,-0.00336543095737867,0.00309252425013843,-0.00942677848764999,0.00269591657289264,0.276509949313095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39925,-0.00744848370247087,0.00684726897698409,-0.0208691308973597,0.00597216349241793,0.27670626008826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,40115,0.00408748235061863,0.00375838150135278,-0.00327894539203282,0.0114539100932701,0.276811404921163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,40198,-0.0027823275243449,0.00256582952729124,-0.00781135339783573,0.00224669834914592,0.278221261925689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42494,0.00248968114377296,0.00230257233859334,-0.00202336063986999,0.0070027229274159,0.27960073672437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40482,-0.00407632444747971,0.00377437255057699,-0.0114740946466106,0.00332144575165118,0.280165007906159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42310,-0.0157479348702136,0.0145837824684753,-0.0443321485084252,0.0128362787679979,0.280239912038951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40531,0.00288071100414325,0.00267335122604479,-0.00235905739890454,0.00812047940719105,0.281250640858998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,40135,-0.00369869317302861,0.00343646632764077,-0.0104341671752045,0.0030367808291473,0.281813657952527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42345,-0.00322065500911204,0.00299458744345723,-0.00909004639828821,0.00264873638006414,0.282174216930981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40481,-0.00358879703368724,0.00334443814042161,-0.0101438957889136,0.00296630172153912,0.283265226955806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,40481,-0.00501799117425532,0.00467869299406276,-0.0141882294426183,0.00415224709410769,0.283509527116865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40450,-0.0094839976676154,0.00885863781072766,-0.0268469277766416,0.00787893244141082,0.284375324332476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42593,-0.0081845666324953,0.00764901232282772,-0.0231766307852376,0.00680749752024702,0.284631318859768
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,40481,-0.0166883036657828,0.0156150833502547,-0.047293867032282,0.0139172597007164,0.285214330998939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42356,0.00348052287703878,0.00327121031435081,-0.00293104933908881,0.00989209509316638,0.287354436338266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,42310,-0.00303540120885646,0.00285294163012862,-0.00862716680390856,0.00255636438619563,0.287368720752862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40135,-0.0058402311086216,0.00549024146937439,-0.0166011043885954,0.00492064217135221,0.287466537766779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,40181,-0.00619135842461532,0.00584685735508585,-0.0176511988405836,0.00526848199135293,0.289659164396172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42561,0.00728091262430799,0.00687604380232805,-0.00619613322825498,0.020757958476871,0.289673079821885
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40301,-0.00564140306117178,0.00533095434050183,-0.0160900735685554,0.0048072674462118,0.289971281258059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40531,-0.00603720031484244,0.0057156263006332,-0.0172398278640835,0.00516542723439862,0.290870923658208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,40135,-0.00936270902342357,0.0088946576449379,-0.0267962380075019,0.00807081996065471,0.292537686441493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARC,SPARC,42678,-0.00715942551370556,0.00680896455338036,-0.0205049960383311,0.00618614501091995,0.293061384079906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,40450,-0.00404512251959151,0.0038523982761746,-0.0115958231408937,0.00350557810171071,0.293728204997356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40531,-0.00271478762454886,0.00258584751844817,-0.00778304876070728,0.00235347351160956,0.293803129810308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42710,0.00328065547764746,0.00312657284846467,-0.00284742730534328,0.0094087382606382,0.294067276106022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40282,-0.00221156381988226,0.00211249179287859,-0.0063520477339243,0.00192892009415978,0.295169360108883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40198,-0.00753363364142933,0.00719669026986358,-0.021639146570362,0.00657187928750329,0.295205960282083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42568,0.00774724352382813,0.00744166154138467,-0.00683841309728583,0.0223329001449421,0.297864815368299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42356,-0.00789750264172279,0.00759324286200249,-0.0227802586512477,0.0069852533678021,0.298326574466232
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,40115,-0.00408115034346573,0.00392652605331068,-0.0117771414079547,0.0036148407210232,0.29865132517624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40481,-0.00328228239011167,0.00317169731634497,-0.00949880913014781,0.00293424434992446,0.300753566829615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42641,-0.00945143380811835,0.00913637240347388,-0.0273587237189272,0.00845585610269046,0.300928416208545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,40115,-0.00321336406085333,0.00310969649798765,-0.00930836919690912,0.00288164107520246,0.301469158077555
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40135,-0.0070791809934723,0.00685584916467004,-0.0205166453562256,0.00635828336928098,0.301825482609918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40301,-0.00818440802152508,0.00793164093198171,-0.0237304242482092,0.00736160820515908,0.302156334218794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESPL1,Separin,40079,-0.0058142536491909,0.00563579175045259,-0.016860405480078,0.00523189818169618,0.302251621849132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,40450,-0.0052899911418881,0.00513102732045646,-0.0153468046899828,0.00476682240620655,0.302571930608469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40181,-0.00713245642327328,0.00696981943032578,-0.0207933025067118,0.00652838966016525,0.30617226511194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40510,-0.00394278946761084,0.00385352681524873,-0.0114957020254983,0.00361012309027668,0.306252237320992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,40460,-0.00238652291453543,0.00233660797219007,-0.00696627454002797,0.00219322871095711,0.307104827795525
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,40198,0.00342658675015354,0.00335917144165769,-0.00315738927549553,0.0100105627758026,0.30771814960189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42753,-0.00343985747879675,0.00337827561023137,-0.0100612776748502,0.00318156271725672,0.308587409371799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40115,-0.00727886168453918,0.00717116140295529,-0.0213343380343316,0.00677661466525319,0.310119482206883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40115,-0.0069010158768439,0.00680413336839241,-0.020237117278893,0.00643508552520522,0.310491300837919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42369,-0.00652684054041214,0.00644459833691923,-0.0191582532807738,0.00610457219994956,0.311192732645414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LXN,Latexin,42460,-0.00668829694277096,0.00660901204501269,-0.0196419605509958,0.00626536666545391,0.311558192281878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40481,-0.00271283432680635,0.00268136608850739,-0.00796831186028083,0.00254264320666812,0.311686034281009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40135,-0.00530410613514243,0.0052613381307217,-0.015616328871357,0.00500811660107211,0.313414960647439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42607,-0.00576753460418172,0.0057236764943429,-0.0169859405330938,0.00545087132473035,0.313634653981692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40222,-0.00393410327775887,0.00390830726352679,-0.0115943855142714,0.00372617895875363,0.314148973868825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,40115,-0.00585134958521157,0.00581774890837309,-0.0172541374456228,0.00555143827519969,0.314545836629041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40135,-0.00525328847120426,0.00523593819806883,-0.0155157273394192,0.00500915039701063,0.315731721771509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42617,-0.00356726596035834,0.00357840456235732,-0.0105809389025787,0.003446406981862,0.318837200734158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,40115,-0.00423404962947546,0.00424927434342819,-0.0125626273425947,0.00409452808364379,0.319069603058361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42310,-0.00596391603288813,0.00599362282565251,-0.017711416771167,0.00578358470539078,0.319733416016476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40208,-0.0077039475990259,0.00776651020421813,-0.0229263075992934,0.00751841240124163,0.321246358462824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42586,0.0052851143697332,0.00534822622655872,-0.00519740903432189,0.0157676377737883,0.323072816894501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40181,-0.00290571522599993,0.00294100215776435,-0.00867007945521805,0.0028586490032182,0.323173556974794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40282,-0.0063586293414156,0.00645192687716479,-0.0190044060206586,0.00628714733782738,0.324380601368001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42589,-0.00226122888636329,0.00229903367672613,-0.0067673348927465,0.00224487712001993,0.325351521581393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,42345,0.00606948360389238,0.00619480826073963,-0.0060723405871573,0.0182113077949421,0.327217980755379
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40482,0.00270240519789629,0.00275961428972997,-0.00270643880997445,0.00811124920576703,0.327467985664932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,40181,-0.00582832846518362,0.00595393785551307,-0.0174980466619892,0.005841389731622,0.327649393807321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40115,-0.00487394037860696,0.00497940685057296,-0.01463357780573,0.00488569704851604,0.327690869192816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,40108,-0.00600307478150195,0.00613315321194516,-0.0180240550769145,0.00601790551391058,0.327704983598297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42345,0.00607903110525972,0.00621115305963505,-0.00609482889162499,0.0182528911021444,0.327732262231039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40450,-0.00446645703089726,0.00456692022911379,-0.0134176206799603,0.00448470661816577,0.328094362979081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40282,0.00394707245495163,0.00404291918234533,-0.00397704914244523,0.0118711940523485,0.328940739052111
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40181,-0.00369067282545455,0.00378073506663805,-0.0111009135560651,0.00371956790515604,0.328997437231322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40115,-0.007921030228476,0.00817497421705136,-0.0239439796938967,0.00810191923694468,0.332598371563424
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40482,-0.00594419556512709,0.00613980566748677,-0.0179782146734012,0.00608982354314697,0.332994863661023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40450,-0.0106831305510605,0.0110539455363888,-0.0323488638023825,0.0109826027002615,0.333837787727907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,42345,0.00551826158842099,0.00571982579886268,-0.00569259697734987,0.0167291201541918,0.334682560246161
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40450,-0.00516780992627421,0.00537701908587434,-0.0157067673345879,0.00537114748203949,0.336526565985864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,40493,0.00439176194015457,0.00456967099265619,-0.00456479320545156,0.0133483170857607,0.336538832254463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40301,-0.00589074279121529,0.0061527556570343,-0.0179501438790025,0.00616865829657195,0.338378485785023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40222,0.00220553711423304,0.00230550231963705,-0.00231324743225558,0.00672432166072165,0.338769661038404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42710,0.0118637599116418,0.0124361281941019,-0.012511051348798,0.0362385711720816,0.340113173800904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42356,-0.00537882394392709,0.00567690149153234,-0.0165055508673305,0.00574790297947629,0.343405059553665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40135,-0.011140245114677,0.0117927513557376,-0.0342540377719226,0.0119735475425687,0.344848814327708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42759,-0.00463656526654714,0.00491131803531148,-0.0142627486157576,0.00498961808266335,0.345157221108142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,40301,-0.00258582846322918,0.0027477541468611,-0.00797142659107693,0.00279976966461857,0.346689553629485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,40222,-0.00167261735365803,0.00177889121226418,-0.00515924412969582,0.00181400942237976,0.347105641418325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40482,0.00250268723559764,0.00266269263631086,-0.00271619033157165,0.00772156480276693,0.347284648624066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,40135,-0.0046155752705067,0.0049169712546827,-0.0142528389296848,0.00502168838867141,0.347904015961545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,42345,-0.00719246695089234,0.00767016082751131,-0.0222259821728145,0.00784104827102983,0.348405292771891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,40198,-0.00298586140356569,0.00319702747272677,-0.00925203525011016,0.00328031244297877,0.350350566085628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40301,0.00395248342939685,0.00424565910710335,-0.00436900842052571,0.0122739752793194,0.351901236033311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40286,-0.00456256637878394,0.00490858037217531,-0.0141833839082476,0.00505825115067967,0.352645934274517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,40181,-0.00323047412726455,0.00347620782567848,-0.0100438414655944,0.00358289321106526,0.352748955089227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,40301,0.00277387410106884,0.00299027341026115,-0.00308706178304302,0.0086348099851807,0.353618511274403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,40181,0.00263948749232652,0.00284848015102145,-0.00294353360367553,0.00822250858832856,0.354138966667341
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,42321,0.00775016391730406,0.00836954227731175,-0.00865413894622697,0.0241544667808351,0.354465004761933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,40450,-0.00379068265521734,0.0040993120581402,-0.0118253342891721,0.00424396897873746,0.355135609462199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42710,-0.00584569216787787,0.00633086714634509,-0.0182541917747143,0.00656280743895851,0.355834246455024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,40222,-0.00606721307241046,0.00659063508113229,-0.0189848578314298,0.00685043168660883,0.357289390987759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,40526,-0.0102330307849913,0.0111231796746384,-0.0320344629472825,0.0115684013772999,0.357606178535293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42356,0.00483785235171148,0.00526933844611418,-0.00549005100267232,0.0151657557060953,0.358576113547098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40285,-0.00918211895129896,0.0100085904135761,-0.0287989561619082,0.0104347182593103,0.358940559819201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42635,0.00607572119119868,0.00663079552499734,-0.0069206380377961,0.0190720804201935,0.359532076320661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,40514,0.00496786206599751,0.00543928947032889,-0.00569314529584711,0.0156288694278421,0.361088864986098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42345,-0.00715765388441851,0.00784912398692543,-0.0225419368987924,0.00822662912995533,0.361835546804563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,40079,-0.00495502610278112,0.0054343518547631,-0.0156063557381168,0.00569630353255457,0.361895745002531
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,40115,-0.00478603377363252,0.00527438817498798,-0.0151238345966089,0.00555176704934391,0.364209924400488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42561,-0.00317612331737271,0.00350110394817958,-0.0100382870558047,0.00368604042105926,0.364329204163227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40079,0.00498720071727945,0.00550686330036333,-0.00580625135143268,0.0157806527859916,0.36514983636262
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,40285,-0.00880366932611769,0.00974588501252155,-0.0279056039506599,0.0102982652984246,0.3663748063626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40514,0.0096503878495777,0.0107215215353679,-0.0113637943597433,0.0306645700588987,0.36808884771508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40115,-0.00654415557893573,0.00728678363256334,-0.0208262514987599,0.00773794034088842,0.369159704746367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,40198,0.00192328240259522,0.00215193624611802,-0.00229451263979611,0.00614107744498654,0.371477853181819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40079,0.00339625497497455,0.00381956654389939,-0.00409009545106826,0.0108826054010174,0.373929826381342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40282,-0.00674743805069782,0.007617590469135,-0.0216779153702024,0.00818303926880678,0.375760338361801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40450,-0.00456952646124418,0.00518039832143162,-0.0147231071712501,0.00558405424876179,0.377752308737475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40181,-0.00654690682329871,0.00743462951655879,-0.0211187806757539,0.00802496702915652,0.378555654102249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,42474,-0.00400390359593431,0.00454732489824365,-0.0129166603964919,0.00490885320462325,0.378606341479728
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40301,-0.00546754545157668,0.00622249377669641,-0.0176636332539016,0.00672854235074828,0.379596897209516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,40482,-0.00599225503945697,0.00683210189581639,-0.0193831747552571,0.00739866467634316,0.380465421131917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40526,0.00251414494670266,0.00286686541771813,-0.00310491127202487,0.00813320116543018,0.380523421724303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,42369,0.00245321797055501,0.00279812477341943,-0.00303110658534707,0.00793754252645709,0.38064579110874
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40301,-0.00543240028396357,0.00619644229894226,-0.0175774271898904,0.00671262662196325,0.380670380626752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSND,Barttin,40079,0.00292937876147133,0.00334498784938741,-0.003626797423328,0.00948555494627066,0.381184362706069
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40115,-0.00287864074275415,0.00329228733419485,-0.00933152391777605,0.00357424243226775,0.381942057663205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40481,0.00488067256474528,0.00559622265271316,-0.00608792383457252,0.0158492689640631,0.383152221158687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42720,-0.00321206964747261,0.00368691527274154,-0.010438423582046,0.00401428428710081,0.383656119166237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40181,-0.00418949362583975,0.00481762486563188,-0.0136320383624782,0.00525305111079873,0.384528157882069
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40198,0.00377832821800864,0.00436092899515829,-0.00476909261250161,0.0123257490485189,0.386287303529092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40427,-0.00235061804768266,0.00271326553991963,-0.00766861850592514,0.00296738241055982,0.386320709010085
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,42356,-0.00299997439698697,0.00346511069033243,-0.00979159135003854,0.00379164255606459,0.386634377158579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40448,-0.00367534159866013,0.00425121004430809,-0.012007713285504,0.00465703008818374,0.38730968300938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42635,-0.00353848967766655,0.00410494420777139,-0.0115841803248985,0.00450720096956537,0.388699173445655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42369,-0.00311582041612056,0.0036207864048318,-0.0102125617695909,0.00398092093734977,0.389508794739643
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40198,0.00516804924977841,0.00601218622310067,-0.0066158357474989,0.0169519342470557,0.390030687995558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40079,-0.00555659933221253,0.00646617421782006,-0.0182303007991398,0.00711710213471479,0.390175538362404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,42356,-0.00196527279920229,0.0022871987608026,-0.00644818237037539,0.0025176367719708,0.390218911607271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42356,-0.00502154885522226,0.00584882889759187,-0.0164852534945023,0.0064421557840578,0.390600995165458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,40538,-0.00192916951145572,0.00224989529264184,-0.00633896428503372,0.00248062526212228,0.391215138079202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40450,-0.00382650154266458,0.00446609306659345,-0.0125800439531877,0.00492704086785858,0.391579482467908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40181,-0.0042881183897776,0.00500861890665158,-0.0141050114468147,0.0055287746672595,0.391934666242394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,40198,-0.00510175563021974,0.005963947879991,-0.0167910934750021,0.00658758221456263,0.392330309919626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,40526,-0.00345722793953068,0.00404299197855261,-0.0113814922174938,0.00446703633843243,0.392504900147963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42586,-0.0045616195068622,0.00534279543028957,-0.0150334985502298,0.00591025953650536,0.393237229349268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42310,0.00424408172728087,0.00498429416582968,-0.00552513483774531,0.014013298292307,0.39451219482142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,40450,-0.00175125654282405,0.00206008807626481,-0.00578902917230308,0.00228651608665498,0.395294138615214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40198,-0.0047190749613565,0.00556499077772641,-0.0156264568857003,0.00618830696298727,0.396460139693824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40135,0.00314313437729453,0.00370664217096649,-0.00412188427779979,0.0104081530323889,0.396471272850492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,40115,0.00357558180757217,0.00422224811963023,-0.00470002450690309,0.0118511881220474,0.397101121632645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F3,Tissue factor,42635,0.00225279581270221,0.00266260289728355,-0.00296590586597356,0.00747149749137798,0.397518831532224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,42310,-0.00275359705973756,0.00325868802914486,-0.00914062559686148,0.00363343147738637,0.398125280065958
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40198,-0.002345917250866,0.0027798998104397,-0.0077945208793278,0.00310268637759581,0.398751714022828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42345,-0.00692322125958735,0.00820435757762576,-0.0230037621117338,0.00915731959255913,0.398770343185311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42310,0.00522137835482657,0.00620393809156113,-0.00693834030463325,0.0173810970142864,0.400014231981756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42635,0.00969442519590218,0.0115217021322321,-0.0128881109832728,0.0322769613750772,0.400135694026279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNST,Consortin,42635,0.00885339144323166,0.0105498297382772,-0.0118242748437917,0.029531057730255,0.401373377631987
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42345,-0.0046140976301877,0.00551760706167347,-0.0154286074710677,0.00620041221069229,0.403029599100812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40135,-0.00599229671353608,0.00716620245765981,-0.0200380535305493,0.00805346010347715,0.403067078904312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40079,-0.00692335347192696,0.00828669107446501,-0.0231652679778784,0.00931856103402446,0.403466600776977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40450,-0.00424734170582641,0.00509735437694548,-0.0142381562846395,0.00574347287298673,0.40472461798359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,40115,-0.00540455108194774,0.00649165996251674,-0.0181282046084806,0.00731910244458507,0.40512376238317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40058,-0.00215232762582358,0.00259446122803773,-0.00723747163277753,0.00293281638113037,0.406791359228549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,42345,-0.0075905055082226,0.00922449275500862,-0.0256705113080395,0.0104895002915943,0.410600102635733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,40079,-0.00384937923647127,0.00468417870927517,-0.0130303695066506,0.00533161103370806,0.411218312262988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40181,-0.00254625187156376,0.00310036426840707,-0.00862296583764163,0.0035304620945141,0.41150742614093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,42345,0.00590802155464158,0.00721087407977371,-0.0082252916417149,0.0200413347509981,0.412618063199718
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40301,-0.00593205884471483,0.00724030690515108,-0.020123060378811,0.00825894268938129,0.412626912186915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,40135,-0.00753266328178301,0.00920928094111716,-0.0255828539263726,0.0105175273628066,0.413407771054925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,40198,-0.00172562862294387,0.00211246439972053,-0.00586605884639611,0.00241480160050838,0.414015043313799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42345,-0.00718768871073266,0.00880619268640255,-0.0244478263760817,0.0100724489546163,0.414395719476855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40222,0.00643066976252162,0.00788715182621018,-0.00902814781685034,0.0218894873418936,0.414898272797011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42615,0.00349784880931693,0.0042910367253512,-0.00491258317237142,0.0119082807910053,0.414999555587098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42593,0.00550180575889681,0.00676207861871857,-0.00775186833379159,0.0187554798515852,0.415873460721392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,40079,-0.00378016448222646,0.00465088089281689,-0.0128958910321476,0.00533556206769465,0.416359328284913
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42678,-0.00450051793432834,0.00553725635695697,-0.015353540393964,0.00635250452530732,0.416364072425293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,42310,-0.00531030691428195,0.00654578243522851,-0.0181400404873298,0.00751942665876594,0.417233249581465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40510,-0.00385683379074497,0.00476947012041156,-0.0132049952267516,0.0054913276452617,0.418733281752713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40450,0.00384717426756332,0.00476117177633654,-0.00548472241405629,0.0131790709491829,0.419089827697455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40450,-0.00336271505335981,0.0041780670717499,-0.0115517265139896,0.00482629640726999,0.420923551988878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42720,-0.00503253187990365,0.00628384250076755,-0.017348863181408,0.00728379942160073,0.423221811392093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,40079,-0.00926828791061039,0.0115749285088896,-0.031955147788034,0.0134185719668133,0.423310679722633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40135,0.00347728768105102,0.00435783518754924,-0.00506406928654548,0.0120186446486475,0.424923070730979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40450,-0.00487490739956622,0.00611877808884218,-0.0168677124536969,0.00711789765456444,0.425634787302408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39844,-0.00401755961913507,0.0050462880609064,-0.0139082842185116,0.00587316498024148,0.425967509166763
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40135,-0.00315882281462794,0.00396954085332417,-0.0109391228871433,0.00462147725788744,0.42618573600809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40448,-0.00401131586210893,0.00504185196443613,-0.0138933457124038,0.00587071398818589,0.426279220255506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,42260,-0.00238594194322778,0.00299968335422367,-0.00826532131750617,0.00349343743105062,0.426396509979691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42610,-0.00282604549021645,0.00355307800956425,-0.00979007838896237,0.00413798740852947,0.426406839486043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42793,0.00506197579474357,0.00641812350147,-0.00751754626813763,0.0176414978576248,0.430300953803968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40079,-0.00428378425648615,0.00544292254110234,-0.0149519124370467,0.00638434392407443,0.431277038186305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,42369,0.00245175538201123,0.00313339147390315,-0.00368969190683895,0.00859320267086141,0.433957992658639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42369,-0.00249779340166403,0.00319701723614707,-0.0087639471845123,0.00376836038118424,0.434646760353485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42610,-0.00240994509747814,0.00308518190305912,-0.00845690162747401,0.00363701143251772,0.434736589833727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42569,0.013912248680688,0.0178864876173493,-0.0211452670493167,0.0489697644106927,0.436696116586514
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,40428,-0.00403065982899194,0.00522066955122021,-0.0142631721493835,0.00620185249139966,0.440096301493892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42345,-0.00386665924278981,0.00501996309230439,-0.0137057869037064,0.0059724684181268,0.441161585838779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,40301,-0.00335159219559764,0.00435191973926881,-0.0118813548845645,0.00517817049336924,0.441232585763665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,40115,0.00363736506659373,0.00472322786160186,-0.00562016154214592,0.0128948916753334,0.441256317927308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,40079,0.00278043569656245,0.00361059713531471,-0.00429633468865439,0.00985720608177929,0.441271277571499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,40198,-0.00652879147472681,0.00848700676659716,-0.0231633247372572,0.0101057417878036,0.441750128823694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42586,0.00526738950438698,0.00685802112821802,-0.00817433190692035,0.0187091109156943,0.44246354048195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42769,-0.00445462602782404,0.00581058504537078,-0.0158433727167508,0.00693412066110268,0.443309008908891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,40079,-0.00320222201543304,0.00417840498843435,-0.0113918957927644,0.00498745176189829,0.443470265531833
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42610,0.00392850157926687,0.0051318740202229,-0.00612997150037001,0.0139869746589037,0.443981299639014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40079,-0.00692559919236471,0.00905292766425713,-0.0246693374143087,0.0108181390295793,0.444280925524131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42635,-0.00860539626994049,0.0112581431243276,-0.0306713567936225,0.0134605642537416,0.444659701760071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40538,-0.00147705206522346,0.00193263855350097,-0.00526502363008535,0.00231091949963844,0.444723982683352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42345,0.00388811982823186,0.00509776661846569,-0.00610350274396088,0.0138797424004246,0.44564978205076
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40301,-0.00404615805451888,0.00530738510048789,-0.0144486328514751,0.00635631674243738,0.445859118948215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42610,-0.004502501141322,0.00592746381741293,-0.0161203302234513,0.00711532794080735,0.447507103568211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40198,-0.00363536172512296,0.00478713895152791,-0.0130181540701177,0.00574743061987174,0.447628530718818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40115,-0.00395631047484548,0.00522174571875082,-0.0141909320835971,0.00627831113390612,0.448670598651793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40079,-0.00467692165116332,0.00620455904322277,-0.0168378573758799,0.0074840140735533,0.450992883813955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,40198,-0.00328011117931096,0.00435901279468157,-0.0118237762568868,0.00526355389826492,0.451772862779548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42593,0.00177095009803324,0.00235365521779709,-0.00284221412884906,0.00638411432491554,0.451808461304515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40198,-0.00255462999037968,0.00340009092425241,-0.00921880820191439,0.00410954822115504,0.452463125571298
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42593,0.00335976323348524,0.00447213812551771,-0.00540562749252947,0.0121251539595,0.452506061962319
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42356,-0.00640326508893862,0.0085424699196372,-0.0231465061314275,0.0103399759535503,0.453521062669551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40198,-0.00284097617628473,0.00379117281269371,-0.0102716748891644,0.00458972253659494,0.453652629608987
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40181,-0.00523195928706892,0.00699022790197086,-0.0189328059749318,0.00846888740079397,0.454194166336482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40481,-0.00270413886002952,0.00362418088092557,-0.00980753338664363,0.00439925566658459,0.455599631401747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40531,-0.00275232588871191,0.0036906901291155,-0.00998607854177829,0.00448142676435447,0.45583493776521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42310,-0.00276789302438234,0.00373250994281429,-0.0100836125122983,0.00454782646353366,0.458365140800821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40115,0.00197215582245551,0.00266457738053241,-0.00325041584338801,0.00719472748829903,0.459231980333641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42586,-0.0050751950223788,0.0068700893274303,-0.0185405701041422,0.00839018005938458,0.460079143548762
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42345,0.00416975622701906,0.00564680957431968,-0.00689799053864751,0.0152375029926856,0.460268235427469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,40515,0.00202174349466744,0.00274016241158836,-0.00334897483204575,0.00739246182138064,0.460639826184385
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,40198,-0.00262214499238725,0.00356994616651713,-0.00961923947876083,0.00437494949398634,0.462656377793604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40115,-0.0027990553105205,0.00381879253065901,-0.0102838886706122,0.00468577804957115,0.463593265472508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40115,-0.00147772649774937,0.00203238098445542,-0.00546119322728199,0.00250574023178326,0.467185623498968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,40249,-0.00605944656300146,0.00834977796411625,-0.0224250113726693,0.0103061182466664,0.46803713165539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40450,0.00315662447348286,0.00435426893140089,-0.00537774263206288,0.0116909915790286,0.46849816753948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42586,-0.00796544212797401,0.0110128168115565,-0.0295505630786247,0.0136196788226767,0.469515379456331
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,40301,-0.0043486902895804,0.00602260486214269,-0.0161529958193801,0.00745561524021927,0.47027195096807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,42369,0.00524551544343581,0.00729428331938557,-0.0090512798625599,0.0195423107494315,0.47207548094165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40079,-0.00403136847157274,0.00562452319025404,-0.0150554339244707,0.00699269698132517,0.473544681801523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40079,-0.00447730903017732,0.00627176285722708,-0.0167699642303424,0.00781534616998775,0.475314427947073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42610,-0.00286326261501095,0.00402125148005475,-0.0107449155159183,0.00501839028589636,0.476456898319422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,40341,-0.0075335818383684,0.0105924895619749,-0.0282948613798392,0.0132276977031024,0.476963300938797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40510,0.00510746742385156,0.00718805632043217,-0.00898112296419549,0.0191960578118986,0.477378296848179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40079,-0.00213198384058003,0.00300067154326799,-0.00801330006538529,0.00374933238422522,0.477407966980306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,40450,-0.00328431707998363,0.00462864029600315,-0.0123564520601498,0.00578781790018255,0.477989173623559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42345,-0.00392652597758941,0.00553892821637764,-0.0147828252816896,0.00692977332651076,0.478401368359898
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,40301,-0.00207249664998011,0.00293842822037924,-0.00783181596192342,0.00368682266196321,0.480633433213595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,40526,-0.002975493268753,0.00422649205707714,-0.0112594177006242,0.00530843116311819,0.48144092416992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,40079,0.0021719781720216,0.00311117997178008,-0.00392593457266736,0.00826989091671056,0.485116821110641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40079,0.00394276578942755,0.00565013930550499,-0.00713150724936223,0.0150170388282173,0.485306271521187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40198,0.00248161194592512,0.00355878154423877,-0.00449359988078286,0.0094568237726331,0.485616864466122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,40181,-0.00213079740803159,0.0030583880041644,-0.00812523789619381,0.00386364308013063,0.486001514962921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42356,0.00224957459115688,0.00324834750321558,-0.00411718651514565,0.00861633569745942,0.4886174479073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42310,-0.00308519544085775,0.0044563437169392,-0.0118196291260586,0.00564923824434309,0.488751529027917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,42369,-0.00440846241436298,0.00638362461129435,-0.0169203666524999,0.00810344182377395,0.48983588234166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42310,-0.00325791962242288,0.00472709426365141,-0.0125230243791796,0.00600718513433388,0.490708775853046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40301,-0.00476134326134132,0.00691219700281193,-0.0183092493868527,0.00878656286417006,0.490943312865493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,40135,-0.00231263994488745,0.00335808803175624,-0.00889449248712968,0.00426921259735478,0.491040789330213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,42310,-0.00391698710689405,0.00569135482668351,-0.0150720425671937,0.00723806835340562,0.491317253020559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40482,-0.00267952923805655,0.00389484003926254,-0.0103134157150111,0.00495435723889803,0.491486434641588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42653,-0.00389691134439504,0.00567642516148587,-0.0150227046609073,0.00722888197211726,0.492404641439564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42345,-0.00384109156433061,0.00559846787240351,-0.0148140885942415,0.00713190546558027,0.492664088274874
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42586,0.006435802180209,0.00942293639858974,-0.0120331531610269,0.0249047575214449,0.49462290754604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,42345,0.00235582211027282,0.00345485550135267,-0.00441569467237841,0.00912733889292405,0.495322221273744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,40301,-0.00394603557633283,0.005787872967532,-0.0152902665926956,0.00739819544002989,0.495394523359499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NENF,Neudesin,40450,-0.00733273748379001,0.0107628460849513,-0.0284279158102946,0.0137624408427145,0.495695085359049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,40382,0.00177724851957835,0.00261766220083211,-0.0033533693940526,0.00690786643320929,0.497186790414398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40301,-0.00346295166850504,0.00511699688113341,-0.0134922655555265,0.00656636221851643,0.498575700062645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42710,-0.00313867660230588,0.00464766324921586,-0.012248096570769,0.00597074336615721,0.499481756156005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40165,-0.00368594080723061,0.00547491059908918,-0.0144167655814454,0.00704488396698418,0.500807404976893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,40035,-0.0022987654143321,0.00342665982094407,-0.00901501866338249,0.00441748783471828,0.502332117078669
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,40222,-0.00262070839161883,0.00390722035985769,-0.0102788602969399,0.00503744351370224,0.502403580798601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,42310,-0.00426755072463571,0.00636259003678295,-0.0167382271967303,0.00820312574745887,0.502407291266973
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40181,0.0024849303296485,0.00370493490737509,-0.00477674208880668,0.00974660274810368,0.50242051796479
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42793,-0.00224978996862091,0.00337261043215802,-0.00886010641565063,0.00436052647840882,0.504734435663758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42494,-0.00776859566382967,0.0116760485537276,-0.0306536508291358,0.0151164595014765,0.505841658280808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,40526,-0.00635067544934391,0.00954564265338572,-0.0250601350499799,0.0123587841512921,0.505874891013155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42586,0.00179482905878461,0.00270428917072897,-0.00350557771584417,0.00709523583341339,0.506895578605182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40482,-0.00388419372420375,0.00586242686481792,-0.0153745503792469,0.00760616293083936,0.507627651565466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42586,-0.00212761255383226,0.00323138657046919,-0.00846113023195187,0.00420590512428734,0.51027900812495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,40115,0.00256259448273284,0.00389447923524159,-0.00507058481834068,0.0101957737838064,0.510547521666234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42345,-0.00230779742948135,0.00351997348305224,-0.00920694545626374,0.00459135059730105,0.512074196262126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40450,-0.00431034146146666,0.00658161214491803,-0.017210301265506,0.00858961834257268,0.512541250672807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42479,-0.00236540636172327,0.00361328651082139,-0.00944744792293319,0.00471663519948665,0.512710098763548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42610,-0.00290501637349962,0.00445303412276128,-0.0116329632541117,0.00582293050711248,0.514175065049641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42688,0.00258728463012009,0.00401161675801655,-0.00527548421559233,0.0104500534758325,0.518971780014082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,40115,-0.00218731632681991,0.00341758096709948,-0.00888577502233489,0.00451114236869508,0.522173754511995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40531,0.00138336429645599,0.00216335120137279,-0.00285680405823469,0.00562353265114667,0.522540334067496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,40482,-0.00386280376230057,0.00604878173060907,-0.0157184159542943,0.0079928084296932,0.523090570638882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,40301,0.00328320167545178,0.00514271518698311,-0.0067965200910351,0.0133629234419387,0.523214813650853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40079,0.00259622168814367,0.00409442720290088,-0.00542885562954206,0.0106212990058294,0.526037589791457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40254,-0.00299882605890717,0.00473315414295186,-0.0122758081790928,0.00627815606127848,0.526368850034259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,40222,-0.00187746995948811,0.00296595544829994,-0.007690742638156,0.00393580271917977,0.526742329707734
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,40301,0.00513419078570675,0.00812085155546281,-0.0107826782630004,0.0210510598344139,0.527254050562079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42593,-0.00420671165259893,0.00665592837995297,-0.0172523312773067,0.00883890797210888,0.527381470169105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40282,0.00306312738768061,0.00484937573198933,-0.00644164904701848,0.0125679038223797,0.527626040074356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40181,-0.0025303198163307,0.0040082211785697,-0.0103864333263273,0.00532579369366592,0.527868971195056
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00336797161802723,0.0053354317438629,-0.0138254178359985,0.00708947459994406,0.52789330513834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42697,-0.00403037421591751,0.00638933999397683,-0.0165534806041121,0.00849273217227708,0.528184174967058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40280,-0.00335514508496335,0.00532263834263644,-0.0137875162365308,0.00707722606660407,0.52847615065359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40418,0.00317749280499887,0.00504166793680516,-0.00670417635113925,0.013059161961137,0.528546250160985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,40198,-0.00196836014212231,0.00313769664923408,-0.0081182455746211,0.00418152529037648,0.530458276130548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40198,-0.00394648690101226,0.00629537813588283,-0.0162854280473426,0.00839245424531808,0.530746711722513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,40079,0.00259744615508702,0.00417104785057525,-0.00557780763204047,0.0107726999422145,0.533473509309289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40481,-0.00249577022912297,0.0040116316364821,-0.0103585682366279,0.00536702777838194,0.533866688442607
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42623,0.00454694688381006,0.00731933662093365,-0.0097989528932199,0.01889284666084,0.53446285668589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,42310,-0.00286923993319206,0.00463600597681817,-0.0119558116477557,0.00621733178137156,0.535990737015628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42345,0.00278452160568249,0.00450852779247289,-0.00605219286756437,0.0116212360789294,0.536841718314692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40301,-0.00405908683821589,0.00659867936156734,-0.0169924983868879,0.00887432471045609,0.538477350523063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIM,Vimentin,42356,-0.00695574219116616,0.011313211817699,-0.0291296373538563,0.015218152971524,0.538675278514471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTD,Biotinidase,40538,0.00123455987618616,0.0020084303635113,-0.002701963636296,0.00517108338866832,0.538772511994107
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42793,-0.00427252008387755,0.00700824442944941,-0.0180086791655984,0.00946363899784329,0.542109175009306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,40531,0.00480843208668538,0.00789511437491963,-0.0106659920881571,0.0202828562615278,0.542510832394387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",40301,-0.0027019002180552,0.00443639144843456,-0.0113972274569869,0.00599342702087653,0.5425163029131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,40301,-0.00242661743814607,0.00400501703586953,-0.0102764508284503,0.00542321595215821,0.544597252118524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40115,-0.00357010866596899,0.00590106374921272,-0.0151361936144259,0.00799597628248794,0.54519549671083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40301,-0.00279305868423597,0.0046289050774681,-0.0118657126360735,0.00627959526760151,0.546258196507499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40181,0.00235092847367182,0.0039049989323972,-0.00530286943382669,0.0100047263811703,0.547166255952957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42572,0.00404712757461919,0.00676181698665619,-0.00920603371922695,0.0173002888684653,0.549498724848295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42753,0.00202060001929858,0.00337976564815236,-0.00460374065108004,0.00864494068967721,0.549948602585468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,40222,-0.00248782565567324,0.00416386227619334,-0.0106489957170122,0.0056733444056657,0.550199027516599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42356,0.00533020355669794,0.0089887387948493,-0.0122877244812067,0.0229481315946026,0.553200166848893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42345,0.00252479585158654,0.00426163485048448,-0.00582800845536303,0.0108776001585361,0.55356100521687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40135,0.00347684175784109,0.00590086423835395,-0.00808885214933265,0.0150425356650148,0.555733309299275
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40481,-0.00429256073296334,0.00731324636009902,-0.0186265235987574,0.0100414021328307,0.55724436378131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42345,-0.00356912790677662,0.00610124857828742,-0.01552757512022,0.00838931930666673,0.558569050475832
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,40481,0.00259963845109978,0.00445302118203803,-0.00612828306569476,0.0113275599678943,0.559371880321985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,42345,-0.00793709214678638,0.0136151336015188,-0.0346227540057632,0.0187485697121905,0.559929538190483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,40079,-0.00380055756539304,0.00653162399255953,-0.0166025405908097,0.00900142546002364,0.560666143303152
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42356,-0.00215803443261932,0.00370889354880876,-0.00942746578828448,0.00511139692304585,0.560675013232888
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,40115,-0.00385151539978998,0.00662436572244014,-0.0168352722157727,0.00913224141619269,0.56097179268913
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40482,-0.00148123626995407,0.00254898521040946,-0.0064772472823566,0.00351477474244847,0.56117911811871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,40198,-0.00234879374258089,0.00405482825960089,-0.0102962571313986,0.00559866964623686,0.562426619389433
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTTG1,Securin,40301,-0.0023080620433333,0.00400469059370134,-0.0101572556069879,0.00554113152032132,0.564397294481431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40481,-0.00321142887406198,0.00558519895487376,-0.0141584188256146,0.0077355610774906,0.565310086765478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,42310,0.00203205518420641,0.00354201153240795,-0.00491028741931317,0.00897439778772599,0.566180059827429
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,40450,-0.00340701213100722,0.00596722031864411,-0.0151027639555497,0.00828873969353524,0.568041789196109
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42593,0.00445715686983382,0.00782726253986929,-0.01088427770831,0.0197985914479776,0.569067081316685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42610,0.00321357057552109,0.00565182863075296,-0.00786401354075471,0.0142911546917969,0.569644249987185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40115,0.00264550617616368,0.00465466322173011,-0.00647763373842732,0.0117686460907547,0.569804887440636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,40115,0.0027948654688745,0.00493013557798504,-0.00686820026397617,0.0124579312017252,0.570797687504886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40079,0.00175012771325054,0.00309055042029289,-0.00430735111052353,0.00780760653702462,0.571212748765373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42678,-0.00247748696120055,0.00437595117828944,-0.0110543512706479,0.00609937734824675,0.571294682788679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42653,-0.00467388299350199,0.008256846466215,-0.0208573020672834,0.0115095360802794,0.571361403609264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40115,-0.00264181558706527,0.00475776632358039,-0.0119670375812828,0.00668340640715229,0.578725582895402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42369,-0.00161277809934248,0.00290583253183888,-0.00730820986174668,0.00408265366306173,0.578894421561886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,40079,0.0040595948549292,0.00731843168607263,-0.0102845312497732,0.0184037209596315,0.579105590190524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40301,0.00237703609745772,0.00429142876917501,-0.00603416429012529,0.0107882364850407,0.579656250496482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42610,0.00297595250574024,0.00539537263545364,-0.00759897785974889,0.0135508828712294,0.581248774872878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40115,0.0034086525605478,0.00618261545110549,-0.00870927372361895,0.0155265788447146,0.581419733388335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40115,0.00181845554716796,0.00332016471743103,-0.00468906729899686,0.00832597839333278,0.583908829842261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40283,-0.0028392939764113,0.00523040562616972,-0.0130908890037039,0.00741230105088135,0.587248169843021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40301,-0.00456461630509482,0.00844127011102685,-0.0211095057227075,0.0119802731125178,0.588690795350951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,40079,0.00405682269720612,0.00753357896792427,-0.0107089920799255,0.0188226374743377,0.59024379397369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40448,-0.00256821864660272,0.00479313737779463,-0.0119627679070802,0.00682633061387475,0.592099347522813
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40135,-0.00371984982397911,0.00695705203217704,-0.0173556718070461,0.0099159721590879,0.59287672590864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40282,-0.00197172212530844,0.00369381868899818,-0.00921160675574487,0.00526816250512798,0.59349778690558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42487,-0.00268418764504107,0.00504747061637369,-0.0125772300531335,0.00720885476305137,0.594881263099795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEB,Nebulin,40115,-0.0019964737363397,0.00375651697651492,-0.00935924701030894,0.00536629953762954,0.595104366062468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40115,0.00363331084619308,0.00683888629906982,-0.00977090629998377,0.0170375279923699,0.595240903108791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,40079,-0.00489906349613705,0.00928548125189295,-0.0230986067498472,0.0133004797575731,0.597784488066954
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42494,0.00275011768385095,0.00521528035916724,-0.00747183182011684,0.0129720671878187,0.597980710047633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40482,0.00216180397921786,0.00410957551973326,-0.00589296403945934,0.010216571997895,0.598870263862475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40450,-0.00393907225514108,0.00749359350241172,-0.0186265155198681,0.0107483710095859,0.599135752685762
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,40282,0.00323012207530085,0.00617869614179383,-0.00888012236261506,0.0153403665132168,0.601135179265315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42793,0.00138566638107941,0.0026626904422715,-0.00383320688577273,0.00660453964793156,0.6027926866465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40181,-0.00213712774203051,0.00410944921895527,-0.0101916482111828,0.00591739272712181,0.6030377327373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42586,-0.00220767200228231,0.00428263405475079,-0.0106016347495939,0.00618629074502924,0.606216396166901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,40181,-0.00195671572002019,0.00384932422097466,-0.00950139119313051,0.00558795975309014,0.611234191570706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,42369,-0.00231750781098016,0.00456302530180174,-0.0112610374025116,0.00662602178055126,0.611540083238902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40144,-0.00189211512000264,0.00374398572957443,-0.00923032714996852,0.00544609690996323,0.613305959151232
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40450,-0.00289961478405648,0.00575029522838466,-0.0141701934316904,0.00837096386357745,0.614092106469847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,40135,-0.0036813415569897,0.00732220448954682,-0.0180328623565015,0.0106701792425221,0.615140255675551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,40181,0.00255741943746225,0.00509605259936256,-0.00743084365728836,0.0125456825322129,0.615787865529678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,42345,0.00231515034852397,0.00461585807440844,-0.00673193147731657,0.0113622321743645,0.61598232247901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40115,-0.00279991944051677,0.00560599206527863,-0.0137876638884629,0.00818782500742936,0.617471621682865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40115,-0.0022305053468479,0.00446813308582379,-0.0109880461950625,0.00652703550136673,0.617646451775392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,40198,-0.00273684498804112,0.00549652327494253,-0.0135100306069285,0.00803634063084623,0.618548313289181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40115,-0.00176355944284828,0.00354664602468247,-0.00871498565122592,0.00518786676552936,0.619024822793657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42310,-0.00351943842010015,0.00709096255189638,-0.0174177250218171,0.0103788481816168,0.619671813399328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40301,-0.00140416452234616,0.00283205687192627,-0.00695499599132164,0.00414666694662932,0.620037679765527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,40481,-0.00315909315882326,0.00637162541661415,-0.015647478975387,0.00932929265774048,0.62004060726558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40135,-0.0026118988165427,0.00527815745228114,-0.0129570874230137,0.00773328978992834,0.620715595899737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,40222,0.00301220109668227,0.00612467705818992,-0.00899216593736998,0.0150165681307345,0.622860722830517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40135,-0.00205837704654695,0.00422508002018084,-0.0103395338861014,0.0062227797930075,0.626140107756488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40282,0.00154689190330234,0.00318613885112362,-0.00469794024489995,0.00779172405150462,0.627326522051168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,42356,-0.00337911964011509,0.00698395555100973,-0.0170676725200942,0.010309433239864,0.628507211503053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40181,-0.00201430003801235,0.00418631536514807,-0.0102194781537026,0.00619087807767787,0.630410241038541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42635,0.00398786283655367,0.00842447170018116,-0.0125241016958014,0.0204998273689087,0.635959400429037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42475,-0.00334809566627055,0.00708778023148769,-0.0172401449199864,0.0105439535874453,0.636666355484554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,40198,-0.00203990317353138,0.00436430948577404,-0.0105939497656485,0.00651414341858575,0.640218893503317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,42291,-0.00166884015723171,0.00357232629133545,-0.00867059968824919,0.00533291937378576,0.64039474169081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGN,Biglycan,42327,0.00544567351783013,0.0117033850927772,-0.0174929612640131,0.0283843082996734,0.64171893962235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42673,0.00324055325843965,0.0069943914363731,-0.0104684539568516,0.0169495604737309,0.643151528142427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40481,-0.00176318556327985,0.00381305216994337,-0.00923676781636886,0.00571039668980916,0.643797726613627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42345,0.00571643728815241,0.0123732365467838,-0.0185351063435438,0.0299679809198486,0.644088846723688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40181,-0.00226766142382675,0.00498167498266189,-0.0120317443898441,0.00749642154219054,0.648973926058425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42653,0.00334727506030547,0.00736011439935126,-0.011078549162423,0.0177730992830339,0.649270726562476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40079,0.00150777501880584,0.003347504993854,-0.005053334769148,0.00806888480675968,0.652418359042411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40172,-0.00120121550270368,0.00267710227467201,-0.00644833596106083,0.00404590495565347,0.653657018526464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42647,-0.00139760678945057,0.00313951747538935,-0.0075510610412137,0.00475584746231257,0.656206876744942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,40301,-0.00178760949339321,0.00401572383327355,-0.00965842820660936,0.00608320921982295,0.656218227719676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,42369,0.00244806771561333,0.00550225725223541,-0.00833635649876807,0.0132324919299947,0.656384428689522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40198,-0.0037399215153824,0.00843223606497661,-0.0202671042027366,0.0127872611719718,0.65739355869494
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42610,-0.00129615098483771,0.00292697783594877,-0.00703302754329731,0.00444072557362188,0.65789648690052
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42688,-0.00183489161292607,0.00416583699008713,-0.00999993211349685,0.00633014888764471,0.6596098064978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,40282,0.00136432390380659,0.00311546687818093,-0.00474199117742803,0.00747063898504121,0.661453121730937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42369,0.00485662748786154,0.0111298169473284,-0.0169578137289021,0.0266710687046251,0.66258136561662
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40538,0.00129503936314535,0.00298998733340819,-0.00456533581033471,0.0071554145366254,0.66493192924752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,40181,-0.00258485762303679,0.00599255891882712,-0.014330273103938,0.00916055785786438,0.666226325775311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42345,-0.0034168102933582,0.00792715510962519,-0.0189540343082236,0.0121204137215072,0.666456499416094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42593,0.00430567449145656,0.0100544106172849,-0.0154009703184219,0.0240123193013351,0.668485185248255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40115,-0.00163959539433178,0.00383131132481471,-0.00914896559096861,0.00586977480230504,0.66869867691911
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42753,-0.00152831925493575,0.00357487111034172,-0.00853506663120553,0.00547842812133402,0.669009374278002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,40478,-0.00128403845805315,0.00301543471172908,-0.00719429049304215,0.00462621357693584,0.670245671893395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40301,-0.00237325382431849,0.00560164365458675,-0.0133524753873085,0.00860596773867153,0.671813990318587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40198,-0.00146257769586115,0.00346520096826633,-0.00825437159366315,0.00532921620194085,0.672977889464319
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,40079,-0.00301661297751039,0.00716162193840977,-0.0170533919767935,0.0110201660217728,0.673603310282487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40301,-0.00328515901236164,0.0078121004494994,-0.0185968758933805,0.0120265578686572,0.674112398934511
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40198,-0.00167956656369195,0.00401654971648849,-0.00955200400800939,0.00619287088062549,0.675837182417374
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40079,0.00226582270279171,0.00544044620979888,-0.00839745186841409,0.0129290972739975,0.677068938793877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40064,-0.002117780084476,0.00510181999435011,-0.0121173472734022,0.00788178710445021,0.678074796605222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,40481,0.00177998647108936,0.00429183549935188,-0.00663201110764033,0.010191984049819,0.678341729889295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42345,-0.00234149108314546,0.00564636276860647,-0.0134083621096141,0.00872537994332322,0.678375500406475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40481,0.00117843450874748,0.00287664804189478,-0.00445979565336628,0.00681666467086125,0.682066498744742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,40222,-0.00288972701000346,0.00707733743074311,-0.01676130837426,0.010981854354253,0.683056166346358
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,42345,-0.00419081479347138,0.0103068822283182,-0.0243923039609751,0.0160106743740324,0.684305813923084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40482,-0.00121871837787265,0.00301929400787334,-0.00713653463330439,0.0046990978775591,0.686482544284262
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40079,-0.000995225124591166,0.00247071595254407,-0.00583782839157753,0.0038473781423952,0.68709709632829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,40135,-0.00146327917702178,0.00363568352533917,-0.00858921888668655,0.005662660532643,0.687340838635986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40115,0.00188896766058419,0.00471733829992194,-0.00735701540726281,0.0111349507284312,0.688847057841758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40301,0.00276207979062038,0.00692076776587913,-0.0108026250305027,0.0163267846117435,0.689827048787317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,40198,-0.00145227319943199,0.00366025276761654,-0.00862636862396041,0.00572182222509643,0.691545835662845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,40115,-0.00132019629477119,0.00337418331211383,-0.00793359558651429,0.00529320299697191,0.695609775110309
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40222,-0.0019871773895791,0.00511258984250562,-0.0120078534808901,0.00803349870173192,0.697518071712336
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42442,0.00430574363435488,0.0111982455415451,-0.0176428176270736,0.0262543048957833,0.700612861627737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40450,-0.00201847003802543,0.00524986210930965,-0.0123081997722724,0.00827125969622149,0.700629548894055
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40222,-0.0101006471013882,0.0264810335236412,-0.0620034728077249,0.0418021786049485,0.702891930791169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42753,0.00147525498420282,0.00387093669663802,-0.0061117809412077,0.00906229090961333,0.703127157782323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40181,-0.00136448229424469,0.00363632711596416,-0.00849168344153445,0.00576271885304506,0.707491905054829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,40181,0.00219909126130859,0.00593378600689599,-0.00943112931220754,0.0138293118348247,0.71093883942244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,40181,0.00191637734676502,0.00517467677263899,-0.0082259891276074,0.0120587438211374,0.711138104671928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,40115,0.0014685725350966,0.00398291683801277,-0.00633794446740842,0.00927508953760162,0.712345189427879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,42291,0.00257479890893305,0.00701777767318846,-0.0111800453305163,0.0163296431483824,0.713702060082213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40058,0.0017811692294632,0.00486864733877215,-0.0077613795545302,0.0113237180134566,0.714488023972623
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40115,0.00154630156884752,0.00428704155786379,-0.0068562998845655,0.00994890302226054,0.718336686223932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40079,-0.00340153250839372,0.00943312673880404,-0.0218904609164496,0.0150873958996622,0.7184096866581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,42213,-0.00291242322924502,0.00808999765622027,-0.0187688186354367,0.0129439721769467,0.718850747958609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,40198,-0.00206701739444929,0.00577874509335764,-0.0133933577774303,0.00925932298853168,0.720579838425098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40115,0.00112754528986039,0.00317696254818704,-0.0050993013045862,0.00735439188430699,0.722661626959585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42593,-0.00206619617445031,0.00585709217086152,-0.0135460968293389,0.00941370448043827,0.724267734686987
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42610,0.00151846321131259,0.00433474170610007,-0.00697763053264355,0.0100145569552687,0.726118512141789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42494,0.00244992882356638,0.00699429464090446,-0.0112588886726064,0.0161587463197391,0.726137628959093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42753,-0.00151188734183237,0.00432685626807375,-0.00999252562725692,0.00696875094359219,0.726779928486088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42678,-0.00276809407054545,0.00800024453791461,-0.0184485733648581,0.0129123852237672,0.729347224214496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42793,0.000784722870153891,0.00229945516297767,-0.00372220924928234,0.00529165498959012,0.732909594329132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42793,-0.0023308203116449,0.00685502791521809,-0.0157666750254724,0.0111050344021826,0.733849604948857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40115,-0.00144053730764367,0.00423670706717466,-0.009744483159306,0.00686340854401866,0.733852952199282
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40115,0.000944573063190592,0.00277932790442375,-0.00450290962947997,0.00639205575586115,0.733971021618857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40135,-0.00258826044267028,0.00764483261967266,-0.0175721323772287,0.0123956114918881,0.734945163164199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40115,-0.00147251342147977,0.00437403462908224,-0.0100456212944809,0.00710059445152142,0.736388147786182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40079,-0.00255937890032169,0.00761445794044763,-0.017483716463599,0.0123649586629557,0.736786133266774
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,42356,-0.0018562369904726,0.00556680508191072,-0.0127671749510176,0.0090547009700724,0.738801857918696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40420,0.000979903405766719,0.00294849321218885,-0.00479914329012343,0.00675895010165686,0.739638444127722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,40282,-0.00253832694361762,0.0076680128364266,-0.0175676321030137,0.0124909782157785,0.740629592072618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,39041,-0.00356690632216083,0.0107912673819869,-0.0247177903908552,0.0175839777465336,0.741001750206094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40115,-0.00224676976041243,0.0068414810657873,-0.0156560726493555,0.0111625331285307,0.74261251386767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,40079,0.00219298469503407,0.00676283728953753,-0.0110621763924595,0.0154481457825276,0.745739922791238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42670,-0.000968859287835438,0.00301850631630756,-0.00688513166779826,0.00494741309212739,0.748235764149005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42635,0.00197136408832348,0.00614855703200286,-0.0100798076944021,0.0140225358710491,0.74850167095334
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,40198,0.000896774449564457,0.00279996641014926,-0.00459115971432809,0.006384708613457,0.748761837226447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42720,0.00149368888351844,0.00473063206275458,-0.00777834995948053,0.0107657277265174,0.752198457935044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40450,-0.000885363457208404,0.00281870575710641,-0.00641002674113696,0.00463929982672015,0.753448760737446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42586,0.00108562156797446,0.00352567615880466,-0.00582470370328268,0.00799594683923161,0.758148995950267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,40153,-0.00206722288259466,0.00672384583745315,-0.0152459607240028,0.0111115149588135,0.758509379641303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42635,-0.00119110332891778,0.00389320867920677,-0.00882179234016305,0.0064395856823275,0.759652121461758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40115,-0.00131809607923539,0.00430868886031828,-0.00976312624545923,0.00712693408698844,0.759674572618166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,40115,0.00116376702444802,0.00385210121944147,-0.00638635136565726,0.00871388541455331,0.762572235922126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40115,-0.00181099198409424,0.00603171339669853,-0.0136331502416234,0.0100111662734349,0.763995972526743
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,40181,-0.00251205002191744,0.0084389467587738,-0.0190523856691141,0.0140282856252792,0.765958071126577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40198,-0.00144711131528534,0.00487482735374833,-0.0110017729286321,0.0081075502980614,0.766583686543181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40115,-0.00130168279782071,0.00438868056694537,-0.00990349670903365,0.00730013111339222,0.766777526471766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40115,-0.00193837194954614,0.00654060296562942,-0.0147579537621798,0.0108812098630875,0.766960938367489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,40115,0.00245332002540884,0.00828348791913964,-0.0137823162961049,0.0186889563469225,0.767105944152612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40510,-0.000854938263080514,0.00288835464492824,-0.00651611336713987,0.00480623684097884,0.767239402675425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,42248,-0.00298367381011327,0.010080591176358,-0.0227416325157749,0.0167742848955484,0.767248515219218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,40222,0.00160782553698332,0.00546627347537052,-0.00910607047474289,0.0123217215487095,0.768659837096733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,40115,-0.00129196258875824,0.00443610956217007,-0.00998673733061159,0.0074028121530951,0.770875020252652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7,Complement component C7,40250,0.000932298863210227,0.00321914097831217,-0.00537721745428163,0.00724181518070209,0.772119227884682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40079,-0.0013523404385581,0.0046703340437602,-0.0105061951643281,0.0078015142872119,0.772158630517616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42710,-0.00169397560561791,0.0058949960183611,-0.0132481678016057,0.00986021659036984,0.773842448067803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40115,0.0011499913942571,0.0040150914009718,-0.00671958775164762,0.00901957054016183,0.774564005534783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42544,-0.00125041604530798,0.00438966562021042,-0.00985416066092039,0.00735332857030444,0.775760027696432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,42310,-0.00146625139844727,0.0052022899711388,-0.0116627397418793,0.00873023694498478,0.778065044646438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42612,-0.000848534789325965,0.00303633975577697,-0.00679976071064882,0.00510269113199689,0.779896319959236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42688,0.00151844508395745,0.00544312180234837,-0.00915007364864536,0.0121869638165603,0.780275309802145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS2,Podocin,40198,-0.0028631205264952,0.0102691388000144,-0.0229906325745235,0.0172643915215331,0.780397228824322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40538,-0.000504773433195054,0.0018311632245092,-0.00409385335323308,0.00308430648684297,0.78281634825664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40448,-0.00399856324685763,0.0145081771843671,-0.0324345905282172,0.0244374640345019,0.782854566113766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,40481,0.00167497546501001,0.00611104828494833,-0.0103026791734887,0.0136526301035087,0.784020695510181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,40198,-0.00123110571416226,0.00450832966999327,-0.0100674318673491,0.00760522043902455,0.784801781179292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40181,0.00205585581844092,0.00753474606915541,-0.0127122464771037,0.0168239581139855,0.784973614607219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40079,0.00135001151244929,0.00495326163800927,-0.00835838129804887,0.0110584043229475,0.785204313002863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40079,-0.00130154291276087,0.00479699549271693,-0.010703654078486,0.00810056825296431,0.786146528219798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40448,-0.00460615404218626,0.0171039286190507,-0.0381298541355256,0.0289175460511531,0.78770079712072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40198,0.00140526601492006,0.00524542670618654,-0.00887577032920555,0.0116863023590457,0.788778937656318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,40123,-0.00254280422461702,0.00962915931796574,-0.0214159564878299,0.0163303480385958,0.791728388665856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42586,-0.00143322310159615,0.00543150802335204,-0.0120789788273661,0.00921253262417385,0.791882581333321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42699,-0.00238145868302131,0.0090588996591578,-0.0201369020149706,0.015373984648928,0.792642390481316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,40198,0.00119492178790059,0.00467294927692087,-0.0079640587948643,0.0103539023706655,0.79817923378534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42310,-0.00142614533898504,0.005580942079253,-0.0123647918143209,0.00951250113635085,0.798311250325036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40115,-0.0014787853856282,0.00579141784507149,-0.0128299643619683,0.00987239359071192,0.798464682673484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40135,-0.00213400143094648,0.00836380825412739,-0.0185270656090362,0.0142590627471432,0.798614282029128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42494,0.000757797114092544,0.00297109954578479,-0.00506555799564565,0.00658115222383074,0.798683700509814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTN,Titin,40115,-0.00163008260572476,0.00642057471053458,-0.0142144090383725,0.010954243826923,0.799589785137254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42553,0.00206831053184848,0.00815077951842953,-0.0139072173242734,0.0180438383879704,0.799687847484965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,40135,-0.0015272525518778,0.00604770194252251,-0.0133807483592219,0.0103262432554663,0.800632801436054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,42369,0.00229957131705842,0.00914849438827626,-0.015631477683963,0.0202306203180799,0.801539223294169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40181,-0.00191956936441591,0.00768399103088097,-0.0169801917849426,0.0131410530561108,0.802735779457241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,40064,0.00197167034541451,0.0079144902019723,-0.0135407304504512,0.0174840711412802,0.803271439954823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42345,-0.00078348758970182,0.00316728287220495,-0.00699136201922353,0.00542438683981989,0.804626526555635
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,40531,0.00175357908119628,0.00710627742463864,-0.0121747246710955,0.015681882833488,0.805094726682591
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40301,-0.00207439975206851,0.00848856470911269,-0.0187119865819294,0.0145631870777924,0.806944300081909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,42369,0.00190282652922662,0.00788955435220871,-0.0135607000011025,0.0173663530595557,0.809417025295401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42550,0.00140496037692995,0.00587827136146024,-0.0101164514915321,0.012926372245392,0.811102189784739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40135,-0.00136524256668697,0.005713392406344,-0.0125634916831212,0.00983300654974728,0.811145103805507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42494,-0.000279019393631623,0.00117190470995374,-0.00257595262514096,0.00201791383787771,0.811814560469962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40198,0.00142684176757382,0.00607221404998109,-0.0104746977703891,0.0133283813055368,0.814229534826207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,40282,0.00162847941956064,0.00693994636703901,-0.0119738154598358,0.0152307742989571,0.814482381911052
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAG,S-arrestin,40135,-0.00118724808648485,0.00511987497980083,-0.0112222030468945,0.00884770687392477,0.816627746423807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42545,-0.00122880493312754,0.00545948688315875,-0.0119293992241187,0.0094717893578636,0.821922817446143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42494,-0.00190133711131766,0.00852477160076422,-0.0186098894488155,0.0148072152261802,0.8235103516327
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,40301,-0.000966915120579526,0.00436041633338009,-0.00951333113400451,0.00757950089284545,0.824513866986647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40222,0.00072387649862014,0.00327586031191562,-0.00569680971273447,0.00714456270997475,0.825117590388201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40222,-0.000852789481130181,0.00386889774722843,-0.00843582906569791,0.00673025010343755,0.825546733960068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,40079,0.00139247907913788,0.00639386744359108,-0.0111395011103006,0.0139244592685764,0.827601853015996
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,42345,-0.00205327427588706,0.00944892357465193,-0.0205731644822048,0.0164666159304307,0.827976016203526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40064,-0.00185666348774338,0.00859540921924601,-0.0187036655574656,0.0149903385819788,0.828986804155124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40450,-0.00118828562278504,0.0055415200495853,-0.0120496649199722,0.00967309367440215,0.830213174046818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,40268,-0.000782046697732808,0.00364771986856664,-0.00793157764012343,0.00636748424465781,0.830244313993114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40181,-0.000963485705234814,0.00450696961431061,-0.00979714614928361,0.00787017473881398,0.830725056173153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40181,0.000758330267207243,0.0035475384275221,-0.00619484505073607,0.00771150558515056,0.830736327601898
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42593,0.00143156519450505,0.0067436103581735,-0.011785911107515,0.0146490414965251,0.831888172551973
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,40079,-0.000645869415487482,0.00306178189500387,-0.00664696192969507,0.00535522309872011,0.832933670621984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,40115,-0.00106018664780101,0.00502687375561129,-0.0109128592087991,0.00879248591319712,0.832966293876928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,42356,0.00118543363534779,0.00564664631278016,-0.00988199313770132,0.0122528604083969,0.833720971158883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,40135,0.00148949175007153,0.0071155549107798,-0.0124569958750569,0.0154359793751999,0.834195338485941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40181,-0.00135460239920752,0.00660001482514514,-0.014290631456492,0.011581426658077,0.837386603523646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,40079,0.00123233245314529,0.00600600437694567,-0.0105394361256682,0.0130041010319588,0.837432667988102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,42345,-0.0012917947944442,0.00633489641585017,-0.0137081917695105,0.0111246021806221,0.838421302951894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,40448,0.000863801787689588,0.0042777763407105,-0.007520639840103,0.00924824341548217,0.839976850715957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40531,0.000561580025594851,0.00278958503207259,-0.00490600663726742,0.00602916668845712,0.840457367326652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40450,0.00093895730921417,0.00467060135788786,-0.00821542135224603,0.0100933359706744,0.840674342651245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,42440,-0.000707217228769937,0.00352367333660235,-0.00761361696851054,0.00619918251097067,0.840932692611285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40526,0.00107645479564569,0.00537812150743131,-0.00946466335891968,0.0116175729502111,0.841363404333967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,40482,0.000439675415364098,0.00220673118484863,-0.00388551770693921,0.0047648685376674,0.842076368735251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40979,0.000619989122511984,0.0031129711979881,-0.0054814344255447,0.00672141267056867,0.842138566653283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40115,-0.00115657380105596,0.00586602154020974,-0.012653976019867,0.0103408284177551,0.843702132870821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40526,-0.000744843746949248,0.00379203512694928,-0.00817723259576983,0.00668754510187133,0.844282446226367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40115,-0.00128959067355987,0.0066124201496481,-0.0142499341668702,0.0116707528197504,0.845376597587908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40079,-0.00161605620424391,0.0084820679990986,-0.0182409094824772,0.0150087970739893,0.848900365762474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42753,-0.00112878035274768,0.0059510531586521,-0.0127928445437058,0.0105352838382104,0.849564762513439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42586,-0.00097799307400356,0.00518736541860675,-0.0111452292944728,0.00918924314646566,0.850461175491382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40301,0.001473567121085,0.00787816740818517,-0.0139676409989579,0.0169147752411279,0.851629234872497
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,40450,0.000794573562512659,0.0042559061088606,-0.00754700241085412,0.00913614953587944,0.851899977635024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42586,0.000987532527575617,0.00532048174566077,-0.00944061169391948,0.0114156767490707,0.852753729930375
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40115,-0.000705165248992905,0.00380124277129948,-0.00815560108073989,0.00674527058275408,0.85283316295261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40115,0.000678412077029875,0.00369149318824027,-0.00655691457192105,0.00791373872598081,0.854191698689249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42593,-0.0014486921192373,0.0079564797361692,-0.0170433924021289,0.0141460081636543,0.855525037121041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,40481,-0.000513426533383584,0.00285897718185301,-0.00611702180981548,0.00509016874304831,0.857482397070181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40510,-0.00115662527568483,0.00652038221558509,-0.0139365744182316,0.011623323866862,0.859208287110407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,40198,-0.00071137439008976,0.00413011031326254,-0.00880639060408434,0.00738364182390482,0.863251222315149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40331,-0.000957019017964947,0.00555741285875772,-0.0118495482211301,0.00993551018520019,0.863278826148884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40450,0.00110395495026867,0.00646401647266206,-0.011565517336149,0.0137734272366863,0.864396149553165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40079,0.000572560552124452,0.00338902628171911,-0.00606993096004501,0.00721505206429391,0.865842692453336
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,40450,0.000623635529277477,0.00373894208467844,-0.00670469095669227,0.00795196201524722,0.867534625947159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,40115,0.000598648160707864,0.00360610431105938,-0.00646931628896851,0.00766661261038424,0.868152418916378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42310,-0.000840689509338282,0.0050841311153817,-0.0108055864954864,0.00912420747680984,0.868666653479163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42537,-0.00115192328334959,0.0069983716187665,-0.0148687316561319,0.0125648850894328,0.869262301387528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,40198,-0.000530914035044392,0.00328449495448496,-0.00696852414583491,0.00590669607574612,0.871590340613559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40228,0.000886702313678119,0.00550865781356113,-0.0099102670009017,0.0116836716282579,0.872123741102856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,40181,-0.0010194377108011,0.00633517903671308,-0.0134363886227587,0.0113975132011565,0.872161767855185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,40198,-0.000643992384027242,0.00401202865907684,-0.00850756855581785,0.00721958378776337,0.872478038080756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,42361,0.000925063814252054,0.00586807574980355,-0.0105763646553629,0.012426492283867,0.874740166247276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,40115,-0.000756077796966422,0.00488654079513261,-0.0103336977554263,0.0088215421614935,0.877039725444036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,42369,-0.000845823240227949,0.00569419721301784,-0.0120064497777429,0.010314803297287,0.881917898049844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40510,0.000417470575115064,0.00287431713844977,-0.00521619101624649,0.00605113216647662,0.884522666288056
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40222,-0.000336732247825955,0.00231955244002439,-0.00488305503027376,0.00420959053462185,0.884578344638947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42586,0.000838107129853814,0.00581150173164642,-0.0105524362641732,0.0122286505238808,0.885332675245847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAT,Catalase,40360,0.000752102559414763,0.00530256527881028,-0.00964092538705338,0.0111451305058829,0.887210928116799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40135,-0.000710738183265207,0.00504035041372021,-0.0105898249941568,0.00916834862762641,0.887864893646927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42345,-0.000808151339763924,0.00584783873566909,-0.0122699152616753,0.0106536125821475,0.8900871702437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42610,0.00129980732270425,0.00947071996711415,-0.0172628038128395,0.019862418458248,0.89083933887153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42112,-0.000495906857376604,0.00367607584528906,-0.00770101551414316,0.00670920179938995,0.89269213237754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40135,0.000823227662646582,0.00611670204359895,-0.0111655083428074,0.0128119636681005,0.892941014515896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42675,-0.000524705157616374,0.00412296231823904,-0.0086057113013649,0.00755630098613215,0.898733258162325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42345,0.00120019260900126,0.00953064987552422,-0.0174798811470262,0.0198802663650287,0.899789437056697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42310,-0.000503747324215213,0.00409094922396688,-0.00852200780319029,0.00751451315475986,0.902000477949691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40448,0.000950575235444002,0.00772103800222397,-0.014182659248915,0.016083809719803,0.90201826857119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40115,-0.000475284660795147,0.003910836568192,-0.00814052433445147,0.00718995501286117,0.903273349886291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40115,0.000551020649546057,0.00475779523342694,-0.00877425800797075,0.00987629930706286,0.907801858864701
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,40538,0.000467176809965184,0.00404919687460192,-0.00746924906425458,0.00840360268418495,0.908149794770017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRN1,Neuritin,40481,0.00040470405805237,0.00355217142592704,-0.00655755193676462,0.00736696005286936,0.909294157016333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40198,0.000318141445786582,0.00289099908940844,-0.00534821676945396,0.00598449966102712,0.912375295483296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCLN,Nicalin,42369,-0.000556140324870376,0.00506391028144909,-0.0104814044765106,0.00936912382676984,0.912550403741778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42610,0.000215915154578005,0.00197110719680349,-0.00364745495115683,0.00407928526031284,0.912775806480146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40301,-0.000578539765223031,0.00528478442716342,-0.0109367172424633,0.00977963771201728,0.91282952976218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42369,-0.000620057401090325,0.00566462402619343,-0.0117227204924295,0.0104826056902488,0.912838241717218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,40064,0.000382640611810151,0.00350292809143055,-0.00648309844739373,0.00724837967101403,0.913018510339753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40301,-0.000744002860030983,0.00689347963938987,-0.0142552229532351,0.0127672172331732,0.914054365482729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42793,-0.000465132874386929,0.00436035800293171,-0.00901143456013308,0.00808116881135922,0.915049903025027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,40198,-0.000592538065927442,0.0055589266255988,-0.0114880342521011,0.0103029581202462,0.91511447169917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40135,-0.000613143137254747,0.00591650989972523,-0.0122095025407162,0.0109832162662067,0.917462837652025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42593,-0.000912971078984271,0.00884214373162989,-0.0182435727929789,0.0164176306350103,0.917764331213013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42345,0.000718219515564495,0.0069927923510076,-0.0129876534924104,0.0144240925235394,0.918195858976444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42171,0.000666173043752734,0.00650751493722974,-0.0120885562332176,0.013420902320723,0.918464730509393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40181,-0.000370133885211358,0.00362876249954514,-0.00748250838431983,0.00674224061389712,0.918758512334902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40079,0.000255323143052962,0.00263546144729671,-0.00491018129364858,0.0054208275797545,0.922823584449911
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42310,0.000591498506402005,0.00612795110022317,-0.0114192856500354,0.0126022826628394,0.923105350013496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,42260,0.000840215093780677,0.00871853565023294,-0.0162481147806759,0.0179285449682372,0.923227301846495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40115,-0.000369812800934808,0.00385644859569954,-0.0079284520485059,0.00718882644663629,0.923606000569754
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,42356,-0.000257550614584427,0.00269531862168915,-0.00554037511309515,0.0050252738839263,0.92387562500957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40115,-0.000552475417794828,0.00586009666260199,-0.0120382648764947,0.0109333140409051,0.924890431279307
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40198,-0.000793230866556963,0.00856784835342901,-0.0175862136392778,0.0159997519061639,0.926237113537904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40115,-0.000337810124131408,0.00370681005902329,-0.00760315783981705,0.00692753759155424,0.927389139578761
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,42369,-0.000364058638751891,0.00411172550508544,-0.00842304062871936,0.00769492335121557,0.929447590340758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,40079,-0.000516843974459799,0.00605428030231091,-0.0123832333669892,0.0113495454180696,0.931970117207579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,40115,0.00042648839310272,0.00504821022978272,-0.00946800365727141,0.0103209804434768,0.932673896490506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRL,Prolactin,42710,0.000614240338720835,0.00730481044082055,-0.0137031881252874,0.0149316688027291,0.932988424966834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40181,0.0004136161821025,0.00506519067106726,-0.00951415753318932,0.0103413898973943,0.934919719107845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40526,0.000200210925919709,0.00246524034541471,-0.00463166015109312,0.00503208200293254,0.935273556113006
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42584,0.000689420809686625,0.00851151944592558,-0.0159931573043275,0.0173719989237008,0.935444309088296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42710,0.000425508240009342,0.00530824416591727,-0.00997865032518851,0.0108296668052072,0.936111281648664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40115,-0.000512211501860221,0.0065488228566392,-0.0133479043008731,0.0123234812971526,0.937659031400826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,40510,0.000218411855790512,0.00292024400047335,-0.00550526638513726,0.00594209009671828,0.940381265777462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42720,0.000366554499057204,0.00521274787771126,-0.00985043134125687,0.0105835403393713,0.943940909454848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,42215,0.000509223202265233,0.00742884272981638,-0.0140513085481749,0.0150697549527053,0.945351440020993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,40198,0.000314649316433783,0.004628260902439,-0.00875674205234666,0.00938604068521423,0.945799326271657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42356,0.000556203403271784,0.00823706502467397,-0.0155884440450892,0.0167008508516328,0.946165212419969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40510,0.000699032332330581,0.0103848387791915,-0.0196552516748847,0.0210533163395458,0.946333894948948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,40526,-0.000602468308358836,0.0090648664348329,-0.0183696065206313,0.0171646699039136,0.947011257032218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,40301,0.000228543617246931,0.0034413601036002,-0.00651652218580945,0.00697360942030331,0.947051934999742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40482,-0.000348268796009461,0.00527453798562312,-0.0106863632478308,0.00998982565581186,0.947356460835277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40115,-0.0003129435048786,0.0047569223927282,-0.00963651139462588,0.00901062438486868,0.947548635348917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGN,Cingulin,40181,-0.000256218908782435,0.00403015404280309,-0.00815532083267649,0.00764288301511162,0.949309426523387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,40181,0.000442516704718111,0.0069739022324699,-0.0132263316709229,0.0141113650803591,0.949406746102472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,40064,-0.00025353120553196,0.00403946360213299,-0.00817087986571262,0.0076638174546487,0.949955919920839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40115,-0.000279608995054017,0.00446424267908041,-0.00902952464605162,0.00847030665594358,0.950059882141903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,40079,-0.000156187046612985,0.00256438759830846,-0.00518238673929758,0.00487001264607161,0.951435047709901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42593,-0.000556179216609297,0.00918657793338577,-0.0185618719660454,0.0174495135328268,0.951724399472145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,42474,0.000306803067579995,0.00518338597749972,-0.00985263344831946,0.0104662395834795,0.952801903055984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,40481,0.000145222290275441,0.0025181319536432,-0.00479031633886523,0.00508076091941611,0.954011998700371
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,40181,-0.000193860482818579,0.00338067260006387,-0.00681997877894376,0.00643225781330661,0.954272403940268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,40482,-0.000141921362450471,0.00254775617890176,-0.00513552347309792,0.00485168074819698,0.955578238488005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40301,-0.000336302843055342,0.00655409389826827,-0.0131823268836611,0.0125097211975505,0.959077928862771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,40181,-0.000161480422106833,0.0032731854937509,-0.00657692398985861,0.00625396314564494,0.960653756040684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,40222,0.000143633732154794,0.0029530682197997,-0.00564437997865262,0.00593164744296221,0.961208019252984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42593,0.000190565426910024,0.00414156247796183,-0.00792689702989516,0.00830802788371521,0.963300629403639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42574,0.0002241926400289,0.00509709723991938,-0.00976611795021309,0.0102145032302709,0.964917514544869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40079,-0.000151257782981971,0.0036015703542601,-0.00721033567733176,0.00690782011136782,0.96650127719887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42617,0.000131197962705809,0.00327010397078162,-0.00627820582002617,0.00654060174543778,0.967997714403256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,42369,0.000128162909287174,0.00322657737313049,-0.00619592874204859,0.00645225456062293,0.968316153881064
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40510,-0.000265233838553826,0.00699890599121793,-0.013983089581341,0.0134526219042333,0.969770895178726
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,40482,-0.000299374595031037,0.00796645846345416,-0.0159136331834012,0.0153148839933391,0.970023710692824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40079,0.000224925909068795,0.00618628045935259,-0.0119001837912623,0.0123500356093999,0.970996909429213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,40301,-0.000167693778270821,0.00599870239608194,-0.0119251504745914,0.0115897629180498,0.977698537120929
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,40198,-0.000112234483614271,0.00436437161163765,-0.00866640284242407,0.00844193387519553,0.979484272809667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42593,-0.00012028395790643,0.00476554210536331,-0.00946074648441852,0.00922017856860566,0.979863627212398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40181,0.000136849035709272,0.00547156981028129,-0.0105874277924421,0.0108611258638606,0.980046701684977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42191,0.00020538072041963,0.0083258886770769,-0.0161133610866511,0.0165241225274904,0.980320378795504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42593,-6.13875393872075e-05,0.00349789294881,-0.00691725771905482,0.0067944826402804,0.985998215946057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42237,3.3647691648201e-05,0.00193268153038244,-0.00375440810790138,0.00382170349119778,0.986109919083241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42678,-0.0001472855855924,0.00950421666754637,-0.0187755502539833,0.0184809790827985,0.987636012906703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,40079,1.83893957040718e-05,0.00452579338762615,-0.00885216564404318,0.00888894443545132,0.9967580849823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40198,-4.81874810494313e-06,0.00439337904012416,-0.00861584166674829,0.00860620417053841,0.999124883931001
